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Abstract 
Transfer of bacteria, including antibiotic resistant strains between companion animals and 
people is likely due to close physical contacts. However, surveillance programs on prevalence of 
antibiotic resistance are focused mainly on food animals and very little is known about the role 
of companion animals in the development and spread of antibiotic resistant bacteria. For this 
study, enterococci were chosen as model organism due to intrinsic and acquired antibiotic 
resistance and several virulence traits that make them the 3
rd
 most important nosocomial 
pathogens. In addition, increased fecal shedding of antibiotic resistant bacteria from stressed 
animals has been reported from studies on food animals. To determine whether the gut 
microbiota of pet animals serves as a reservoir of clinically important enterococci, 360 
enterococcal isolates from two groups: healthy group and pyoderma (stressed) group with 9 dogs 
in each were identified and screened for resistance to 10 antibiotics and 4 virulence traits. The 
transferability of resistance determinants and clonality of selected isolates were assessed by 
horizontal gene transfer assays and pulsed-field gel electrophoresis, respectively. In addition, 
overall diversity of bacteria as well as antibiotic and metal resistance genes in feces of healthy 
dogs was assessed by tag-encoded parallel pyrosequencing and microarray analysis, respectively. 
The most prevalent enterococcal species identified was E. faecalis: healthy group 
(70.5%); pyoderma group (44.0%). In the pyoderma group, antibiotic resistance and virulence 
traits (esp, gelE) were more frequent than in the healthy group; however, the overall prevalence 
of antibiotic resistant strains was low (< 37%) in both groups. The most prevalent resistance 
genes were tet(M)and tet(S). The antibiotic resistance traits were transferable in-vitro in E. 
  
faecalis (tetracycline, erythromycin, doxycycline) and E. faecium (tetracycline). Genotyping 
revealed less diverse E. faecalis community in pyoderma infected dogs.  
Pyrosequencing (~7,500 sequences per dog) revealed Firmicutes as the dominant phylum 
and most common genera included Turicibacter, Lactobacillus, Ruminococcus, Clostridium, and 
Fusobacterium. Two phyla Lentisphaerae (<1%) and Fibrobacteres (<1%) are reported for the 
first time from healthy dogs. Microarray data revealed the presence of several tetracycline, 
erythromycin, aminoglycoside, and copper resistance genes; however, most of these originated 
from one animal with history of chronic skin infection two year prior to our sampling.  
Higher prevalence of antimicrobial resistance in pyoderma infected dogs may be related 
to stress; however, this requires further investigation. In conclusion, based on our data, healthy 
and pyoderma infected dogs do not represent an important reservoir of clinically significant 
antibiotic resistant microbiota. 
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Abstract 
Transfer of bacteria, including antibiotic resistant strains between companion animals and 
people is likely due to close physical contacts. However, surveillance programs on prevalence of 
antibiotic resistance are focused mainly on food animals and very little is known about the role 
of companion animals in the development and spread of antibiotic resistant bacteria. For this 
study, enterococci were chosen as model organism due to intrinsic and acquired antibiotic 
resistance and several virulence traits that make them the 3
rd
 most important nosocomial 
pathogens. In addition, increased fecal shedding of antibiotic resistant bacteria from stressed 
animals has been reported from studies on food animals. To determine whether the gut 
microbiota of pet animals serves as a reservoir of clinically important enterococci, 360 
enterococcal isolates from two groups: healthy group and pyoderma (stressed) group with 9 dogs 
in each were identified and screened for resistance to 10 antibiotics and 4 virulence traits. The 
transferability of resistance determinants and clonality of selected isolates were assessed by 
horizontal gene transfer assays and pulsed-field gel electrophoresis, respectively. In addition, 
overall diversity of bacteria as well as antibiotic and metal resistance genes in feces of healthy 
dogs was assessed by tag-encoded parallel pyrosequencing and microarray analysis, respectively. 
The most prevalent enterococcal species identified was E. faecalis: healthy group 
(70.5%); pyoderma group (44.0%). In the pyoderma group, antibiotic resistance and virulence 
traits (esp, gelE) were more frequent than in the healthy group; however, the overall prevalence 
of antibiotic resistant strains was low (< 37%) in both groups. The most prevalent resistance 
genes were tet(M)and tet(S). The antibiotic resistance traits were transferable in-vitro in E. 
  
faecalis (tetracycline, erythromycin, doxycycline) and E. faecium (tetracycline). Genotyping 
revealed less diverse E. faecalis community in pyoderma infected dogs.  
Pyrosequencing (~7,500 (mean) sequences per dog) revealed Firmicutes as the dominant 
phylum and most common genera included Turicibacter, Lactobacillus, Ruminococcus, 
Clostridium, and Fusobacterium. Two phyla Lentisphaerae (<1%) and Fibrobacteres (<1%) are 
reported for the first time from healthy dogs. Microarray data revealed the presence of several 
tetracycline, erythromycin, aminoglycoside, and copper resistance genes; however, most of these 
originated from one animal with history of chronic skin infection two year prior to our sampling.  
Higher prevalence of antimicrobial resistance in pyoderma infected dogs may be related 
to stress; however, this requires further investigation. In conclusion, based on our data, healthy 
and pyoderma infected dogs do not represent an important reservoir of clinically significant 
antibiotic resistant microbiota. 
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Chapter 1 
 
Literature review 
 
1.1 Introduction 
Multi-drug resistance is an emerging problem in human pathogens, including zoonotic 
pathogens (Tenover et al., 1996; Akkina et al., 1999). Antimicrobial agents are routinely used to 
treat and prevent diseases in human and veterinary practices. Overuse and misuse of antibiotics 
provides tremendous selection, perhaps contributing spread of resistant clones, and acquisition of 
resistance determinants from resistant bacteria (Levy, 2002). Examples of common antibiotic 
resistant bacteria include MRSA (Methicillin resistant Staphylococcus aureus), MR-CoNS 
(Methicillin resistant coagulase negative Staphylococcus aureus), vancomycin resistant 
enterococci (VRE) and beta-lactam and macrolide resistant S. pneumoniae. The problem of 
antimicrobial resistance has been declared to be one of the top concerns of the U.S. Centers for 
Disease Control (CDC) (www.cdc.gov/ncidod/aip/research/ar.html).  
In the United States, the annual healthcare cost associated with the treatment of antibiotic 
resistant infections exceeds $4 billion/year (Stacey et al., 2003). A 2008 study that was carried 
out in a Chicago teaching hospital estimated the cost associated with treatment of antibiotic 
resistant infections in 188 patients accounted for between 13.35-18.75 million dollars (Roberts et 
al., 2009). This economic burden is associated with increased severity of illness due to treatment 
failure and long term hospitalization. Longer hospital stays caused increased healthcare costs and 
more exposure to antibiotics. There has increased severity of illness and mortality rate is also 
high.  
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Inappropriate use of antibiotics for therapeutic and prophylactic purposes is considered a 
significant contributor to emergence of antibiotic resistance in zoonotic pathogens (McGowan JE 
Jr. 1983) such as MRSA, VRE, and extended spectrum β-lactamase producing Escherichia coli. 
Commensal bacteria have become reservoirs of antibiotic resistance genes (Marshall, 2009). For 
example: Penicillin resistant Staphylococcus aureus which emerged after the introduction of 
penicillin, later became resistant to methicillin and then third generation penicillins. Similarly, 
there are other commensal bacteria such as Enterococcus species and Escherichia coli present in 
the intestinal tract of animals and humans that have emerged as antibiotic resistant pathogens 
globally and pose a threat to public health. Studies performed by Calva et al.,(1996) and Levy et 
al.,(1988) revealed a high frequency of antibiotic resistance among the fecal microbiota in 
humans (Salyers et al., 2004). Further, commensals can act as a source of horizontal transfer of 
resistance genes to pathogens. Similarly, clonal spread (Kuhn et al., 2000; van den Bogaard and 
Stobberingh, 2000) and transfer of resistant genes from animal bacteria to human bacteria (van 
den Bogaard and Stobberingh, 2000) is a concern associated with antimicrobial resistance among 
commensal bacteria.  
Resistance gene transfer between commensals and pathogens depends on several factors 
such as total number of donors and recipients, nutrition, selective pressure and transfer 
mechanisms. The gut gene pool is large, harboring diverse population of microbes and thus 
providing a suitable environment for antibiotic resistance gene transfer (Marshall, 2009). The 
level of resistance among gut commensals such as Enterococcus spp. is considered a good 
indicator of antibiotic resistance (Capriolo et al., 2000).  
During the recent decades, enterococci have gained considerable attention among public 
health officials because of their increasing antimicrobial resistance and as important nosocomial 
3 
 
pathogens. Enterococci are associated with a variety of infections such as bacteremia, urinary 
tract infections (UTI) and surgical wound infections (Murray, 1990) in humans. They are 
intrinsically resistant to antibiotics used in hospitals such as cephalosporins, lincosamides, 
nalidixic acid, and low level of clindamycin and aminoglycosides (Murray, 1990), which is 
believed to contribute to their ability to cause infection. Additionally, they readily acquire high 
level of resistance to antibiotics, including penicillin, high level aminoglycosides, vancomycin, 
chloramphenicol, erythromycin, high level clindamycin, tetracycline, and fluoroquinolones 
(Murray, 1990; Chow et al., 2000). These resistant bacteria or their resistance determinants may 
be transmitted from an animal reservoir to humans (Witte, 1998). 
A major factor associated with the dissemination of resistant determinants is selection 
pressure exerted by the use of antibiotics, selecting resistant bacteria by killing the susceptible 
ones. The removal of selection pressure will not eliminate the resistance genes from this bacterial 
population (Salyers and Amabile-Cuevas, 1997). This increase in the fitness cost in the absence 
of any antibiotic selection pressure allows rapid spread of antimicrobial resistant strains by 
replacing the susceptible ones (Enne et al., 2004; Luo et al., 2005). 
Besides selective pressure by the antibiotics, there are other factors such as “stress in 
animal” that can play a role in the prevalence of resistant bacteria in the gut (Moro et al., 2000; 
Moro et al., 1998; Molitoris et al., 1987). All bacteria including commensals, obligate or 
opportunistic pathogens within the host are subjected to stressful conditions. For example enteric 
bacteria have to overcome the effects of gastric acid (with varying pH depending on the diet of 
the individual), bile and organic acids, competing gut commensals (for binding the receptor sites 
and for nutrition), and host immune responses. Animals subjected to stressors such as infection, 
transportation, change in the environment, etc, can release stress hormones via the enteric 
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nervous system. Evidence indicates that these stress hormones enhance the bacterial growth and 
expression of virulence determinants in enteric pathogens (Lyte and Ernst, 1992; Lyte et al., 
1996) and affect intestinal functions such as decreasing gastric acidity (Bailey, 2010). 
Systemic surveillance and timely reporting of antibiotic resistance among bacteria has 
been developed by National antimicrobial resistance monitoring system for food animals and 
humans. However, the data from companion animals with regard to trends in the antibiotic 
resistant bacteria and risk assessments are absent or scarce. Pet animal numbers have 
substantially increased and based on market research statistics, the dog population accounts for 
72 million in USA (http://www.avma.org/reference/marketstats/sourcebook.asp). Direct contact 
with pet animals is considered a source of pathogenic bacteria for humans (Simoons-Sumit et al., 
2000). The risk factors responsible for the transmission of resistant bacteria to humans includes 
direct contact (petting, licking, physical injuries, etc.) or through the domestic environment 
(contamination of food, furnishings, etc.) (Guardabassi et al., 2004). Moreover, most of the 
antimicrobials used in small animal veterinary practice are used in human medicine as well and 
are regarded as critically important for human use (Heuer et al., 2005). Once the bacteria from 
the pet animals develop resistance to antibiotics used for human treatment, transmission of these 
resistant bacteria may become a public health concern. 
1.2 Zoonotic pathogens 
Zoonosis is defined as a disease or infection that is communicable between animals and 
man under natural conitions (WHO/FAO, 1959) and can affect humans or animals. The majority 
of the infections in humans are caused by the zoonotic pathogens. For instances, classification of 
1709 human infectious agents such as viruses, bacteria, prions, rickettsia, fungi, protozoa and 
helminthes revealed that 55% of them were zoonotic pathogens (Taylor and Woodhouse, 2000). 
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During the past three decades about 30 new human pathogens were detected and 75% of them 
were considered zoonotic (WHOb, 2006). Several factors contribute to the emergence of 
zoonotic pathogens: close physical contact between animals and man, advanced transportation, 
ecological and environmental changes and bioterroism (Murphy, 1998). In developing countries, 
growing populations of humans and animals provide suitable conditions for the microorganisms 
to adapt to human hosts (Bhatia and Narain, 2010). 
Zoonotic diseases impact the global economy. The World Bank estimated that a severe 
avian influenza pandemic could cause reduction in the cost of world‟s gross domestic product by 
$40 trillion to US $1.25 trillion (The World bank, 2008). Another example of global economic 
loss due to rabies in humans that is transmitted from dogs, which account for US$ 1 billion on 
rabies prevention programs (WHOa, 2007). From 2008-2010 the animals tested positive for 
rabies in Kansas State includes skunk, bovine, equine, fox, feline, bat, raccoon, sheep, goat,  
coyote, and bobcat (http://www.vet.k-state.edu/depts/dmp/service/rabies/2010/KS10_map.gif). 
For example, zoonotic pathogens include viruses (rabies, avian influenza, Japanese encephalitis), 
bacteria (salmonellosis, anthrax, leptospirosis), and parasites (toxoplasmosis, taeniasis, 
hydatidosis) with domestic and wild animals acting as a reservoir. Development of antimicrobial 
resistance in these zoonotic pathogens and the transmission of the antibiotic resistant zoonotic 
pathogens from animals to humans  is a public health concern. For example, MRSA of pig origin 
was detected in the severly diseased human patients (van Loot et al., 2007) 
1.3 Antimicrobial resistance 
Antimicrobial resistant bacteria has the ability to survive within the labeled drug dose 
because the systemic drug concentration of the agent will be lower than the MIC of the causative 
agent with normal drug dosage and/or fall in the range or where specific microbial resistance 
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mechanisms are likely and clinical efficacy has not been reliable in treatment studies 
(CLSI/NCCLS M31A2).  
Antibiotic resistance traits were present in the environment before the introduction of 
antibiotics for therapeutic use but were present only in the antibiotic producing microorganism 
(Levy, 1992). In order to overcome the inhibitory effect of these antibiotics, the nearby bacterial 
species might have developed resistance mechanism or acquired the resistance genes from their 
neighboring antibiotic producing bacteria. Moreover, conjugative plasmids in bacteria collected 
during the pre-antibiotic era were lacking the resistance determinants (Hughes et al., 1983).  
With the introduction of new drugs, resistant strains started evolving. The association 
between antibiotic use and its impact on resistance development has been discussed extensively 
(Kummerrer, 2004; Shea, 2004; Seveno et al., 2002; Barbosa et al., 2000).  
Therapeutic use of antibiotics in the treatment of human and animal infections eliminates 
not only the infectious organism but also the non-disease producing beneficial commensal 
bacteria, thus altering the natural microbiota and creating an imbalance between the susceptible 
and resistant strains. This disruption in the microbial ecology may lead to emergence of distinct 
populations of bacteria that are drug resistant variants of the same bacterial population that were 
already present or a different population of resistant bacteria (Levy, 1997). Once they acquire 
resistance, they reproduce giving rise to large numbers of resistant progeny in the presence of the 
antibiotic. 
There are multiple mechanisms by which a bacterium can be resistant to any drug. 
Resistance to the antimicrobials can be intrinsic or acquired (Guardabassi et al., 2006). Intrinsic 
resistance can be due to the lack of cellular mechanism required for the drug to have activity. 
Acquired resistance is mainly due to chromosomal mutation or through horizontal gene transfer. 
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Chromosomal mutations can lead to structural alterations such as active efflux pump 
(tetracyclines); enzymatic inactivation of antibiotics (beta-lactamase); alteration in cell wall 
impermeability (chloramphenicol); alteration in target sites (aminoglycosides); low drug affinity; 
or increased production of metabolites (sulfa drugs). The second mechanism, horizontal gene 
transfer can occur by three different ways: transduction, transformation and conjugation 
(Sorensen et al., 2005). Transduction is the process of phage mediated plasmid DNA transfer 
from one bacterium to another. Through transformation, naked DNA is transferred between the 
bacterial cells. Conjugational DNA transfer is mediated by F pilus and driven by the conjugative 
plasmids, transposons or integrative conjugative element from a donor to recipient cell. These 
resistant microbes can spread genes for resistance to other bacteria (Boerlin et al., 2007). Thus 
bacteria have diverse mechanisms to transmit resistance traits to other members of the same or to 
other species. 
After acquiring antimicrobial resistance genes, resistance transfer can occur irrespective 
of presence of antibiotics in the environment (Kruse et al., 1994). A bacterium can be resistant to 
multiple antibiotics due to the presence of different resistant determinants on the same genetic 
element or same genetic element conferring resistance to different antibiotics (Anderson et al., 
2010). 
1.4 Antimicrobial resistance in zoonotic pathogens 
The development of antimicrobial drug resistance among zoonotic bacteria has emerged 
as a major public health concern and tend to be associated with the use and overuse of 
antimicrobial agents in human and veterinary practices.  
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1.4.1 Food animals 
It has been reported that the use of antibiotics for the nontherapeutic purpose of growth 
promotion accounts for a significant fraction of total antibiotics used in United States (Mellon et 
al., 2001; National research council, committee on drug use in food animals, 1999). Antibiotics 
for growth promotion are fed to cattle, swine and poultry. There are reports where antibiotic 
resistant bacteria are found in associated animal food products and also in the farm workers. The 
environment is also considered as a potential pathway of resistant bacteria to humans where 
animal wastes are applied to agricultural fields (Smith et al., 2002). Food animals also act as 
reservoir hosts for some of the food-borne and zoonotic pathogens such as Salmonella, 
Campylobacter, Yersinia, Methicillin resistant Staphylococcus aureus, Enterococci and 
enterrohaemorhagic E. coli. There is considerable evidence that these antibiotic resistant bacteria 
of animal origin cause infections in humans (Neu, 1992; Witte, 1998) and are likely to be 
transferred through food chain. 
There are reports of transfer of resistant Salmonella spp. from animals to humans. Food 
animals such as cattle, sheep, goat, pigs and poultry can be carriers of Salmonella spp. in their 
intestinal tract. In the U.S, it is estimated that 95% of human Salmonella infections are acquired 
through food chain (Mead, et al., 1999). Some species of Salmonella such as Salmonella 
typhimurium cause serious enteric infections in animals. Therapeutic use of antibiotics in 
infected animals selects for resistance in these strains. Molecular typing of fluoroquinolone 
resistant Salmonella typhimurium DT 104 strains obtained from infected humans in Denmark 
was indistinguishable from a swine isolates (Molbak et al., 1999). Similarly, typing of 
ceftriazone resistant Salmonella typhimurium isolated from a diarrhic child revealed that the 
strain was of cattle origin (Fey et al., 2000)  
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Campylobacter jejuni and Campylobacter coli are commensal bacteria of cattle, poultry 
and swine and serve as a reservoir for human Campylobacter infections. In the U.S, 
Campylobacter is a leading cause of foodborne gastroenteritis (Mead et al., 1991). In the 
Netherlands, enrofloxacin was introduced in 1987 for therapeutic purposes in poultry. Endtz et 
al.(1991) studied the prevalence of antibiotic resistant Campylobacter jejuni from human stools 
from 1982-1989 and observed that the prevalence increased from 0%-11%; suggesting the 
possible transfer of resistant bacteria from poultry to man via food chain. 
Animals such as pigs, rodents, livestock and rabbits act as a reservoir for Yersinia 
(Gutman et al., 1993). The outbreak of Yersinia enterocolitica infection in U.S invoved several 
serotypes such as O:8; O:13a,b; O:3 and O:1,2,3 (Bottone, 1997; Stock and Wiedemann, 1999). 
Susceptibility patterns differ in the biogroups within the serotypes. In serotype O:8, biogroup 1B 
are resistant to carbenicillin, ticarcillin and cephalothin while 1A are resistant to 
amoxicillin/clavulonic acid (Preston etal., 1994; Ahmedy et al., 1985); in serogroup O:1,2,3, 
biotype 3 are resistant to amoxicillin/clavulonic acid and cefoxitin (Pham et al., 1991); and 
serotype O:3 are resistant to carbenicillin, ticarcillin and ampicillin (Pham et al., 1995). Perez-
Trallero et al., (1988) reported the transfer of Yersinia enterocolitica from animals to humans 
with reduced susceptibility to chloramphenicol. 
In the Netherlands, Canada, and the Unites States, high prevalence of MRSA is found in 
humans having direct contact with swine (van Cleef et al., 2010; Golding et al., 2010; Smith et 
al., 2009). For indigenous bacteria such as E. coli and enterococci, emergence of antibiotic 
resistance clones has been documented several times (Lewis et al., 2007; van der Auwera et al., 
1996). In humans, E. coli resistance to extended spectrum cephalosporins is of major concern 
due to their involvement in urinary tract infections (Pitout and Laupland, 2008) and pose a threat 
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to the drugs of last resort such as ceftazidime, cefepime and azetonam (Beovic, 2006). Among 
the enterococcal isolates in animal feces (pigs and chickens), emergence of glycopeptide 
resistance was assumed to be linked to avoparcin (glycopeptide feed addative) feeding in those 
animals (Klare et al., 1997). The majority of the glycopeptide resistant enterococcal strains 
causing outbreaks worldwide belonged to the clonal complex CC17 (E. faecium) that are 
characterized by their resistance to ampicillin (Willems et al., 2005; Top et al., 2008). 
1.4.2 Companion animals 
Pet animals also act as a reservoir for several zoonotic pathogens. Pet animals are 
considered a source for campylobacteriosis in humans, contributing about 6% of infections 
(Saeed et al., 1993). Damborg et al.,(2004) examined the clonality in Campylobacter jejuni in 
dogs and humans living in different geographical regions. Pulsed field gel electrophoresis 
(PFGE) revealed identical clones in dogs and humans, suggesting the clonal lineage in these 
hosts. 
There are various reports documenting dog-human transmission of MRSA (Cefai et al., 
1994; Simoons-Smit et al., 1997). Humans can acquire infection through contact with pets 
colonized with MRSA (Manian, 2003). Pets can also acquire MRSA from people. Genotyping of 
MRSA isolates from dogs and cats confirmed the isolates were indistinguishable to the human 
hospital acquired clones (Leonard and Marky, 2008). Staphylococcus pseudintermedius, 
indigenous flora present on the skin of dogs are reported to be found commonly among 
veterinary staff treating dogs and owners of dogs with dermatitis and pyoderma infections 
(Harvey et al., 1994; Guardabassi et al., 2004). In cases where pyoderma is a chronic and 
recurrent infection, prolonged antibiotic treatment can lead to development of resistance in 
Staphylococcus pseudintermedius.  
11 
 
Pet animals are considered to be responsible for 1% of reported Salmonellosis infections 
in humans annually in the U.S. (Stehrgreen and Schantz, 1987). Direct contact with pets, their 
feces, and commercial pet food treats and supplements are reported to be the possible routes for 
the transmission of Salmonella species from pets to man (Cherry et al., 2004; Health Canada, 
2006). In the U.S., genotyping of Salmonella isolates from an outbreak revealed 
indistinguishable PFGE profile in Salmonella typhimurium DT104 isolates from animal 
healthcare workers, pet owners and their pets. These strains exhibited penta-resistance phenotype 
(resistance to ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracycline) 
(Centers for Disease Control and Prevention, 2001)  
Similarly, Johnson et al.,(2001) compared the clonality and virulence genotype of E. coli 
isolates from canine UTI with human extraintestinal pathogenic E.coli. Most of the isolates of 
canine origin harboured the virulence determinants that were specific for human extraintestinal 
pathogenic E.coli. Pulsotype of E. coli isolates from canine UTI clustered with human 
extraintestinal pathogenic E.coli suggesting dog-human transmission of the coliforms. 
Willems et al.,(2000) used amplified fragment length polymorphism (AFLP) analysis to 
explore the genetic relationship between vancomycin resistant Enterococcus faecium isolated 
from various sources such as hospitalized patients, nonhospitalized people and different animals 
(dogs, cats, pigs, veal calves, chickens and turkeys). Isolates from non hospitalized patients 
(75%) clustered with all pig isolates (100%) while isolates from hospitalized patients (84%), 
dogs (100%), cats (100%) and veal calf (25%) formed a separate cluster. 
These studies indicate an increasing concern for transfer of these resistant zoonotic 
bacteria from pet animals to humans.  
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1.5 Epidemiology of antimicrobial drug resistant bacteria in dogs 
There are studies reporting antimicrobial resistance in bacterial species recovered from 
pet animals. Lloyd et al.,(1996) reported that coagulase positive Staphylococcus recovered from 
skin, ear and mucosa infections in dogs over 1980-1986 showed increased resistance to penicillin 
(69-89%), and oxytetracycline (40%). While the isolates collected from 1987-1989 showed a 
20% increase in the antimicrobial resistance prevalence for the antibiotics erythromycin and 
lincomycin and a 15% increase to sulphonamides/trimethoprim.  
Normand et al.,(2000) studied antimicrobial resistance trends for Escherichia coli and 
Staphylococcus species isolated from clinical cases of canine and feline origin in the United 
Kingdom. These cases included the samples received by a diagnostic laboratory from 1989-1997 
for culture and sensitivity testing. They found a significant rise in antibiotic resistant Escherichia 
coli showing resistance to amoxicillin, amoxicillin-clavulanic acid and streptomycin; as well as 
increasing resistance to erythromycin among the Staphylococcal species. For Staphylococcal 
spp. a decreasing trend in resistance was observed for ampicillin and penicillin. 
A study was conducted in Sweden by Holmes et al.,(2002) to compare the resistance 
profile of Staphylococcal spp. from the canine pyoderma cases isolated from the first infection 
and recurrent infections during 1995-1996. The isolates that were resistant to three or more 
antibiotics were defined as multidrug resistance. There was a significant increase in resistance 
for macrolides, lincosamides, fusidic acid and streptomycin from recurrent cases compared with 
the first infection. Forty five percent of isolates from recurrent cases had multidrug resistance 
profiles while only 20% of isolates from first infection had multidrug resistance.  
Prescott et al.,(2002) determined the prevalence of antibiotic resistant, coagulase positive 
Staphylococcus aureus in clinically infected dogs from 1984-1998. A significant increase in 
13 
 
resistance towards cephalothrin, enrofloxacin and gentamicin and decrease in penicillin and 
ampicillin resistance were observed among these isolates. While no change in trend was 
observed for clindamycin and erythromycin resistance. This fluctuating trend in the resistance 
patterns of Staphylococcus aureus was correlated to the type of antibiotic used.  
Several multidrug resistant gram negative bacteria such as Actinobacter baumannii and 
Salmonella enterica have also been identified in hospitalized dogs (Tillotson et al., 1997). In 
Switzerland, the nosocomial pathogen, Actinobacter baumannii was isolated from clinically 
diseased dogs. Genotypic fingerprinting by restriction polymorphisms of ribosomal DNA 
suggested this pathogen was responsible for the infections (Francey et al., 2000).  
1.6 Sources for acquisition of antibiotic resistant pathogens 
The major source for acquisition of antibiotic resistant pathogens is the use of antibiotics  
in human and agriculture practices. In human medicine, a patient admitted to the hospital can 
acquire resistant bacteria from the hospital through various sources such as instruments, and 
workers hands. Once the patient is discharged, the antibiotic resistant bacteria persist and can act 
as a source for household transmission of resistant bacteria to other individuals.  
Antibiotics in agriculture are used for veterinary practices, feed additives and biocides for 
crop production. These chemicals can enter the environment through various routes such as 
disposal of drugs and containers, disposal of waste from drug manufacturing plants, and 
application of animal waste on the farm as a source of manure (Buchberger, 2007; Utah 
Department of Health, 2007; Daughton, 2004). Much of the antibiotics fed to the animals are not 
absorbed and are excreted in the feces as parent compound and its breakdown metabolites 
(Boxall et al., 2004; Feinman and Matheson, 1978). It has been reported that about 25% of orally 
administered tetracycline is excreted in the feces and 50-60% in urine indeed, 67% of 
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administered tylosin is excreted via feces (Feinman and Matheson, 1978). Once the animal waste 
is applied to the land, antibiotics can be carried through surface and ground waters (Krapac et al., 
2004; Yang and Carlson, 2003). The use of water from these sources for vegetation and human 
use can transmit these resistant pathogens to humans causing public health concerns. There are 
also reports of antibiotic drug residues in meat which can also be a threat to human health and 
companion animals fed on it (Martínez, 2005). 
1.7 Stress 
Stress is a non specific response of the body to external stimuli such as psychological or 
physical stimuli that disrupts the internal homeostasis (Bhatia et al., 2005). Stress was first 
described by Seyle in (1936) who used a rat model and observed rats exposed to stressors such as 
nocuous environmental factors responded with a symptom termed “General Adaptation 
Syndrome” irrespective of the type of stimuli. This symptom is divided into three stages: 
Exposure to a stressor results in alarm stage that is characterized by hyperfunction of the adrenal 
glands. The second stage is the “resistance stage” during which the body remains alert and the 
animal become resistant to that particular stressor and the body continues to function normally. 
The last stage is the “stage of exhaustion” during which the animal fails to maintain homeostasis 
resulting in loss of resistance and may result in illness (Seyle, 1937; Seyle, 1946).    
1.7.1 Animal stress and bacteria 
Stress in animals can be caused by external factors, nutritional or physiological disorders 
(Siegal, 1995), inadequate nutrition, heat, cold, overcrowding, handling, transportation, 
unfamiliar environments (visit to a clinic) and ill state (Roatango, 2009). Stress imposed on an 
animal host can cause impairment in the growth, development, or reproduction (Hochachka & 
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Somero, 2002) and can suppress the immune system increasing vulnerability to infections 
(Moberg, 2000).  
In response to stressors, the hypothalamic-pituitary-adrenal axis is stimulated leading to 
secretion of “stress hormones”; catecholamines (epinephrine and norepinephrin), 
adrenocorticotrophin and glucocorticoids (cortisol and corticosteroid) (Axelrod and Reisine, 
1984; Greenberg and Wingfield, 1987). These hormones can be responsible for increased 
severity and susceptibility of infection associated with stress in humans and animals (Dreau et 
al., 1999; Groves, et al., 1973). Studies have revealed that catecholamines administered in 
healthy subjects caused increased severity of Clostridium perfringenes infection in humans and 
enterohemorrhagic Escherichia coli in calves (Lyte, 2004; Vlisidou et al., 2004; Williams et al., 
2006). Norepinephrin treatment also increases virulence in bacteria, including Salmonella 
enterica (Methner et al., 2008), Campylobacter jejuni (Cogan et al., 2007) and E. coli O157:H7 
(Dowd, 2007). Additionally, stress in swine has a role in colonization and fecal shedding of 
pathogens such as E. coli (Moro et al., 1998; Moro et al., 2000). Stress in these animals 
increased the intestinal motility and fecal shedding of resistant E. coli harboring the lower GIT. 
In piglets, stress in reponse to weaning and cold stress has increased antibody titer and fecal 
shedding of E. coli (Jones et al., 2001). 
The above studies suggest that stress in the animals cause alterations in the GIT 
functions, expression of virulence genes, increased colonization and fecal shedding of resistant 
bacteria.  
1.7.2 Stress and gastrointestinal tract (GIT) 
The enteric nervous system (ENS) is invervated within the wall of the GIT. The ENS 
programs the different functions of the GIT such as microcirculation, motility and exocrine and 
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endocrine secretions. The enteric nervous system forms the gut-brain axis with the central 
nervous system (brain and spinal cord) by connecting through the sympathetic and 
parasympathethic nervous systems. During physical and psychological stress, neuroendocrine 
mediators are released from the central nervous system and endocrine system. The hypothalamus 
releases corticotrophin releasing hormone which stimulates adrenocorticotrophin secretion from 
the pituitary which in turn stimulates the release of glucocorticoids from the adrenal gland 
(Burnett, 2005). These neuroendocrine mediators example norepinephrin are released in the gut 
by the gastrointestinal neurons. About half of the total norepinephrin produced in the body might 
be in the ENS (Aneman et al., 1996).  
Several studies done involving E.coli suggests that norepinephrine (NE) released by the 
ENS under stress increases growth, iron acquisition, and motility among the bacteria. NE also 
causes increased expression of certain virulence factors such as type III secretion, Shiga like 
toxins and locus of enterocyte effacement (LEE) encoded proteins in enterohemorrhagic E. coli 
O157:H7 (Freestone et al., 2003; Lyte et al., 1997; Dowd, 2007; Sperandio et al., 2003) and K99 
pilus adhesion in enterotoxigenic E. coli (Lyte 1997). It has been also demonstrated in 
Salmonella that NE increases motility, expression of iron uptake genes (Bearson et al., 2008; 
Bearson et al., 2008; Karavolos et al., 2008), and stimulates the invasion of porcine jejunal 
explants (Green et al., 2003). Thus NE released in the gut in response to host stress, seems to 
contribute to the the pathogenicity of enteropathogens.  
These mediators are responsible for inducing alterations in gastrointestinal functions 
(Enck, et al., 1989), thus altering the microenvironment of the gut. Stress induces a variety of 
disturbances in the GIT such as alterations in gut microbiota, changes in intestinal motility, 
decreased gastric acid secretion (Hayase and Takeuchi, 1986), increased intestinal permeability 
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(Kiliaan et al.,1998) and increased susceptibility to colonic inflammation. Stress can also cause 
alterations in the normal gut microbiota that prevent pathogen colonization by competitive 
exclusion and induction of antimicrobial peptides production (defensins and IgA in the animal 
host which aid inprotecting the host from colonization of pathogen by competitive exclusion and 
induce production of antimicrobial peptides such as defensins and IgA (Guarner and Malagelada, 
2003). Stressor-induced reduction in Lactobacilli has been demonstrated in mice during 
rehousing into new cages (Schaedler and Dubos, 1962). This reduction in the number of lactic 
acid bacteria may increase the susceptibility of host to enteric infections as these bacteria, eg. 
Lactobacillus species are contributors to microbiota mediated colonization exclusion. Bailey et 
al.,(2006) reported overgrowth of Enterobacteriaceae in the small and large intestine and cecum 
of mice when they were restraining for prolonged period. Similarly, changes in the GIT functions 
such as decreased gastric acid production will increase the pH in the stomach, which may 
increase survival and colonization of food-borne pathogens to survive and colonize in the gut. 
Stress-induced increase in the intestinal permeability leads to greater probability of bacterial 
translocation in GIT. Gastrointestinal motility is thought to facilitate normal cleansing 
mechanism of the intestine (Gangrosa, 1977). Decreased motility can result in replication of 
pathogens and their invasion of host tissue. Therefore, stress induced alteration of the normal 
intestinal microbiota will reduce the host‟s innate immune mechanism increasing the potential 
for proliferation of pathogenic bacteria or creating niches for opportunistic proliferation of 
normal, commensal species. 
Quorum sensing is a cell-to-cell signaling mechanism of bacteria. In this process, each 
cell produces and releases chemical molecules known as autoinducers. When the density of the 
bacterial population increases and the level of autoinducers reach a critical threshold 
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concentration, it leads to alteration in the bacterial gene expression (Miller and Bassler, 2001). 
Sperandio et al.,(2003) observed that the normal GIT microbiota produces the quorum sensing 
AI-3 signalling cascade in response to host stress hormones, which in turn activates the 
expression of bacterial genes essential for colonization of the host intestine. 
1.7.3 Association between stress and antimicrobial resistance in the gut microbiota 
There are some reports documenting stress under transport, overcrowding in pens and 
rough handling in food animals before slaughter associated changes in the antimicrobial 
resistance phenotypes in the gut microbiota. Molitoris et al., (1987) studied the changes in the 
antimicrobial resistance prevalence in fecal coliform and fecal streptococci in pigs with a variety 
of transit and holding time at slaughter houses. Comparison of streptococcal and coliform 
isolates from the live pigs at slaughter houses and pigs at farms revealed that antimicrobial 
resistance in streptococcal and coliform isolates were much higher in the slaughter house pigs 
after short transit time (2 hours) and long holding time. Long holding time (39 hours) of pigs also 
increased the rate of resistance gene transfer in coliforms. Thus, transit and holding stress in pigs 
increased the proportions as well as resistance transfer ability of antimicrobial resistant strains of 
E. coli . 
Effect of loading and transportation stress on the prevalence of antibiotic resistant fecal 
Gram negative enteric bacteria in pigs was reported by Langlois and Dawson,(1999). They 
observed a significant increase in the proportion of these antibiotic resistant bacteria. Further, the 
mean number of antimicrobial agents these bacteria were resistant to also increased, in 
association with loading and transportation for 30 min.  
Langlois et al.,(1988) studied the effect of age and housing location on antibiotic 
resistance of fecal coliforms from pigs that had no prior contact with antibiotics for 126 months. 
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Pigs less than seven months of age and the pigs housed in the finishing unit had a higher level of 
antibiotic resistance as compared to older pigs and the pigs housed in the farrowing house, 
respectively. Greater than 80% of isolates from pigs under 6 months were resistant to 
tetracycline, streptomycin and sulfisoxazole. Pigs in the finishing unit harboured fecal coliforms 
that were significantly more resistant to ampicillin, tetracycline and carbenicillin as compared to 
pigs in the farrowing pen. 
According to Hedges and Linton,(1988), simply moving the animal in and out of their 
pen changed the antimicrobial resistance frequency. The antimicrobial resistance prevalence in 
E. coli was studied within group of pigs not exposed to antibiotics for 156 months. Withdrawal 
of subtherapeutic feeding of antibiotics for 13 years showed progressive decrease in the 
prevalence of antibiotic resistant E. coli. However, transportation of these animals caused a 
significant increase in antibiotic resistant E.coli despite the fact that they were still on the 
nonantibiotic diet (Langlois et al., 1986). 
Moro et al.,(1998) found a 6-27% increase in resistance to ampicillin and tetracycline 
among E. coli from the fecal samples in a swine herd exposed to excessively cold conditions. 
The same authors investigated the effect of heat stress on the prevalence of antibiotic resistant E. 
coli from the intestinal tract of swine and showed an increased level of antibiotic resistant E.coli 
in pigs kept at +34ºC for 24 hours as compared with isolates from a control group. Stress also 
increased the incidence of multiple drug resistance in these isolates as compared to their 
resistance profile prior to stress exposure. They further demonstrated that increased intestinal 
motility increased the occurrence of resistant E. coli in the colon and rectum. These stressed 
animals had reduced intestinal transit (Moro et al., 2000). 
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In a study by Minton et al.,(1983), antibiotic resistant fecal coliforms were isolated 
during acute phase of enteritis from a 10 month old dog that had never been exposed to 
antimicrobial agents. After restoration of animal to normal health, the coliform isolates had lost 
their resistance to several antibiotics. 
These studies suggest that stress can increase the prevalence of antibiotic resistance of 
bacteria in the gut.  
1.8 Enterococci, the opportunistic pathogen 
Enterococci are gram positive facultative anaerobes occurring singly, in pairs or short 
chains. The genus Enterococcus belongs to the phylum Firmicutes, class Bacilli, order 
Lactobacillales and family Enterococcacaceae. These gut commensals are present in the intestine 
in numbers as high as 10
8 
colony forming units per gram of feces but account for less than 1% of 
total intestinal microbiota (Jett et al., 1994). Enterococci can tolerate a wide range of 
temperatures (10°C-45°C or up to 60°C for 30 min) (Hancock et al., 2000) or pH of 9.6. They 
are also tolerant of high salt (6.5%) and bile concentrations (40%). Their resistance to chemical 
and physical stress aids in survival outside the natural host for long periods (Kuhn et al., 2000). 
Viable enterococci have been recovered from inanimate objects for up to 4 months (Went et al., 
1998).  
There are 37 species classified under this genus. E. faecalis is the most prevalent 
enterococci found in the gut of dogs. Other species may include E. faecium, E. avium, E. hirae, 
E. cecorum (Gilmore, 2002). These organisms are responsible for a variety of nosocomial 
infections including urinary tract infections, bacteraemia, endocarditis, neonatal sepsis, intra 
abdominal and pelvic infections and meningitis (Marothi et al., 2005). In humans E. faecalis and 
E. faecium are the most common pathogens, 60% and 40%, respectively (Hidron et al., 2008; 
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Top et al., 2007). E. faecium exhibit resistance to more antibiotics (Kawalee et al., 2001; 
Harbarth et al., 2002; Tokars et al., 2001; Mundy et al., 2000).  
1.8.1 Antibiotic resistance in enterococci 
Enterococci are commensal inhabitants of the GIT of humans and animals. Although a 
variety of enterococcal species are present in healthy individuals, enterococci are also 
opportunistic pathogens causing infection under certain conditions such as an impaired immune 
response. They are one of the leading cause of nosocomial infections in humans (Huycke et al., 
1998) ranking as the second most common agent of blood, third in catheter associated urinary 
tract infections, tenth in ventilator associated pneumonia, third in surgical site infections (Hildron 
et al., 2008; Wisplinghoff et al., 2004) and the second leading cause of endocarditis in U.S. 
(Huycke et al., 1998). VRE is a serious problem from public health point of view as they are 
capable of transferring vancomycin resistant vanA to other bacteria such as Staphylococcus 
aureus (Weigel et al., 2003). They have been observed to spread their resistance genes to other 
species including Listeria monocytogenes, and Bacillus species (Kuhn et al., 2000; Leclercq et 
al., 1996). Thus antibiotic resistant enterococci are a serious threat to public health from the 
perspective of treatment failure. 
The factors that limit the choice of antimicrobial for the treatment of these organisms 
include intrinsic resistance to antibiotics and ability to acquire resistance to antibiotics including 
chloramphenicol, erythromycin, tetracycline and vancomycin primarily through conjugation 
(Walsh, 2000).  
Enterococci are intrinsically resistant to most beta-lactam antibiotics. These cell wall 
active antibiotics (penicillins, cephalosporins) were used in combination with aminoglycosides 
(streptomycin, gentamicin, kanamycin) in the treatment of enterococcal infections. In the early 
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1970‟s, streptomycin resistance followed by gentamicin resistance was reported in enterococci 
thus exhibiting resistance to cell wall active antibiotics-aminoglycosides combination 
(Mollering, 1990). In 1983, Murray and Mederski-Samoraj reported the β-lactamase determinant 
in E. faecalis that was believed to be acquired from Staphylococcus aureus and resulted in major 
concern associated with treatment. 
Emergence of vancomycin resistant enterococci provided another therapeutic challenge. 
Vancomycin is an antibiotic of last resort in the treatment of Gram positive bacterial infections 
including enterococcal infections. Emergence of vancomycin resistant enterococcal strains and 
the risk of transmission of resistance genes to the susceptible bacteria poses a serious risk to  
public health (Pearson, 2002). Presence of VRE in clinical patients results in a 20% increase in 
treatment failure, and mortality is also increased from 27-52% (Brown et al., 2006); Walsh, 
2000).  
The contribution of enterococci to the problem of antimicrobial resistance is associated 
with its ability to pass the resistance determinants to other bacteria of the same species or 
different species by the process of conjugation. Thus, resistance gene transfer to pathogenic 
species and emergence of new type of resistance is a serious concern associated with these 
bacteria. Genome sequences have revealed that one-fourth of the total genome of E. faecalis 
V583 is composed of mobile genetic elements (Paulsen et al., 2003). About three to five 
coresident plasmids are commonly found in clinical isolates (Dunny et al., 1981; Tomich et al., 
1979). 
The sex pheromone system in E. faecalis plays an important role in activating the 
conjugative system and transfer of pheromone inducible plasmids. There are two types of 
conjugative plasmids present in enterococci: pheromone responding plasmids and the plasmids 
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that do not use pheromone signals for conjugal transfer. Pheromone inducible plasmids are 
conjugative elements present in the donor cells that respond to the pheromone produced by the 
recipient cells and initiate the mating process. Pheromones are peptides made of 7-8 amino acids 
and are encoded on the chromosome of most of the E. faecalis strains. Pheromones are produced 
from the donor and recipient cells but the donor synthesizes inhibitor peptides to prevent self 
induction. The donor produces pheromone binding protein on its cell surface. The pheromone 
binding protein recognizes the pheromone produced by the recipient cells and this protein along 
with a chromosomally encoded oligopeptide permease system import the pheromone into the 
cytoplasm of the donor cell. Transport of pheromone into the donor cell and its binding to a 
negative regulator of expression of transfer genes stimulates the induction process in the donor 
cell. Thus there is activation of conjugal gene expression along with cell surface adhesin. This 
cell surface adhesin mediates cell to cell contact followed by formation of a mating channel 
between the donor and recipient cell through which the plasmid transfer occurs. After acquisition 
of the plasmid by the recipient cell, synthesis of cell surface adhesion stops, and expression of 
inhibitor peptides and negative regulator of expression of conjugation function begins (Chandler 
et al., 2004). Each E. faecalis strain possesses only one pheromone plasmid and it will not 
excrete the corresponding pheromone. However, it can excrete another pheromones 
corresponding to other pheromones plasmids that it lacks. Thus the strains can accumulate many 
conjugal plasmids (Wirth, 1994). These plasmids are encoded by antibiotic resistance and 
virulence traits such as hemolysin and bacteriocin. Thus E. faecalis can be a gene pool for other 
bacteria (Clewell, 1981). 
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1.8.2 Virulence factors 
There are several virulence factors associated with the pathogenecity of these species 
example host cell attachment (aggregation substance, enterococcocosal surface protein) and cell 
and tissue damage (cytolysin, gelatinase). Gelatinase, a zinc metalloendopeptidase can hydrolyse 
host collagen which helps in formation and remodeling of tissue through its extracellular matrix 
degrading function. It provides nutrients to the bacteria by degrading the host tissue (Gilmore, 
2002). Unregulated activity of gelatinase causes several pathological conditions. Reports indicate 
the involvement of gelE in the severity of systemic diseases (Eaton et al., 2001).The regulation 
of the protease, gelatinase occurs through a quorum sensing system encoded by fsr (fecal 
streptococci regulator), a locus similar to staphylococcal agr locus (Peng et al., 1998). Bacterial 
population communicates via production of autoinducing peptides, which increase in 
concentration as the cell density increases. These peptides enter/reenter the cells and causes 
transcription regulation (Alksne and Projan, 2000; Gobbetti et al., 2007). The fsr locus is 
comprised of three genes: fsrA, fsrB, fsrC. In this system, GBAP (gelatinase biosynthesis 
activating pheromone), an autoinducer peptide is synthesized by fsrB. The gelE gene encoding 
gelatinase is located downstream of fsrC. GBAP interacts with fsrC, a signal transducer and 
cause phosphorylation of fsrA, the response regulator. This is followed by the autoregulation of 
gelE gene (Gilmore, 2002). 
 Cytolysin and aggregation substance are encoded on conjugative elements. Cytolysin 
causes lysis of erythrocytes and is encoded on pheromone responsive plasmids near the genes for 
aggregation substance or within pathogenecity islands in close proximity to the esp gene 
encoding enterococcal surface protein (Shanker et al., 2002). Expression of cytolysin is regulated 
by a quorum sensing system. Aggregation substance, a surface glycoprotein induces the 
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clumping of bacterial cells. Along with other virulence factors such as enterococcal surface 
protein, aggregation substance mediates the adhesion of bacteria on the host cell surface. When 
the cell density increases to a level required for quorum sensing, it results in autoinduction of 
cytolysin (Gilmore, 2002). 
Aggregation substance is a pheromone responsive surface protein produced by E. 
faecalis. During the process of conjugation, aggregation substance is produced by the donor cell 
in response to pheromone produced by the recipient cell. This facilitates close cell to cell contact 
between donor and recipient cell resulting in the clumping and transfer of conjugative plasmids 
between the cells (Jett, 1994). In addition to conjugal transfer mechanism, it also helps in the 
binding of bacteria to the host cell (Kreft et al., 1992). Sussmuth et al.,(2000) has shown that 
aggregation substance helps the bacterium to invade the host immune system by opsonin 
independent binding, adhesion, and internalization of E. faecalis by macrophages. In the same 
study, the authors also showed that aggregation substance positive strains were able to escape 
from phagocytosis by inhibiting the respiratory burst. 
Enterococcocal surface protein (esp) is associated with the bacterial cell wall. The close 
proximity of esp to cytolysin operon which is regulated by a quorum sensing mechanism, helps 
in the biofilm formation due to the accumulation of large number of bacteria. Esp also 
contributes to cell adhesion, colonization, and evasion of immune system (Moreno et al., 2006). 
1.9 Epidemiology of antibiotic resistant (AMR) enterococci in dogs 
Enterococci are a leading cause of nosocomial infections in humans (Richards et al., 
2000) including urinary tract infections, hepatobiliary sepsis, endocarditis, surgical wound 
infection, bacteremia and neonatel sepsis (Poh et al., 2006). In the U.S., the therapeutic cost 
associated with treating ~800,000cases/year of enterococcal infections is estimated to be $0.5 
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billion (Tendolkar et al., 2003).  The following reviews the studies done on antibiotic resistant 
enterococci isolated from dogs from different parts of the world. 
1.9.1 United States 
Simjee et al., (2002) studied AMR in clinical enterococcal isolates from dogs. Urine 
samples were collected from dogs with UTI at Michigan State University Veterinary Teaching 
Hospital. A total of 35 enterococcal isolates were recovered and evaluated for susceptibility to 
gentamicin, vancomycin, erythromycin, penicillin and tetracycline antibiotics. The isolates 
belonged to four different species: E. faecium (n=13), E. faecalis (n=7), E. gallinarum (n=11), E. 
casseliflavus (n=4). Most isolates were resistant to three or more antibiotics. One E. faecium 
isolate showed high level resistance to gentamicin, vancomycin, tetracycline and penicillin. 
Molecular and PFGE analysis revealed the presence of the transposon Tn1546 carrying vanA 
gene, which has been reported to be found only in human vancomycin resistant isolates in the 
U.S. 
In a recent report, 420 enterococcal isolates were recovered from nasal, teeth, rectal, belly 
and hindquarters of clinically healthy (155) dogs and (121) cats that came to veterinary clinics in 
Athens, GA, (Jackson et al., 2009). A total of 80% of dogs and 60% of cats were positive for 
enterococcal isolates. E. faecalis was the most dominant species in dogs and E. hirae from cat 
samples. Based on the antimicrobial susceptibility testing for 17 antibiotics, the highest level of 
resistance was observed to ciprofloxacin, chloramphenicol and gentamicin in dog samples while 
in cat samples resistance was observed for nitrofurantoin. Multidrug resistance was observed to a 
minimum of 2 and maximum of 8 antibiotics. The same authors studied the mechanism of 
antimicrobial resistance. Among the tetracycline resistant strains, five tet genes were detected 
with tet (M) (60%) being the most prevalent. About 96% of erythromycin resistant strains 
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harboured erm (B). The majority of kanamycin resistant isolates were positive for aph(3’)-IIIa 
gene. Gentamicin and streptomycin resistant isolates showed the presence of bifunctional 
aminoglycoside resistance gene, aac(6’)-Ie-aph(2’) and ant(6’)-Ia, respectively. PFGE analysis 
revealed genetic relatedness of AMR enterococcal strains. Dogs and cats from the same 
geographical area share the same profile, indicating the possibility of exchange of resistance 
traits and resistant bacteria between dogs and cats. About 80% of the dogs positive for 
enterococci were boarded at the clinic. The authors concluded that this increased MDR 
enterococci isolated from different body parts could be a source of infection in humans. 
1.9.2 European countries 
Denmark 
Damborg et al.,(2008) monitored the prevalence of antibiotic resistance in indicator 
bacteria: E. coli and Enterococcus spp. in healthy dogs. Fecal swabs were collected from 127 
dogs and all  E. coli (n=117) isolates were screened for resistance to 12 antibiotics, and E. 
faecalis (n=51) and E. faecium (n=10) isolates were screened for 10 antibiotics. Based on the 
questionnaire study, a significant association was observed between the antibiotic treatment and 
resistance in E. coli. Ampicillin resistant E. faecium was found in two dog fecal swabs. 
Genotyping of these two isolates by multilocus sequence typing revealed that two isolates 
belonged to sequence types including those associated with human nosocomial infections and 
one isolate was related to clonal complex 17, an important nosocomial pathogen. 
Belgium 
Devriese et al.,(1996) examined the prevalence of Vancoycin resistant enterococci in 
animals including pet animals from 557 different farms/homes. Vancomycin resistant E. faecium 
was isolated from fecal samples of horses, dogs, chickens, and pigs. Eight percent of E. faecium 
from dog samples were positive for vancomycin resistance. It was concluded that pet animals 
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could have acquired vancomycin resistant E. faecium from the feeding of meat products 
originating from the farm animals fed with a glycopeptides antibiotic avoparcin as growth 
promoter.  
De Graef et al.,(2004) determined antimicrobial susceptibility patterns among E. coli and 
E. faecalis from healthy individually-owned and kennel dogs. Isolates were collected from dogs 
of 92 different owners and 8 breeding kennels. Resistance to antibiotics tested was higher in the 
E. coli strains from kennel as compared to individually owned dogs. Among E. faecalis, 
resistance was observed for gentamicin with high level resistance for tetracycline, and 
macrolides. 
The Netherlands 
Wagenvoort et al.,(2003) conducted a study to determine the prevalence of vancomycin 
resistant enterococci in sick urban dogs of Parkstead Limburg, Netherlands. No VRE was 
recovered from rectal swabs of 100 diseased dogs.  
Finland 
A study by Rantala et al.,(2004) evaluated AMR in canine Staphylococci, E. coli and 
Enterococci. The study included two groups: treatment group (n=22) that included dogs with 
pyoderma infection that received antibiotics and the control group (n=56), which were not 
exposed to antibiotics for at least for 6 months prior. E. coli and Enterococcus spp. were isolated 
from faecal samples and Staphylococci from perianal mucosal swab. The total number of 
colonies isolated for each species was 2 per sample. Susceptibility testing revealed that 
staphylococcal and E. coli isolates from pyoderma dogs were more resistant to sulphamethoprim 
than the control dogs. Among the enterococcal isolates from both the groups, ampicillin 
resistance was low (4-7%) and all the enterococcal isolates were resistant to vancomycin.  
New Zealand 
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Manson et al.,(2003) reported vancomycin resistant E. faecalis (VREF) from a dog with 
mastitis infection. The isolate harbored vanA, erm (B), and tet (M) genes encoding vancomycin, 
erythromycin and tetracycline resistance, respectively. Pulsotyping and comparison of this 
isolate with poultry and human VREF isolates from New Zealand revealed clonal lineage of 
VREF. The isolate also harbored the trasnposon Tn 1546. 
Portugal 
Poeta et al.,(2005) evaluated the mechanism of vancomycin resistance in fecal 
enterococci from healthy dogs, poultry, humans and wild animals. A multidrug resistant E. 
faecium containing vanA was detected from one dog of 71. This isolate showed resistance to 
vancomycin (MIC>128 mg/L), teicoplanin (MIC-64mg/L), ampicillin, kanamycin, tetracycline, 
erythromycin and ciprofloxacin. They also identified vanA among fecal enterococci from poultry 
and humans. All isolates from wild animals were negative for the presence of the vanA gene. 
The same authors evaluated the antimicrobial resistance and mechanism of resistance in 
fecal enterococci from healthy dogs, poultry, and humans that were not exposed to antibiotics for 
4 months prior to sample collection. Among the collection of 440 enterococcal isolates, E. 
faecium (n=227), E. faecalis (n=177), E. hirae (n=32) and E. durans (n=4) were present. Among 
the isolates from different sources, poultry isolates showed the highest  level of resistance 
followed by pet isolates with intermediate resistance to ampicillin, tetracycline, erythromycin 
and chloramphenicol. E. faecium, E. faecalis, E. hirae were identified from the canine fecal 
isolates. When tested for susceptibility to 11 antibiotics, canine isolates showed a lower level of 
resistance (10%) for most antibiotics except for tetracycline (50%), erythromycin (47%) and 
kanamycin (18%). E. faecium were resistant to more antibiotics as compared to E. faecalis and 
E. hirae among canine fecal samples. Tetracycline and erythromycin resistance was higher 
among E. faecalis (Poeta et al., 2005). 
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Morris et al.,(2007) studied the susceptibility to antimicrobials among enterococci 
isolated from dogs with UTI (n=40), otits externa (n=11) and pyoderma (n=4) infections. Eighty 
four percent of isolates were E. faecalis and 10.9% were E. faecium while the remaining 5.5% 
were E. durans, E. gallinarum and E. hirae. Higher level of resistance to aminoglycosides 
(gentamicin [12.7%]; streptomycin [36.4%]; gentamicin+streptomycin [10.9%] and 
fluoroquinolones (ciprofloxacin [45.5%]; levofloxacin [41.8%]; moxifloxacin [41.8%]) were 
observed. All the isolates were susceptible to ampicillin, penicillin and vancomycin   
Spain 
Torres et al.,(2003) and Herrero et al.,(2004) reported higher percentage of vanA positive 
enterococcal isolates from companion animals in Spain. Torres et al. analyzed VRE from fecal 
samples of healthy pigs (n=66) and pets (dogs+cats=22). VRE were detected in 4.5% pig 
samples and 22.7% pet samples. All the van A positive isolates harbored tet (M) while 6 isolates 
were positive for erm (B) gene and 3 isolates were positive aac(6')-Ie-aph(2")-Ia gene. 
 Herrero et al.,(2004) investigated the presence of VRE in 87 diseased dogs in 
Spain. Among 87 dog fecal samples, they isolated 15 VRE strains, 11 belonging to E. faecium 
and 4 E. gallinarum. Most of the vancomycin resistant Enterococcus faecium (VREFe) were 
resistant to multiple antibiotics, example: tetracycline (n=11), erythromycin (n=10) and 
bacitracin (n=10), chloramphenicol
 
(n=6), ciprofloxacin (n=6), streptomycin (n=5), penicillin 
(n=2), and quinupristin-dalfopristin (n=1) with only one VREFe isolate susceptible to 
erythromycin and bacitracin. 
Italy 
A study was carried out in Italy by Ossiprandi et al.,(2008) to determine the prevalence 
of antibiotic resistance in fecal enterococcal strains from dogs exposed or not exposed to 
antibiotic treatments. The treatment group included the dogs exposed to at least one antibiotic(s) 
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dose for 6 months prior to the study. All isolates showed high level of resistance to 
erythromycin, tetracycline, rifampicin and enrofloxacin. None of their isolates were resistant to 
vancomycin. There was no significant difference in the resistance profile between both groups 
except for E. faecium from treatment group that showed high resistance to tetracycline antibiotic.    
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1.10 Summary 
Enterococci, the normal gut commensal of many animals, are also present in the GIT of 
dogs. However, during last few years, their importance is increasing from the medical point of 
view. The enterococci have emerged as a medically important nosocomial pathogens 
contributing mortality rates up to 61% (De Fatima Silva Lopes et al., 2005). Stress in animals 
selects for antibiotic resistant bacteria (Langlois et al., 1999; Corrier et al., 1990) and causes 
increased shedding of resistant (Moro et al., 2000; Moro et al., 1998) and pathogenic (Whyte et 
al., 2001; Pfeiffer et al., 2009) bacteria in the feces of cattle (Corrier et al., 1990; Pfeiffer et al., 
2009), swine (Moro et al., 2000; Moro et al., 1998;) and poultry (Whyte et al., 2001). However, 
this has not been investigated in dogs. Dogs are prone to stress due to several causes such as 
change in environment, mistreatment by owners and others, physical pain, fear, aggression and 
illness. Resistant bacteria, if shed in the feces of stressed dogs, can be transmitted to the people 
in contact with them, such as veterinary staff or dog owners and thus in theory could be a source 
of opportunistic infections.     
Published research on the prevalence of antibiotic resistant enterococci from dogs in the 
U.S. is sparse. The most recent publication documenting the prevalence of antibiotic resistant 
enterococci in U.S. dogs was by Jackson et al.,(2009), where they reported the presence of 
antimicrobial resistant enterococci from different body parts of healthy animals. They found that 
E. faecalis was the most dominant species in dogs and was isolated more from the rectal 
samples. However, these data are not sufficient to represent the entire gut, as the sample size in 
the study was very small (n=86 from rectal samples collected from 155 dogs). Although this 
study highlighted the risk associated with the transfer of resistant bacteria from pet animals to 
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humans, it does not provide information about of the prevalence of antibiotic resistant 
enterococci in the gut of pet animals. 
Other studies documenting trends in antibiotic resistant enterococci in dogs have been 
reported from different parts of the world (Damborg et al., 2008; De Graef et al., 2004; 
Wagenvoort et al., 2003; Rantala et al., 2004). To date, there is only one study in the literature 
reporting the prevalence of antimicrobial resistant enterococci in dogs with pyoderma (Rantala et 
al., 2004). In this study the authors tested for resistance to ampicillin and vancomycin among the 
enterococci recovered from the dogs with pyoderma infection and compared with control group, 
healthy dog isolates. They reported low prevalence of resistance to these antibiotics in 
enterococcal isolates tested. The findings of this study are expected, as vancomycin is not the 
drug of choice for treatment of infections in dogs. The explanation for finding low ampicillin 
resistant enterococcal strains is because this antibiotic is not incorporated in their treatment 
regimen during the course of study. Moreover, the sample size was small to represent the entire 
gut microbiota. No veterinary studies have been published determining the effect of pyoderma 
infection on the antimicrobial resistance and virulence in enterococci of intestinal microbiota of 
dogs.
34 
 
  
1.11 Research objectives 
In the present study I hypothesized that stress due to pyoderma infection in dogs can 
increase the antibiotic resistance in the fecal microbiota and may play a role in the dissemination 
of antibiotic resistance genes.  
The two main research goals are: 
1. To assess the role of dogs as a potential reservoir of clinically important 
enterococci. 
2. To investigate a potential correlation between stress from pyoderma and antibiotic 
resistance and virulence frequency in enterococci from the intestinal tract of dogs.  
Specific objectives 
1. Determine the prevalence, phenotypic and genotypic characterizations of 
antibiotic resistance and virulence traits, intra-species resistance gene transfer and 
clonal population structure of antibiotic resistant enterococcal strains from healthy 
and pyoderma infected dogs. 
2. Assessment of overall bacterial diversity within the intestinal microbiota of 
healthy dogs. 
3. Assessment of overall diversity of antibiotic and metal resistance genes in the 
feces of healthy dogs  
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Chapter 2 
 
Population size, diversity, polyphasic characterization of 
antimicrobial resistance and virulence traits, horizontal transfer of 
resistance genes and clonal structure of enterococci from the feces of 
healthy and dogs with pyoderma  
 
2.1 Abstract 
Enterococci, the commensal organism of humans and animals, are well known to be 
carriers of antibiotic resistance genes and for their contribution to the nosocomial infections in 
humans. Some studies have shown that changes in the antimicrobial resistance phenotypes in the 
gut microbiota are associated with the stress conditions in animals such as transportation, 
overcrowding and rough handling. To determine whether the gut microbiota of healthy and 
pyoderma infected dogs serves as an antimicrobial resistance reservoir, 180 enterococcal isolates 
from fecal samples of 9 dogs in each group were cultured, enumerated, identified, and screened 
for resistance to 10 antibiotics and for 4 virulence traits. None of the animals in the either group 
received antibiotic treatment for at least 7 months prior our sampling. The intra-species 
transferability of resistant determinants was investigated by the horizontal gene transfer assay. 
Clonality of selected E. faecalis and E. faecium isolates was assessed by pulsed field gel 
electrophoresis (PFGE). 
The most prevalent species were E. faecalis (44.0%) and E. faecium (38.0%) from 
pyoderma dogs and E. faecalis (70.5%) and E. hirae (22.2%) from healthy dogs. Enterococci 
isolated from pyoderma infected dogs were more resistant to antibiotics than those from healthy 
dogs. Overall, E. faecium were resistant to more antibiotics than any other species. Resistance to 
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erythromycin was most frequent in the pyoderma group [36.6%] and tetracycline in the healthy 
group [17.7%]); no isolates were resistant to vancomycin or linezolid. The most prevalent tet 
genes were tet(M) and tet(S) in both animal groups. Most (≥ 80%) of the erythromycin resistant 
isolates were negative for erm(B) gene. No mutation within codon 83 and codon 87 of gyrA was 
detected in fluoroquinolone resistant strains. The gelE and esp genes were the most prevalent 
virulence genes in E. faecalis and E. faecium in both groups with the exception in E. faecium 
from healthy animals, where no esp gene was detected. The antibiotic resistance traits were intra-
species transferable among E. faecalis (tetracycline, erythromycin, and doxycycline) and E. 
faecium (tetracycline) by in-vitro conjugation. PFGE analysis revealed that healthy animals 
harbored more genetically diverse E. faecalis as compared to that of pyoderma dogs. The overall 
study results show that the prevalence of antibiotic resistant enterococci in pyoderma dogs as 
well as healthy dogs was low. The association between pyoderma infection and higher 
antimicrobial resistant enterococci in these dogs may be related to stress due to the infection. Our 
findings help to better understand the role of pet dogs as a reservoir for antibiotic resistant 
enterococci and transfer of resistant bacteria and antimicrobial resistance genes to people. 
Key words: Dogs, antimicrobial resistant enterococci, pyoderma 
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2.2 Introduction 
Antibiotic resistant pathogens are causing substantial burden to public health by 
confounding the clinical treatment of patients (Andrighetto et al., 2001; Baumgartner et al., 
2004). Antimicrobial resistant infections cause approximately $4 billion treatment cost in the 
United States per year (Stacey et al., 2003). Antimicrobial resistance has become a serious issue 
in bacteria of animal and human origin both in terms of clonal spread (Kuhn et al., 2000; van den 
Bogaard and Stobberingh, 2000) and exchange of resistance genes between human and animal 
bacteria (DuPont and Steele, 1987; Phillips et al., 2004). These factors may contribute to 
increasing challenge to treatment of resistant infections which ultimately may lead to increased 
morbity and mortality. Hence, the World Health Organization has recommended developing 
surveillance programs to monitor antimicrobial resistance in humans, food animals and retail 
foods (WHO, 2001). 
The problem of antimicrobial resistance in enteric bacteria has become a major issue in 
terms of public health (Marano et al., 2000; WHO, 2000; Tollefson et al., 1999). The commensal 
bacteria of gastrointestinal tract (GIT) may serve as a reservoir of antimicrobial resistant 
organisms and resistance genes for pathogenic or zoonotic bacteria (Capriolo et al., 2000). One 
such enteric bacterial group that gained the global attention are enterococci, due to their role as a 
reservoir for antibiotic resistance genes and for being one of the leading causes for nosocomial 
infections (Marshall, 2009; Huycke et al., 1998). They are regular inhabitants of the intestinal 
tract of animals and humans. Although a variety of enterococcal species are present in healthy 
individuals, enterococci are also opportunistic pathogens. Over the past three decades, the overall 
incidence of enterococcal infections has increased as the second most important cause for urinary 
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tract infections (Huycke et al., 1998), and the third most frequent cause for nosocomial blood 
infections and endocarditis in the U.S. alone (Wisplinghoff et al., 2004; Mc Donald et al., 2005). 
Not only do enterococci carry antimicrobial resistance genes, but they are also well known for 
their ability to transfer them to bacteria of the same or different genera (Weigel et al., 2003). 
Thus enterococci have emerged as a medically important antimicrobial resistant and virulent 
pathogen (Tendolkar et al., 2003; Upadhyaya et al., 2009). Besides the digestive tract, 
enterococci are also widely distributed in the environment including food, water, soil and plants 
(Gilmore, 2002; Macovei and Zurek, 2006). 
Selection pressure due to antibiotic use is often considered to be the major factor for 
dissemination and maintenance of antimicrobial resistance in bacteria. However, there are also 
data showing antimicrobial resistance in animal populations never exposed to antibiotics 
(Langlois and Dawson, 1999). Animal stress has been implicated as one of the factors 
responsible for increase of antibiotic resistant enteric bacteria (Langlois and Dawson, 1999; 
Corrier et al., 1990) and increased pathogen shedding (Corrier et al., 1990; Hussein et al., 2001; 
Issacson et al., 1999; Schwartz, 1991). Animals are prone to stress and that has severe effect on 
overall physiology, health and productivity of animals (Moberg and Mench, 2000). While most 
research has focused on people and food animals, the importance of companion animals as a 
reservoir of bacterial pathogens and antibiotic resistance genes is unknown. According to the 
statistics from the U.S. pet ownership and demographics sourcebook, in 2006, pet dogs 
accounted for more than 72 million in U.S. and the average expenditure cost per household per 
pet was estimated to be $366. (http://www.avma.org/reference/marketstats/sourcebook.asp). 
Companion animals play an important role in the society. Dogs are used as a therapeutic purpose 
for elderly and mentally ill people and to relieve stress. Studies have shown that pets are very 
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sensitive to their owners stress levels. Stress due to temperature, crowding, starvation or other 
dietary conditions, fear and other extreme emotions can cause disturbances in the gut microbiota 
(Moon et al., 1979; Savage, 1982; Tannock, 1983) and contribute to the increase of antimicrobial 
resistance (Sorum and Sunde, 2001). Some studies have reported increased shedding of drug 
resistant intestinal bacteria such as E. coli animals stress due to shipping and moving, 
transportation, overcrowding, and holding in a pen (Moro et al., 2000; Moro et al., 1998; 
Molitoris et al., 1987; Langlois et al., 1986). A higher prevalence of resistance in E. coli was 
found in swine herds not exposed to antimicrobial agents (Langlois et al., 1988) after shipping 
(Molitoris et al., 1987) and exposure to extreme cold or heat conditions (Moro et al., 1998, 
2000). An association between stress in animals and altered GIT has been reported (Kiliaan et 
al., 1998; Gangrosa, 1977). These changes include altered gut microbiota, pH, motility and 
decreased integrity of intestinal epithelium (Schaedler and Dubos, 1962; Kiliaan et al., 1998; 
Enck, 1989). Studies suggest that such intestinal changes are caused by the increased 
corticosteroids, the neuroendocrine mediators secreted from central nervous system and 
endocrine system due to stress imposed on animals (Enck, et al., 1989). During the episodes of 
stress, these hormones are released in the gut by the enteric nervous system and affect the 
commensal bacteria (Freestone et al., 2000; Zhou et al., 2004; Dreau et al., 1999) as well as 
pathogens such as E. coli (Chen et al., 2006; Vlisidou et al., 2004; Green et al., 2003), 
Salmonella (Chen et al., 2006; Green et al., 2003), Campylobacter (Cogan et al., 2007) and 
Vibrio (Nakano et al.,2007). The role of these stress hormones in relation to increased growth, 
motility and virulence of bacteria is also documented (Sperandio et al., 2003). Evidence suggests 
that these stress hormones can cause upregulation of bacterial genes required for colonization 
and virulence (Bansal et al., 2007).  
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In USA, there are several surveillance programs including National Antimicrobial 
Resistance Monitoring system, FDA, and CDC that monitor the trends in antibiotic resistance in 
bacteria of human and food animal origin; however, none of them include companion animals. 
Considering the fact that dogs share the common environment with people, their close physical 
contact, and use of same antibiotics for their therapeutic purpose (Guardabassi et al., 2004), there 
is a high potential for transmission of resistant bacteria or mobile genetic elements between  pets 
and humans (Pedersen et al., 2007). 
 Recent evidence suggests that dogs can act as a reservoir for antimicrobial resistant 
enterococcal strains (Simjee et al., 2000). Despite this fact, very few studies are available on the 
epidemiology of antibiotic resistance in healthy dog‟s microbiota (Hirsh et al., 1980; Monaghan 
et al., 1981; Devriese et al., 1996; van Belkum et al., 1996). The studies published from 
countries other than U.S. on diseased or healthy dogs have reported decreased susceptibility to 
antibiotics among the enterococcal strains and most of these studies focused on investigating the 
prevalence of vancomycin resistant enterococci.  
There are only two scientific reports from the U.S. documenting antibiotic resistant 
enterococci of the canine fecal origin (Simjee et al., 2002; Jackson et al., 2009). Because of the 
difference between theses two studies in terms of study design, methodology, and reports 
documenting the prevalence of resistant enterococi, estimation of an overall prevalence of 
antimicrobial resistance in enterococci of canine gut is difficult. Until now, no published data 
from U.S. has evaluated the prevalence of antimicrobial resistance in enterococci from dogs with 
pyoderma infection. Additionally, the only study available in the literature demonstrating the 
prevalence of antibiotic resistant enterococci from pyoderma infected dogs was conducted in 
Finland (Rantala et al., 2004). However, the data available from this study are not representative 
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of resistance prevalence of enterococci from GIT of dogs due to the small sample size 
(enterococcal isolates in control group [73] versus pyoderma group [37]). We hypothesized that, 
stress due to pyoderma, a common bacterial infection in dogs, is correlated with higher antibiotic 
resistance in the fecal microbiota of dogs and plays a role in the dissemination of antibiotic 
resistance genes. 
The objectives of the present study were i) phenotypic and genotypic characterization of 
antimicrobial resistance and virulence traits and clonal structure of enterococcal strains isolated 
from the healthy and pyoderma infected dogs. ii) determine the potential for horizontal gene 
transfer of antibiotic resistant genes/traits in-vitro. 
2.3 Materials and methods 
2.3.1 Study animals 
Two groups of dogs were included in this study: 1) healthy group and 2) pyoderma group  
The healthy group included nine clinically healthy household dogs from Manhattan, 
Kansas. Healthy dogs varied in sex, breed, diet, and age (Table 2.1). According to the history 
taken from the owners, these animals were not exposed to antibiotics for at least one year prior to 
sample collection (Table 2.1). 
The pyoderma group included nine dogs brought to the Kansas State University, 
Veterinary Teaching Hospital, Manhattan, Kansas, who were diagnosed and treated for 
pyoderma. This group also included dogs belonging to different sex, breed, and age. The history 
of prior antibiotic exposure of theses group of dogs are shown in (Table 2.2). Samples from these 
dogs were collected on the day of visit and prior to treatment. These dogs were not exposed to 
antibiotics for at least 7 months before sample collection (Table 2.2).   
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2.3.2 Fecal sampling and processing 
Fecal sample from each dog was obtained either from the rectum by swabbing with 
sterile cotton- tipped applicator moistened in sterile phosphate buffer saline (PBS) and placed 
into a sterile tube containing 500 µl of PBS or fresh feces were collected with a sterile glove in a 
sterile tube. Samples were immediately stored at 4°C and were processed within 24 h after 
collection. 
The details of the primer sets for the PCR used in this study are shown in Table 2.3. 
2.3.3 Isolation of enterococci 
The following procedures were used to isolate and enumerate enterococci from the canine 
fecal samples. 
2.3.3.1 Selective plating 
One gram of fecal sample from the center of the fresh collected feces was mixed and 
homogenized in 10 ml of PBS (pH 7.2; ICN Biomedicals, Ohio) and dilutions were made up to 
10
-3
. One hundred microliter of each dilution of fecal material was drop plated on m-
Enterococcus agar (Becton Dickinson, Massachusetts), and incubated at 37°C for 48 h.  
The rectal swabs were processed by properly immersing the swab in the PBS present in 
the tube followed by spread plating of 100µl of this solution onto m-Enterococcus agar and 
incubated at 37°C for 48 h.  
Twenty presumptive enterococcal colonies with red pigment were picked randomly from 
the m-Enterococcus agar plate representing each sample and plated onto Trypticase soy agar 
(Becton Dickinson, Massachusetts), incubated at 37°C for 48 h, and stored at 4°C for further 
analysis. 
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2.3.3.2 Bacterial enumeration 
Red pigmented colonies from each m-Enterococcus agar plate were counted, and 
bacterial numbers were expressed as colony forming units per gram (CFU/g) of feces. Mean 
bacterial count was determined from the triplicate spread plate from the dilution representing 
each sample. 
2.3.3.3 Biochemical test to confirm Enterococcus genus 
Ninty six microwell plates containing Enterococcossel broth (Becton Dickinson, 
Massachusetts) (0.2ml) were inoculated with  red pigmented enterococcal colonies picked from 
Trypticase soy agar plates and incubated at 37°C for 24 h for the esculin hydrolysis. 
Enterococcal species can hydrolyze esculin and results in the development of black colored 
media. Based on the biochemical reactions each isolate was identified to the genus level. 
2.3.4 Species determination 
Multiplex PCR was employed for identification of four common species, E. faecalis, E. 
faecium, E. casseliflavus and E. gallinarum (Kuhn et al., 2000).  
2.3.4.1 DNA preparation 
Cell suspension of 3-4 presumptive enterococcal colonies of each isolate were made in 
50µl. The boiling method was used to extract DNA from the bacteria (Kariyama et al., 2000).  
One to several colonies from the medium were suspended in 50µl of sterile distilled water with 
7.5% Chelex 100 (Bio-Rad laboratories, Hercules, California), heated at 100°C for 15 min in a 
heating block and centrifuged in a microcentrifuge (6000g for 1 min) and supernatant liquid was 
collected and stored at -20°C for our multiplex PCR assay. 
2.3.4.2 Multiplex PCR 
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Primers and PCR conditions were chosen according to the guidelines of Kariyama et al., 
(2000) and Dutka-Malen et al., (1995). The primers were designed to amplify ddl (941 bp), ddl 
(658 bp), vanC1 (822 bp), vanC2 / C3 (484 bp) and 16S RNA (320 bp) genes for the detection of 
E. faecalis, E. faecium, E. gallinarum, E. casseliflavus and 16S RNA, respectively. The reaction 
components were as follows: 10x buffer-2.5µl, 25mM MgCl2-0.15µl, 1mM dNTP-2.00µl, 1 unit 
Taq polymerase-0.20µl, 5 sets primers-5.00µl ddH2O-12.65µl, template DNA-2.50µl to 
25µl/reaction.  
The thermal cycling were conducted as follows: denaturation of DNA at 94°C for 5 min 
followed by 30 cycles of 94°C for 60min, followed by annealing at 54°C for 60 min, elongation 
at 72°C for 60 min. After 30 amplification cycles, a final extension step was performed at 72°C 
for 10 min. 
The negative control used was E. mundtii ATCC-43186.  
 PCR reaction products were resolved by electrophoresis on a 1.5% agarose gel 
containing ethidium bromide (0.5µg/ml) in 10X TBE buffer. The DNA size marker was 1500 bp. 
The gel was visualized on a ultraviolet transilluminator. In case of unclear results, the 
enterococcal isolates were confirmed by amplification and sequencing of conserved sodA gene 
(superoxide dismutase) approach as described by Poyart et al.,(2000).  
2.3.5 Antibiotic susceptibility test 
2.3.5.1 Phenotypic characterization 
Antimicrobial susceptibility testing was performed as recommended by Clinical and 
Laboratory Standards Institute (Clinical and laboratory standards institute 2000). 
Disc diffusion technique for all identified isolates were carried out on Mueller-Hinton 
agar (Difco) plates with standard antibiotic disks (Becton Dickinson, Franklin Lakes, NJ) using 
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eight antibiotics, gentamicin (120µg/ml), erythromycin (15µg/ml), tetracycline (30µg/ml), 
doxycycline (30µg/ml), ampicillin (10µg/ml), ciprofloxacin (5µg/ml), enrofloxacin (15µg/ml), 
and vancomycin (30µg/ml).  The zone of inhibition was measured and compared to the standard 
zone size predetermined for the enterococcal species and then the isolate was classified as 
sensitive and resistance. Screening for streptomycin (2000µg/ml) and linezolid (8µg/ml) 
resistance were performed by using the agar dilution technique in brain heart infusion agar plate. 
For quality control of disc diffusion and agar dilution techniques, appropriate positive and 
negative controls were included in this study. 
2.3.5.2 Genotypic characterization 
All identified isolates that were resistant to tetracycline and erythromycin by disc 
diffusion technique were screened for tet and erm(B) genes, respectively. The presence of these 
resistance genes were tested either by multiplex or single PCR using the gene specific primers 
and conditions for the amplification of tet(A), tet(C), tet(Q), tet(M), tet(S), tet(K), tet(O), tet(W) 
and erm(B) genes as described previously (Macovei et al., 2006). The group I multiplex PCR 
was designed to amplify tet(A) (210bp), tet(C) (418bp), and tet(Q) (904bp) genes, and group II 
covered tet(M) (406bp), tet(S) (667bp), tet(K) (169bp), and tet(O) (515bp)genes. 
Extraction of bacterial DNA was performed by the boiling method as described earlier. 
Amplification reaction consisted of 10x buffer-2.5µl, 25mM MgCl2-0.20 µl, 1mM dNTP-2.00µl, 
1 unit Taq polymerase-0.30µl, 3 sets of primers-3.00µl (groupI) and 4sets of primers- 4.00µl 
(groupII), ddH2O-15.50µl, template DNA-3.00µl to 25µl/reaction. Cycling conditions for group I 
and II multiplex PCR assay were as follows:  denaturation at 94°C for 5 min followed by 24 
cycles of 94°C for 1.5 min, followed by annealing at 55°C for 1 min, elongation at 72°C for 1.5 
min and final extension step of 10 min at 72°C . 
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Amplification of tet(W) (168bp) and erm(B) (639bp) genes were performed by single 
PCR respectively. The reaction mixture consisted of 25 µl Master Mix with 10x buffer-2.5µl, 
25mM MgCl2-0.20 µl, 1mM dNTP-2.00µl, 1 unit Taq polymerase-0.30µl, 1set primers-2.00µl 
(tet(W) or erm(B)), ddH2O-16.50µl, template DNA-3.00µl from freshly boiled cells. Cycling 
parameters were as follows: a) For tet(W) - denaturation at 94°C for 5 min followed by 24 cycles 
of 94°C for 30 sec, followed by annealing at 64°C for 30 sec, elongation at 72°C for 30 sec and 
final extension step of 7 min at 72°C. b) For erm(B)- denaturation at 94°C for 3 min followed by 
30 cycles of 94°C for 30 sec, followed by annealing at 54°C for 30 sec, elongation at 72°C for  
30 sec and final extension step of  4 min at 72°C. 
PCR was used to amplify the regions of gyrA gene in quinolone resistant strains isolated 
in this study (Korten et al., 1994) and the nucleotide sequence in the amplified regions were 
determined by 3730 DNA analyzer for sequencing (Applied biosystems). The sequences 
containing quinolone resistance determining region (QRDR) were aligned and compared with 
quinolone susceptible and resistant strains of enterococcal species. Conversion of the nucleotide 
sequences into corresponding amino acid sequences were performed by using Sequencher 4.7 
(Gene Codes Corporation, AnnArbor, MI) (Table 2.7)  
2.3.6 Virulence factors 
2.3.6.1 Phenotypic characterization 
In the gelatinase assay, enterococcal strains were inoculated in Trypticase soy agar 
supplemented with 3% skim milk. Plates were incubated for 24 hrs at 37°C. Formation of a 
clearance zone surrounding the colonies was monitored (Gilmore et al., 2002).  
The assay for hemolytic activity were evaluated by plating the enterococcal strains on 
Columbia blood agar (Becton Dickinson, Franklin Lakes, NJ) supplemented with 5% human 
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blood. Strains were streaked on the surface of the plate and incubated at 37°C for 48-72 h. The 
criteria for cytolysin expression were determined as development of complete clearance zone 
around the colonies (Gilmore et al., 2000). Enterococcus faecalis strains, OG1X (pAD) and 
OG1RF (pAD) were used as positive control and V583 as negative control.  
Production of aggregation substance in the presence of sex pheromone was conducted by 
clumping assay (Dunny et al., 1978). For the phenotypic expression of the asa1 gene, E. faecalis 
JH2-2 were grown for 6 h at 37°C in Todd-Hewitt broth followed by centrifugation at 6,000 rpm 
for 10 min on a Sorvall RC-5B refrigerated (4°C). The supernatant contains the pheromone that 
causes induction of pheromone-responsive plasmids. This supernatant was removed and 
autoclaved for 15 min.One milliliter of the supernatant was added to Todd-Hewitt broth (5 ml) 
containing 6 h grown enterococcal isolates. After incubating overnight at 37°C on a shaker (150 
rpm), isolates that showed clumping (examined by naked eye and under a compound 
microscope) were considered positive for aggregation substance expression. E. faecalis OG1RF 
(pCF10) was used as a positive control. 
2.3.6.2 Genotypic characterization 
Multiplex PCR for the detection of the following virulence genes were performed: gelE, 
asal, cylA, and esp coding for gelatinase, aggregation substance, cytolysin and enterococcus 
surface protein respectively, for all the identified isolates (Vankerckhoven et al., 2004). The 
reaction mixture for targeting these virulence genes consisted of 10x buffer-2.5µl, 25mM MgCl2-
0.20 µl, 1mM dNTP-2.00µl, 1 unit Taq polymerase-0.30µl, 4sets Primers-5.00µl, ddH2O-
13.50µl, template DNA-1.5µl from freshly boiled cells for 25 µl master Mix/ reaction. 
Conditions for the PCR were as follows: denaturation at 94°C for 5 min followed by 29 cycles of 
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94°C for 1 min, followed by annealing at 54°C for 1 min, elongation at 72°C for 1.5 min and 
final extension step of 10 min at 72°C. 
2.3.7 Pulsed-field gel electrophoresis (PFGE) 
PFGE was performed performed in CHEF-MAPPER 
TM
 (BIORAD) at 14°C in 5X TBE 
as described by Murray et al., (1990). 
2.3.7.1 Casting PFGE plugs 
1.6% SeaKem Gold® agarose (FMC trademark) was prepared in 25ml distilled water and 
2.5ml 10% SDS and kept at 56°C waterbath until use.  
Following overnight incubation of bacterial suspension in brain heart infusion broth 
(5ml), samples were adjusted to optical density 1.2nm. The cells were pelleted by centrifugation 
at 11000rpm for 1.5 min. The pellet was suspended in 500µl of 0.85% NaCl and centrifuged. 
Finally the pellet was suspended in 200µl of 0.85% NaCl and kept on the hot plate at 50°C for 10 
min. Plugs were casted by mixing the cell suspension with 250µl of 1.6% SeaKem Gold® 
agarose and poured into two plug molds and allowed to solidify for 25 minutes at room 
temperature.  
2.3.7.2 Lysis of cells 
Solidified plugs were transferred to the 10 ml lysis buffer (1M Tris-HCl (pH-7.4), 5M 
NaCl, 0.5M EDTA, 20% Sodium Lauroyl Sarcosine, 10% Brij, 10% Deoxycholate, distilled 
water, 500µg/ml lysozyme, 20µg/ml RNase A) They were then incubated at 37°C in a water bath 
with shaking at 100rpm for 4hrs. Then the plugs were removed from the lysis buffer and 
transferred to a new tube with 10ml ESP buffer (10mM Tris-HCl (pH-7.4), 1mM EDTA, 1% 
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SDS, 50µg/ml Proteinase K) and incubated at 50°C in a water bath with shaking at 80rpm for 
16hrs.  
2.3.7.3 Washing plugs 
Washing of the plugs was performed one time for 20 minutes followed by four times for 
10 minutes. Each time the washing was done in 10ml of fresh TE buffer (0.5M EDTA; 1M Tris 
HCL (pH-7.4)). 
2.3.7.4 Restriction enzyme digestion 
One third of the washed plug was cut and equilibrated by placing in 1.5ml 
microcentrifuge tube containg10µl bufferA and 90µl autoclaved distilled water. After incubation 
at at room temperature for 10 minutes, the buffer solution was aspirated off. Clevage of the 
agarose embedded DNA was achieved with 0.5µl ApaI in 10µl of buffer and making the volume 
to 100µl with distilled water and incubating at 37°C waterbath for 4 hours. 
2.3.7.5 Loading of plugs 
After digestion, the restricted fragments were separated by electrophoresis at 1% SeaKem 
Gold® agarose (FMC trademark) prepared in 100ml distilled water and 10ml 5X TBE buffer. 
After digestion of plugs, the digestion mixture was aspirated off and incubated in 200µl 
0.5X TBE buffer at room temperature for 10 minutes. Then the plugs were placed on the 
0.75mm gel comb and allowed to remain there at room temperature for 30 minutes. The gel 
comb was then placed in the casting tray and 100ml 1% SeaKem Gold® agarose (FMC 
trademark) was poured and allowed to solidify at room temperature for 45 minutes. Following 
solidification, the comb was removed and the wells were closed with1% SeaKem Gold® agarose 
(FMC trademark). 
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2.3.7.6 Electrophoresis parameters 
Initial switch time 1 second; final switch time 20 seconds; temperature 14°C; total run 
time 21 hours; included angle 120; voltage 6 V/cm.    
2.3.7.7 Gel staining 
Gels were stained with 1% ethidium bromide for 30 minutes at room temperature 
followed by two times 20 minutes destaining in distilled water. 
To estabilish the clonal relatedness and diversity among the drug resistant E. faecium and 
E. faecalis from healthy and diseased groups, the PFGE pulsotypes were analyzed after 
importing the gel images into BioNumerics software. Dendrograms were created using Dice 
similarity coefficient (1% optimization) and unweighted pair group method with arithmetic 
means (UPGMA) clustering analysis with 1.5% band position tolerance. The E. faecium ATCC 
19454 was used as reference strain. 
2.3.8 Conjugation assay 
Conjugation assay was performed for antibiotic resistant E. faecalis and E. faecium. 
Selection of antibiotics on the agar plate was done based on the resistance pattern of the donor 
and recipient. Conjugation frequencies were determined by filter mating and broth mating 
assays. 
Broth mating and filter mating were performed in overnight grown (37°C) cultures of 
donor and recipient strains as described previously (Dunny et al., 1978; Tendolkar et al., 2006). 
The broth mating was performed as follows: overnight grown bacterial cultures in brain heart 
infusion broth (BHI) (5ml) were mixed in a ratio of 1:10 donor: recipient in 4.5ml of fresh BHI 
broth. This broth containing donor recipient culture was incubated at 37°C for 4 h.  
75 
 
For filter mating, 1:10 donor: recipient ratio of overnight grown bacterial culture was 
passed through autoclaved 0.22µm pore size nitrocellulose membrane filter (Whatman 
International Ltd., Germany). This membrane filter was placed on the BHI agar plate with 
bacteria side up and incubated at  37°C for 16 h. Following incubation, cells from the filter were 
harvested by suspending the filter in 1ml BHI broth.  
For both the mating procedures, controls, donor and recipient cultures were serially 
diluted and spread plated on BHI plate containing appropriate selective antibiotics. Colonies 
were counted after 48 h of incubation at 37°C. 
Transfer frequency was determined by number of transconjugants per donor and per 
recipient cell.  
2.3.9 Statistical analysis  
For all analyses, the GLIMMIX procedure of SAS® (SAS Institute Inc, 2008) was used 
with the binomial distribution and logit link function to fit logistic models. Results included F-
statistics and corresponding p-values to test fixed effects in each model, as well as the mean 
diversity percents and 95% confidence intervals. All tests were declared significant at a 
significance level of 0.05. 
First, to examine species diversity (i.e., the percent of isolates out of 20 isolates per dog), 
separate logistic models were run for each species to compare groups. The experimental design 
for this analysis was a completely randomized design with group (healthy versus pyoderma 
dogs) as the treatment factor and dog as the experimental unit. The same analysis was performed 
for prevalence of tet genes or virulence genes (i.e., the percent of isolates with a specific tet gene 
out of the total number of tetracycline resistant isolates per dog; the percent of isolates with a 
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specific virulence gene out of the total number of E. faecalis and E. faecium isolates, respectively 
per dog), separately for each gene but pooling over all isolates. 
Second, to examine antibiotic resistance (i.e., the percent of resistant isolates out of the 
number of isolates observed for each dog), separate logistic models were fitted for each species-
group combination. Only the antibiotics that had some resistance for each group-species 
combination were included in that model. For example, for the combination of group=pyoderma 
and species=E. dispar, only the antibiotics ciprofloxacin, enrofloxacin, erythromicin, and 
tetracycline were included in the model, as the other six antibiotics were 100% susceptible for 
this group-species combination. For the species E. casseliflavus and E. canintestine, there was 
only one dog per group-species combination and hence those data were not statistically 
analyzable. The experimental design for this analysis was a randomized complete block design 
where dog was the random block factor and antibiotic was the treatment factor. 
In addition, percent resistance was analyzed in a model that contained both groups and 
antibiotic as treatment factors. The design for this was a completely randomized design with a 
split-plot. Group was the whole-plot treatment factor and dog was the whole-plot experimental 
unit. Antibiotic was the split-plot factor. This analysis was again done separately for the three 
species E. faecalis, E. faecium, and E. hirae, which were the only three species to occur in both 
healthy and pyoderma groups. Each model only contained those antibiotics for which resistance 
was greater than 0% in both groups.  
2.4 Results 
2.4.1 Prevalence of enterococci 
A total of eighteen dogs were included in this study. Twenty isolates of enterococci were 
selected from each sample (total isolates from pyoderma group, n=180; total isolates from 
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healthy group, n=180). The mean ± standard error mean from the fecal samples of healthy (based 
on 8 samples) and  the mean  from pyoderma dogs (based on 2 samples) were 6.7 ± 0.2 × 10
6 
and 
1.2 × 10
6  
respectively (Table 2.4).   
Based on the multiplex PCR, E. faecalis, E. faecium, E. casseliflavus and by sodA 
analysis E. hirae, E. canintestini, and E. dispar were identified. As shown in Figure 2.1, 
diversity of enterococcal species was evident in fecal samples from both groups. Fecal samples 
from pyoderma dogs demonstrated greater species diversity than the isolates from  healthy group 
(Figure 2.2, 2.3). Among 180 isolates collected from each group of dogs, four species of 
enterococci were identified from healthy dogs and six species from pyoderma dogs (Figures 2.2; 
2.3). The predominant enterococcal species isolated from the fecal samples of dogs was E. 
faecalis. Other common enterococcal species found in healthy dogs were E. hirae and E. 
faecium, while in pyoderma dogs E. hirae, E. faecium and E. dispar were commonly present 
(Figure 2.2). Rare enterococcal species such as E. casseliflavus and E. canintestini were also 
detected in our study; however, these collectively comprised ≤ 5% of total isolates. There was a 
significant difference in the number of E. facealis, E. faecium and E. hirae isolates from both 
groups (P<0.05). Of the total isolates identified, the percentages of the enterococcal strains from 
healthy and pyoderma groups respectively were as follows: E. faecalis (70.5/44), E. faecium 
(6.1/38), E. hirae (22.2/5.5), E. casseliflavus (1.6/1.0), E. canintestini (0/5.5), and E. dispar 
(0/6.0) (Figure 2.1). 
2.4.2 Antibiotic susceptibility test 
2.4.2.1 Phenotypic characterization 
Enterococcal isolates from the pyoderma dogs expressed higher frequency of resistance 
to tetracycline, erythromycin, doxycycline, ampicillin, ciprofloxacin, enrofloxacin, gentamicin 
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and streptomycin antibiotics than the healthy dog isolates (Figure 2.4). Considering all  isolates 
that were tested, isolates from both groups were susceptible towards vancomycin and linezolid, 
and only 20 out of 180 isolates from the pyoderma group were resistant to ampicillin. Typically, 
high frequency of resistance to erythromycin and tetracycline were detected among the isolates 
tested. The percentage of resistant isolates recorded for following antibiotics were as follows: 
tetracycline (healthy [17.7%]; pyoderma [29%]); erythromycin (healthy [4.4%]; pyoderma 
[36.6%]); and enrofloxacin (healthy [8.3%]; pyoderma [25.5%]); gentamicin (healthy [5%]; 
pyoderma [8.3%]); doxycycline (healthy [0.5%]; pyoderma [5%]); ampicillin (healthy [0%]; 
pyoderma [11%]); ciprofloxacin (healthy [5%]; pyoderma [14.4%]); and streptomycin (healthy 
[1.6%]; pyoderma [14%]).  
At the species level, E. faecium were resistant to more antibiotics (8 antibiotics) than any 
other isolates including E. faecalis (7 antibiotics) (Figure 2.5, 2.6). At the species level, E. 
faecalis and E. faecium showed no significant difference in their resistance profile between both 
groups (P<0.05). Resistance level to tetracycline, ampicillin, ciprofloxacin, enrofloxacin, 
gentamicin, doxycycline and streptomycin was higher in E. faecium isolates from pyoderma 
infected dogs as compared to healthy dog isolates (Figure 2.6). Among the E. faecalis isolates, 
resistance to gentamicin, erythromycin, doxycycline, ampicillin and streptomycin was higher as 
compared to the healthy group isolates. Very low level antimicrobial resistance (≤10 
isolates/species/antibiotic tested) was observed in E. hirae (Figure 2.7), E. dispar (Figure 2.8), E. 
canintestini (Figure 2.9), and E. casseliflavus (Figure 2.10) isolates for the different antibiotics 
used in this study. Among E. dispar, and E. canintestini strains, all the isolates from healthy 
group and E. casseliflavus from pyoderma infected dogs were susceptible to all the 
antimicrobials in the test panel. 
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2.4.2.2 Genotypic characterization 
All tetracycline resistant enterococcal isolates were screened to identify the tet genes. The 
tet genes were detected in 50% of total enterococcal isolates tested. Screening of tetracycline 
resistant enterococcal isolates by PCR revealed tet(A), tet(M), tet(S), and tet(O). No tet(C), 
tet(Q), tet(K) and tet(W) were detected (Figure 2.11). The prevalence of tet(M) and tet(O) 
positive isolates was higher from the pyoderma group as compared to healthy group isolates. The 
tet(A) gene was not detected in pyoderma group isolates, but was observed in 18.7% of isolates 
from the healthy group (Figure 2.11). Three percent of isolates from the healthy group and nine 
percent of isolates from the pyoderma group expressed the tetracycline resistance phenotypically 
but did not carry any of the tet genes tested. The overall distribution of tet genes in the 
enterococcal isolates tested are shown in Figure 2.11. Multiple tet genes co-existed in 18.7% 
(6/32) and 2.0% (1/52) of isolates from healthy and pyoderma groups respectively. In these, 
among the healthy group, one isolate harbored tet(A)+tet(M); one isolate had tet(M) )+tet(S) 
genes and five isolates carried tet(A)+ tet(S); while among the pyoderma group one isolate 
harbored tet(M) +tet(S).  
The resistance phenotype for erythromycin was confirmed by the detection of erm(B) 
gene. However, only 12.5% (1/8) of healthy group isolates and 19.5 % (13/66) of pyoderma 
group isolates that were resistant to erythromycin phenotypically, harbored the erm(B) gene. 
All of the resistant isolates with reduced susceptibility to fluoroquinolones (healthy group 
[24], pyoderma group [72]) were subjected to gyrA gene amplification. Sequencing of the 
quinolone resistance determining region (QRDR) of the gyrA gene positive isolates revealed no 
amino acid change corresponding to codon 83 and 87 of the enterococcus gyrA in the isolates 
tested (Table 2.7). 
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2.4.3 Virulence factors 
One or more putative virulence genes (asa1, gelE, esp) were detected in 120 (66.6%) 
healthy group isolates and 92 (51.5%) pyoderma group isolates. E. hirae and E. casseliflavus 
from the healthy group and E. hirae and E. dispar from the pyoderma group, did not harbor any 
of the virulence determinants tested, while they were found at a very low frequency among E. 
canintestine (6 isolates) from pyoderma group isolates. None of the strains examined showed the 
presence of cylA gene in this study. 
The distribution of virulence determinants among E. faecalis and E. faecium is shown in 
Figure 2.12. The gelE was the most widespread virulence determinant present in 67% of the total 
enterococcal isolates (E. faecalis and E. faecium). A higher percentage of gelE and esp positive 
isolates were found in E. faecalis (gelE 92.4%; esp 52.0%) and E. faecium (gelE 16.2%; esp 
1.47%) isolates from the pyoderma group compared with the isolates from healthy group. Also, 
in the E. faecalis isolates from the pyoderma group, asa1 positive isolates was lower (53.2%) 
than in the isolates from healthy group (63.7%).  
Gelatinase, haemolysin and aggregation substance production was tested by phenotypic 
assays. Most of the gelE positive E. faecalis isolates expressed this gene phenotypically in 
gelatinase assay (Figure 2.13). Among the E. faecium strains, only one strain from the healthy 
group and none from the pyoderma group was positive for gelE and gelatin hydrolysis. However, 
13% of E. faecalis isolates from both groups and eleven E. faecium isolate from the pyoderma 
group displayed specific gelE PCR product but did not degrade casein.  
Haemolytic activity was detected in one isolate from the healthy group and five isolates 
from pyoderma group, but cylA gene was not found. 
81 
 
None of the isolates positive for the asa1 gene showed the production of aggregation 
substance by clumping assay. 
2.4.4 Clonal diversity 
E. faecalis and E. faecium strains were selected for PFGE analysis. PFGE clusters were 
based on the similarity cut off of 90% (Cook et al., 2002).  
2.4.4.1 E. faecalis isolates 
Out of 206 E. faecalis strains, 60 isolates were selected (5 isolates per dog): 35 isolates 
from the healthy group and 25 isolates from the pyoderma group.  
Among the healthy group isolates, six different PFGE patterns [type „A‟ (n=5), type 
„B‟(n=15), type „C‟(n=8), type „D‟(n=1) type „E‟(n=5), type „F‟(n=1)] were observed (Fig 2.14.). 
The largest PFGE cluster consisted of 15 isolates. The PFGE type „B‟ and type „C‟ were 
commonly distributed among different dogs. The similarity indices within each clusters were 
>92%. Within the isolates from each dog, the fingerprinting patterns had 100% similarity except 
for one dog (H7) where three different sets of patterns were observed. The minimum similarity 
between different clusters was 53% (Figure 2.14). 
Five major clusters [type „G‟(n=5), type „H‟(n=5), type „I‟(n=6), type „J‟(n=5), type 
„K‟(n=4)] were formed among the pyoderma group isolates (Figure 2.15.). The largest PFGE 
cluster consisted of 6 isolates. The minimum similarity between different clusters was 54%. The 
similarity indices within each clusters were >90%. No clonal relation was detected among the 
isolates from different dogs except for the PFGE cluster type „I‟ where one isolate from P3 and 
five isolates from P5 were included in the same cluster. Except for P3, all dogs showed 
homogenous population of Enterococcus faecalis. 
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2.4.4.2 E. faecium isolates 
All E. faecium strains from the healthy group (n=10) and a group of 15 isolates (3 isolates 
per dog sample) from the pyoderma group were picked randomly to be analyzed by PFGE. 
PFGE clustering grouped 10 isolates from healthy group into 7 different restriction profiles 
[type„A‟ (n=2), type „B‟(n=3), type „C‟(n=1), type„D‟(n=1), type „E‟(n=1), type „F‟(n=1)] 
(Figure 2.16.) and 15 isolates from pyoderma group into 7 types [type „H‟(n=1), type „I‟(n=1), 
type „J‟(n=2), type „K‟(n=1), type „L‟(n=6), type „M‟(n=1), type „N‟(n=3)] (Figure 2.17). 
Among the healthy group isolates, 6 different clusters were found among the isolates 
collected from one dog (H7), suggesting strain diversity within the animal.  
Among the pyoderma group also strain diversity was also observed within the dogs 
except for P5 and P7 dogs. Three dogs i.e P1 (2 isolates), P3 (2 isolates) and P5 (3 isolates) 
shared the same PFGE cluster (type „L‟). 
2.4.5 Conjugation results 
We tested if the tetracycline resistant E. faecalis and E. faecium could transfer their 
resistance traits. Additionaly, we also performed the mating experiment for the remaining E. 
faecalis and E. faecium isolates showing resistance towards other antibiotics included in this 
study and for this, we randomly collected five isolates each from E. faecalis and E. faecium for 
each antibiotic.  
Sixty five tetracycline (30 E. faecalis; 35 E. faecium); 16 erythromycin (6 E. faecalis; 10 
E. faecium); 13 streptomycin (8 E. faecalis; 5 E. faecium); 7 doxycycline (4 E. faecalis; 3 E. 
faecium); 15 gentamicin (10 E. faecalis; 5 E. faecium); 6 ampicillin (1 E. faecalis; 5 E. faecium) 
and 11 enrofloxacin (3 E. faecalis; 8 E. faecium) resistant donors were tested for the conjugative 
transfer of resistance traits in filter and broth mating traits (Table 2.5). 
83 
 
Twenty seven tetracycline resistant isolates (8 E. faecalis; 19 E. faecium); 1 erythromycin 
resistant E. faecalis and 1 doxycycline resistant E. faecalis yielded their respectively antibiotic 
resistant transconjugants. The transfer frequency ranged from 10
-2
 to 10
-12
 transconjugants/ donor 
and 10
-5
 to 10
-13
 transconjugants / recipient (Table 2.5). 
Among the tetracycline resistant isolates, we were able to transfer tet(M) and tet(S) in E. 
faecium, while tet(M) was the only tet gene transferred in E. faecalis. The transfer frequencies 
are shown in Table 2.6. Transconjugants positive for tet genes were confirmed by the PCR assay. 
2.5 Discussion 
The development and spread of antimicrobial resistance in clinical practice is a major 
threat to the public health (Levy et al., 2004). The commensal gut bacteria are likely to be the 
major contributor for the development of resistance in bacterial pathogens (Salyers et al., 2004). 
Gram positive cocci, in the genus Enterococcus, the common gut microbiota of humans and 
animals, are one of the medically important antibiotic resistant nosocomial pathogen (Hildron et 
al., 2008). There are several sources for the acquisition of antibiotic resistant enterococci 
including care providers, food animals, contaminated meat, waste water and pet animals 
(Hammerum et al., 2010). Studies have shown that stress in the host animals can alter the 
gastrointestinal microbiota (Moon et al., 1979; Savage et al., 1982; Tannock et al., 1983) and 
increases the antimicrobial resistance in the intestinal microbiota (Dawson et al., 1984; Langlois 
et al., 1986; Molitoris et al., 1987). Animals, particularly the pet animals are believed to be a 
reservoir of antibiotic resistant bacteria (Guardabassi et al., 2004). Several studies in Europe and 
U.S. have reported increased prevalence of resistance to antibiotics in bacterial species such as 
Staphylococcus intermedius, Escherichia coli and Enterococcus isolated from pet animals 
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(Guardabassi et al., 2004). One of the major concerns is the potential transmission of 
antimicrobial resistant pathogens from pet animals to humans.  
Relatively sparse data are available from the U.S. with regard to enterococcal prevalence 
in dogs except for the studies done in dogs with urinary tract infection (UTI) (Simjee et al., 
2002) and one study in clinically healthy dogs (Jackson et al., 2009). Simjee et al.,(2002) 
determined the antibiotic susceptibility profile of urinary tract isolates, while Jackson et al., 
(2009) reported susceptibility profile of enteroccci from nasal, teeth, rectal, belly and hindquarter 
sites of dog. Simjee et al.,(2002) observed high incidence of resistance to gentamicin (37%), 
penicillin (74%) and tetracycline (77%) in their total 35 enterococcal isolates. E. faecium isolates 
were found to be resistant to more antibiotics than other enterococcal species identified in this 
study. Molecular analysis of one E. faecium isolate with higher level of resistance to gentamicin 
and vancomycin revealed the presence of two transposons, Tn1546 and Tn5281 associated with 
vanA and aac6’-aph2” genes, respectively (Simjee et al., 2002). Genotypic analysis of this 
canine E. faecium clone suggests that Tn1546 associated with vanA was acquired from the 
human vancomycin resistant E. faecium. Jackson et al.,(2009) isolated enterococci from healthy 
dogs and found that ≥33% of the isolates were resistant to three antibiotics: lincomycin (58%), 
flavomycin (33%) and tetracycline (33%); while ≤7% of isolates were resistant to the remaining 
antibiotics tested: erythromycin (7%), tylosin (7%), penicillin (6%), kanamycin (6%), 
streptomycin (6%), gentamicin (4.5%), chloramphenicol (4%), ciprofloxacin (2%), 
nitrofurantoin (1%). None of their isolates were resistant to vancomycin, daptomycin and 
linezolid. These studies reported the data from different sites of body which is not sufficient to 
determine the antimicrobial resistance of the gut microbiota in companion animals. Only one 
study is available reporting the susceptibility profile of enterococci from dogs with pyoderma 
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infection (Rantala et al., 2004). They compared 37 enterococcal isolates from pyoderma infected 
dogs (collected after an antibiotic treatment) with 73 isolates from the control group. For 
studying the resistance prevalence in these isolates, they screened for two antimicrobial agents: 
ampicillin and vancomycin. The frequency of ampicillin resistance was lower (4-7%) with no 
significant difference between the two groups. The enterococcal isolates from both groups were 
susceptible to vancomycin. Examining published data, it could be concluded that they examined 
only few isolates and there is lack of information regarding how many isolates were collected 
from each fecal sample (Rantala et al., 2004).  
Our study is the first to address the potential association between pyoderma infection and 
the increase in antimicrobial drug resistance and virulence of enterococci from the feces of dogs 
in the U.S. In addition, it also provides detailed susceptibility profile, virulence profile of 
enterococci and genotypic relationship of these resistant isolates in dogs. Pyoderma is a common 
bacterial skin infection in dogs most often caused by Staphylococcus pseudintermedius. It can be 
a acute or chronic problem (Pedersen et al., 2007) with clinical symptoms characterized by 
scaling. Chronic infections can cause stress in animals due to several factors including 
discomfort and pain. Furthermore, some studies in humans have demonstrated that the plasma 
level of catecholamines was altered in several skin diseases such as psoriasis (Weigl, 2000; 
Schmid-Ott et al., 1999), cystic acne (Schulpis et al., 1999), alopecia (Puchalski, 1986) and 
vitiligo (Zaki et al., 2009). Hence, the study was proposed that stress due to pyoderma infection 
increases antimicrobial resistance and virulence and decreases the clonal diversity of the 
enterococcal population of dogs.  
In this study, samples were collected from clinically healthy dogs and pyoderma infected 
dogs. Both groups consisted of dogs belonging to different age, sex, breed and owners. In the 
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healthy group, animals were not exposed to antibiotics for at least one year prior to sample 
collection. In pyoderma group, 3 dogs were never exposed to antibiotics prior to the collection of 
the samples for this study; while 6 dogs had prior exposure to antibiotics but none of these 6 
dogs received antibiotics for at least seven months prior to sampling. The concentration of 
enterococci in healthy dogs ranged from 10
5
-10
7
 CFU/g which is similar to the concentration 
reported in healthy humans (Jett et al., 1994; Kleessen et al., 2000), birds (Middleton and 
Ambrose, 2005) and cattle (Anderson et al., 2008). The concentration of enterococci in 
pyoderma infected dogs could not be determined due to samplying type (rectal swab). 
Ossiprandi et al.(2004), reported that E. faecalis was the most prevalent species in dogs 
with and without previous antibiotic treatment. A similar result was reported by Jackson et 
al.,(2009) where E. faecalis was the dominant species isolated from rectal samples of healthy 
dogs. Indeed, E. faecalis and E. faecium are the two species reported to be most frequently 
isolated from feces of dogs and cats (Rodrigues et al., 2002; Poeta et al., 2006; Jackson et al., 
2009). In the present study also E. faecalis was the dominant spp. in the healthy dogs. A new 
species, E. canintestini as described by (Naser et al., 2005) was found in the fecal microbiota of 
one dog from the pyoderma group.   
Based on the antibiotic resistance phenotype, erythromycin and tetracycline resistance 
were encountered most frequently as compared to the other antibiotics tested; and the similar 
results are reported in previous studies (Poeta et al., 2006; Ossiprand et al., 2008; De graef et al., 
2004; Jackson et al., 2009). This relatively high prevalence of tetracycline resistant isolates may 
explain the wide distribution of tetracycline in the environment. Still the overall prevalence of 
tetracycline resistance in our dog isolates were low to what was found in cattle and people where 
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tetracycline resistance levels were more than 40% (Hershberger et al., 2005; Anderson et al., 
2008; Atkinson et al., 1997) 
Although the tetracycline resistance was ≤ 30%, the level of doxycycline resistance was 
only ≤5% in our study. Similarly, lower level of doxycycline resistance has also been reported in 
enterococci isolated from human clinical infections from the U.S. (Low et al., 2001; Evans et al., 
1997). Doxycycline is a semisynthetic tetracycline derivative and was developed to enhance the 
antibacterial activity of tetracycline. This may be the reason for finding doxycycline to be more 
effective against our enterococcal isolates than tetracycline.  
In the present study, resistance to aminoglycoside antibiotics (gentamicin, streptomycin) 
was detected in both groups, but at low frequency. Absence of high level gentamicin resistance 
has been reported previously (Poeta et al., 2006). Damborg et al.,(2008) studied resistance levels 
among enterococci isolated from the healthy dogs in Portugal, showing low resistance to 
gentamicin (6%).  
The beta-lactam antibiotic, ampicillin was more effective. Only 11% of isolates were 
resistant to ampicillin from the pyoderma group while all the isolates from the healthy group 
were susceptible. All of these ampicillin resistant isolates were E. faecium isolated from one dog. 
Low levels of ampicillin resistance in enterococci from pet animals with pyoderma infection has 
been previously reported (Rantala et al., 2004) which may be because this antibiotic is not 
usually included in their treatment regimen due to their ineffectiveness against Staphylococcus 
pseudintermedius.  
A relatively low percentage (≤ 25%) of quinolone resistant isolates was observed in this 
study (Figure 2.4). This is higher when compared to the results described by Poeta et al., (2006), 
reporting 8% of ciprofloxacin résistance in enterococcal isolates from pets. Fluoroquinolones are 
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broad spectrum antibiotics and are often used for treating infections in animals and humans. In 
the U.S., enrofloxacin, difloxacin and orbifloxacin are liscensed for use in pet animals and are 
usually used for treating skin/wound, urinary tract and respiratory infections 
(http://whqlibdoc.who.int/hq/1998/WHO_EMC_ZDI_98.10.pdf). 
Linezolid, a drug used as second line of treatment option for human enterococcal 
infections (Damborg et al., 2008) was active against all the enterococcal isolates which is 
consistent with the results reported by Jackson et al., (2009).  
No pets were positive for vancomycin resistant enterococci (VRE) in this study which 
matches with studies of healthy dogs reported from the U.S. (Jackson et al., 2009); Portugal 
(Delgado et al., 2007), and Italy (Ossiprandi et al., 2008). Our results are in contrast to the 
observation reported from other studies from Europe where VRE was identified from dogs 
(Devriese et al., 1996). This might be probably due to their association with farm animals fed 
with glycopeptides, avoparcin as a growth promoter or might be due to ingestion of VRE 
contaminated raw meat from these animals (Van Belkum et al., 1996; Borgen et al., 2001).  
The resistance mechanism for the observed phenotypes were determined for 
erythromycin, tetracycline and quinolone antibiotics as these were the only antibiotics with 
greater than 25% phenotypic prevalence. None of our macrolide resistant enterococcal species 
other than E. faecalis (none in the healthy group; eleven isolates in pyoderma group) and E. 
faecium (one isolate in healthy group; two isolates in pyoderma group) species carried the 
erm(B) gene, thus partly confirming the data of Jackson et al.,(2010). They found erythromycin 
resistance only in E. faecalis and E. faecium isolates with erm(B) gene gene detected in 95.6% 
resistant isolates. The erm(B) gene, the most frequently found macrolide resistance gene among 
the enterococcal isolates (Poeta et al., 2006; Jensen et al., 1999) also exhibits macrolide-
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lincosamide-streptogramin cross-resistance (Jensen et al., 1999). About ≥80% of the macrolide 
resistant isolates examined in this study were negative for the presence of erm(B) gene, 
suggesting the presence of other erythromycin resistance genes such as erm(A), erm(C), mef(A), 
mef(E), msr(A), mre(A), that were not tested for in the present study. 
For tetracycline resistance, there are twenty-nine known tetracycline genes: 18 of the tet 
genes code for efflux pumps and 7 for ribosomal protection protein (Chopra and Roberts, 2001). 
The tet(M) gene is reported to be the most frequent tetracycline resistance gene in enterococci 
(Jackson et al., 2010; Devriese et al., 1992). This is partly in accord with our results where 
tet(M) was present in 33% of isolates in the pyoderma group. In both the groups, tet(S) (healthy 
[65.6%]; pyoderma [34.6]) was more commonly found. The gene, tet(S) encodes for ribosomal 
protection protein and has 79% and 72% sequence identity with tet(M) and tet(O) genes, 
respectively (Charpentier et al., 1994). The observation that few of our tetracycline resistant 
isolates tested negative for all the tet genes suggests that there are other tet genes that we did not 
screen for. 
Mutations in the codon-83 and codon-87 have been associated with quinolone resistance 
in E. faecalis and E. faecium (Korten et al., 1994). In this study, amplification and sequence 
analysis of gyr A positive isolates revealed no mutation in both the codons suggesting that, the 
mechanism of resistance in these isolates may be due to other mutations (Korten et al., 1994). 
Widespread dissemination of several antimicrobial resistance genes among enterococci 
may be attributed to horizontal transfer (Wirth, 1994). Most of the tet genes such as tet(M), 
tet(Q), tet(S) are commonly present on mobile genetic elements (Paulsenet al., 2003; Davis et 
al., 2005). The tet genes have been shown to transfer in enterococcal species isolated from 
different sources, but not from canine fecal samples. Since prevalence of resistant isolates were 
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high in E. faecalis and E. faecium strains, these two species were included in the intraspecies 
conjugal transfer of antibiotic resistant traits conjugation experiments. Some of the resistant E. 
faecalis or E. faecium failed to transfer their respective resistance traits, suggesting the presence 
of genes encoding their respective antibiotic resistant traits on non-conjugative element. In E. 
faecalis, tetracycline, erythromycin and doxycycline were transferable while tetracycline was the 
only antibiotic resistance trait transferred in E. faecium. The rate of gene transfer was relatively 
higher for tetracycline resistance determinants than any other antibiotics tested (Table 2.5). The 
conjugal gene transfer that occurred with low frequency (≤10-13) for erythromycin and 
doxycycline resistance determinants is likely due to mutations. The only tet genes that were 
transferred were tet(M) and tet(S) which is not surprising as these two genes are known to be 
associated with conjugative elements (Flanngan et al., 1994; Roberts et al., 2006). 
There are several virulence factors present in the enterococcal isolates that have been 
reported  in animal infection model experiments (Jett et al., 1999). Here, we detected virulence 
traits such as haemolysins, agglutination substance, enterococcocal surface proteins, and 
gelatinase in our enterococcal isolates. Most of the isolates positive for the virulence 
determinants were either E. faecalis or E. faecium. Very few isolates were positive in the 
hemolysin assay with 0.5% and 2.5% prevalence in healthy and pyoderma isolates, respectively. 
Similar were results reported by (Gulhan et al., 2006) where cytolysin activity was absent in all 
enterococcal isolates of canine origin. None of our isolates including the hemolysin positive 
isolates were positive for the cylA gene. This may suggest the occurence of other genes in the cyl 
operon. All our isolates were tested for their casein degradation ability. The prevalence of gelE 
was higher in the E. faecalis isolates from pyoderma dogs than from healthy ones, as already 
reported by Archimbaud et al.,(2002). Most of the gelatinase positive isolates showed the 
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correlation with the expression of the gelE gene. We determined the occurrence of the esp gene 
in E. faecalis and E. faecium isolates, with higher incidence in the pyoderma group (52%) as 
compared to the healthy group (15.7%). In contrast, Harada et al.,(2005) reported low prevalence 
of esp-positive isolates from pet animals with most of the esp-positive strains from the healthy 
animals. The conjugative transfer in E. faecalis is mediated by the aggregation substance (Kreft 
et al., 1992). Although it is found mostly in E. faecalis, there are reports indicating the presence 
of asa1 in vancomycin resistant E. faecium (Varaldo et al., 2003). In the present study, 
aggregation substance was found only in E. faecalis. It was associated more frequently with the 
healthy group isolates. Thus these asa1 isolates may act as a source for horizontal transfer to 
other E. faecalis isolates in the gut of dogs which could result in a threat to public health. 
We used PFGE to study the clonal structure of selected E. faecalis and E. faecium strains. 
The genetic diversity was defined by comparing the number of different PFGE types between 
both groups. Our expectation was to show a less diverse gut microbiota in pyoderma animals as 
compared to the healthy animals due to stress in pyoderma dogs. We found that there was no 
difference in diversity among E. faecium isolates from both groups while among E. faecalis 
isolates, pyoderma infected dogs harbored less diverse isolates as compared to healthy dogs. One 
of the plausible explanations for finding no difference in the diversity among the E. faecium 
isolates from both groups would be due to the variation in the number of isolates between the 
healthy and pyoderma group included for PFGE analysis. For E. faecium strains, we had only 10 
isolates from the healthy group and in the pyoderma group, 15 isolates were selected for this 
study. Hence it is necessary to analyze large number of isolates in order to determine clonal 
diversity with respect to health status of animal. Cluster formation in the PFGE dendrogram 
depends mainly on the choice of similarity cutoff (Stenske et al., 2009). In the present study, 
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based on the similarity cutoff of 90%, (Cook et al., 2002) dominant genetic profiles were 
observed among healthy and pyoderma groups, except for E. faecium strains from the healthy 
group that showed no overlap (Fig 2.6.). The potential explanation for sharing the same PFGE 
pattern by the isolates from different healthy dogs is that of all the healthy dogs included in this 
study were owned by the people who were working at the same place. Enterococci, often 
reported from the hospital settings, might also exist in the community settings that are not 
directly linked to the hospital settings, as these are the gut commensals in humans and all warm 
blooded animals (Larsen et al., 2010). Close physical contact between pets and their owners 
might have provided a suitable environment for the possible transfer of these enterococcal strains 
to their pet animals (Guardabassi et al., 2004; Simjee et al., 2002). Another explanation for 
finding some clones in the same cluster might be due to the use of single restriction enzyme for 
digestion of DNA in the PFGE protocol used in this study (Davis et al., 2003). Use of additional 
enzymes may be required to detect mutations and other changes in the bacterial chromosome. 
The clones clustered in the PFGE type „C‟ were originated from the same age group dogs. 
Among the pyoderma group isolates, an overlap was observed among dogs P1, P3, P5 (Figure 
2.15.; Figure 2.17.). But none of these dogs belonged to the same age and breed, and even the 
time of the sample collected from these animals was different. However, this overlap infers 
clonal spread of these strains to some extent within the healthy and pyoderma dogs. No overlap 
among the E. faecium strains from healthy animals might be due to fewer number of isolates and 
also most of the isolates originated from the single animal. Thus, clonal relationships were 
observed within both group isolates except for E. faecium strains from healthy animals. Among 
the healthy group isolates, dog H7 harbored a most diverse population of enterococcal species 
(Figure 2.14; Figure 2.16). The majority of the different PFGE types identified in this study were 
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found in individual dogs only. The similarities of PFGE patterns within the dog suggests that 
there is animal to animal variation in the genetic diversity of these strains. This variation in 
individual animals may be attributed to factors that enhance their survival and growth in the GIT. 
Taken together, PFGE results show that pyoderma infection resulted in lower genotypic diversity 
in E. faecalis strains. There are studies where PFGE analysis was performed in enterococcal 
isolates from dogs (Jackson et al., 2010; Simjee et al., 2002; Manson et al., 2003), but none of 
these isolates were from the pyoderma infected dogs. This is the first study, where the genetic 
diversity of enterococcal strains in pyoderma dogs were studied. 
Taken together, these data indicate that enterococci are common intestinal microbiota of 
dogs (De Graef et al., 2005). Each fecal sample showed diversity in the enterococcal strains, and 
this difference in the enterococcal population might be due to factors that influence the 
composition of intestinal microbiota such as age, sex, diet and genetic makeup of the individual 
animal (Tannock 1999; 2005). Data on antimicrobial resistance in dogs show that the overall 
resistance rates for all the enterococcal strains were low for all the antibiotics tested (range: 0-
36.6%). All of our isolates were susceptible to linezolid and vancomycin antibiotics, that are 
commonly used for treatment of multidrug resistant gram positive bacteria such as MRSA and 
VRE in human healthcare. However, the proportion of resistant isolates was higher among the 
pyoderma group in comparison to the healthy group isolates eventhough the difference was not 
statistically significant. Genotyping revealed less diverse E. faecalis isolates from pyoderma 
dogs as compared to the healthy group isolates. In the pyoderma group, three dogs were never 
exposed to antibiotics prior to sampling (P1, P6, and P8). Antimicrobial resistance was observed 
among the isolates from P1 and P6 samples against tetracycline, erythromycin, ciprofloxacin and 
enrofloxacin. These changes might be attributed to stress on animals due to pyoderma and/or 
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visit to the clinic (unfamiliar environment, people) (Rostango, 2009). This may cause alteration 
in the intestinal pH and ultimately affect the gut microbiota (Mathew et al., 1996). Bacterial 
resistance may be indirectly affected, if these changes in the gut environment cause changes in 
the efflux mechanism or expression of proteins involved in antibiotic resistance. Stress-related 
factors might have influenced horizontal transfer of resistance genes; this might also explain the 
prevalence of certain resistant strains. Studies have shown that stressed animals selectively shed 
bacteria in their feces that are closely adherent to the intestinal mucosa (Langlois and Dawson, 
1999). If such organisms harbor antibiotic resistant genes, the prevalence of resistant bacteria 
will be higher in the feces of animals that experience significant stress (Mathew et al., 2002).  
Hence, our study demonstrates that antimicrobial resistance in enterococci from 
pyoderma dogs was higher as compared to healthy dog isolates. Pyoderma group dogs harbored 
less diverse population of E. faecalis isolates than the isolates from healthy dogs. Further studies 
will be necessary to assess whether this difference in the resistance prevalence and diversity was 
related to the host stress. Since enterococci are known to transfer resistance genes to other 
bacteria of same or different species, appropriate husbandry measures should be carried out to 
relieve animals from stress in order to reduce the prevalence of antibiotic resistant strains.  
The results from this study are important from a public health point of view as most of 
the antibiotics employed in the present study are commonly used for treatment of infections in 
humans.  
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2.6 Conclusions 
The reports on the community-acquired and nosocomial infections have identified 
antibiotic resistant enterococci as one of the important clinical group (Hammerum et al., 2010). 
This study was conducted to characterize enterococci from healthy and pyoderma infected dogs. 
The concentration of enterococci in the fecal samples from the healthy group was 6.7 ± 0.2×10
6 
CFU/g. Considerable diversity was observed within the enteroccal population, with E. faecalis as 
the dominant species in both groups. Antimicrobial resistance in the pyoderma infected dogs was 
higher than the healthy dogs with highest resistance frequency observed to erythromycin 
(36.6%). At the species level, relatively high resistance was observed in E. faecium isolates. No 
obvious difference was observed in the virulence traits. Intra-species transfer by the conjugation 
assay revealed tetracycline, erythromycin and doxycycline resistance traits transferable in E. 
faecalis while in E. faecium, only tetracycline transferred. Genotyping of E. faecium strains 
revealed no difference in the heterogenicity while among the E. faecalis strains, isolates in the 
gut of pyoderma dogs were less diverse as compared to healthy animals.  
The findings in this study suggest that although, the overall antimicrobial resistance, 
virulence and horizontal gene transfer remained low, pyoderma in dogs appears to be associated 
with higher frequency of antimicrobial resistance in enterococci. This may be due to pyoderma 
related stress that might have altered the resistant enterococci in canine feces. Further studies are 
needed to understand the mechanism by which stress induces susceptibility in the gut 
commensals to explain the difference in the resistance profile of pyoderma and healthy dogs. 
Healthy and pyoderma infected dogs do not represent major reservoir of antibiotic 
resistant enterococci and serious public health risk. 
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2.7 Figures and Tables 
 
 
Table 2.1  Information on healthy dogs 
 
Dogs Neuter/Spay Age Breed Diet 
H-1 FS 5 yr Golden retriever/Yellow labrador mix Maintanence diet 
H-2 MN  1 yr Terrier mix Maintanence diet 
H-3 FS  17 yr Border Collie Maintanence diet 
H-5 FS  12 yr Terrier mix Maintanence diet 
H-6 FS  7 yr Pomeranian/healer mix Maintanence diet 
H-7 MN  3 yr Labrador/ Shepherd Maintanence diet 
H-8 MN  4 yr Yorkshire terrier+bichon Maintanence diet 
H-9 MI  6 yr Yorkshire Maintanence diet 
H-10 MI  3 yr Rottweiler Shepherd Maintanence diet 
           Yr, Year 
           MI, Male intact; MN, Male neutered; FS, Female spayed 
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Table 2.2  Information on pyoderma dogs 
 
Dogs Sex Age Breed History of antibiotic 
exposure  
Antibiotics used for treatment 
P-1 MI 4 months German Shepherd No previous exposure N/A 
P-2 MN 7 yrs Australian Shepherd mix 9 months cephalosporin, ampicillin, enrofloxacin  
P-3 MN 5 yrs Wheaten Terrier 1 year metronidiazole  
P-4 FS 4 yrs Boxer 1yr and 4 months Amoxicillin-clavulanic acid  
P-5* MN 10.5 yrs Australian Shepherd 11 months gentamicin (topical use), doxycycline 
P-6 MN 11 yrs German Shepherd No previous exposure N/A 
P-7 MN 3.5 yrs Mixed Breed 7 months gentamicin (topical use), no systemic antibiotics 
P-8 FS 4.5 yrs Dalmatian No previous exposure N/A 
P-9* FS 14 yrs Australian Shepherd 7 months cephalosporin, gentamicin (tropical use)  
N/A, Not applicable 
MI, Male intact; MN, Male neutered; FS, Female spayed 
* History of chronic pyoderma 
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Table 2.3  Primer sets for PCR used in this study 
 
Gene Sequence(5’-3’) Product 
size(bp) 
Reference 
Species specific genes 
E. faecalis F-TCAAGTACAGTTAGTCTTTTATTAG 
R-CGATTCAAAGCTAACTGAATCAGT 
941 Kariyama et al.,(2000) 
E. faecium F-TTGAGGCAGACCAGATTGACG 
R-TATGACAGCGACTCCGATTCC 
658 Kariyama et al.,(2000) 
E. casseliflavus F-CGGGGAAGATGGCAGTAT 
R-CGCAGGGACGGTGATTTT 
484 Malen et al.,(1995) 
E. gallinarum F-GGTATCAAGGAAACCTC 
R-CTTCCGCCATCATAGCT 
822 Malen et al.,(1995) 
16S rRNA F-GGATTAGATACCCTGGTAGTCC 
R-TCGTTGCGGGACTTAACCCAAC 
320 Kariyama et al.,(2000)  
sodA F-CCITAYICITAYGAYGCIYTIGARCC 
R-ARRTARTAIGCRTGYTCCCCAIACRTC 
438 Poyart et al.,(2000) 
Antibiotic resistance genes   
tet(A) F-GCTACATCCTGCTTGCCTTC 
R-CATAGATCGCCGTGAAGAGG 
210 Ng et al.,(2001) 
tet(C) F-CTTGAGAGCCTTCAACCCAG 
R-ATGGTCGTCATCTACCTGCC 
418 Ng et al.,(2001) 
tet(Q) F-TTATACTTCCTCCGGCATCG 
R-ATCGGTTCGAGAATGTCCAC 
904 Ng et al.,(2001) 
tet(M) F-GTGGACAAAGGTACAACGAG 
R-CGGTAAAGTTCGTCACACAC 
406 Doherty et al.,(2000) 
tet(S) F- CATAGACAAGCCGTTGACC 
R-ATGTTTTTGGAACGCCAGAG 
667 Ng et al.,(2001) 
tet(K) F-TCGATAGGAAACAGCAAGTA 
R-CAGCAGATCCTACTCCTT 
169 Ng et al., (2001) 
tet(O) F-AACTTAGGCATTCTGGCTCAC 
R-TCCCACTGTTCCATATCGTCA 
515 Ng et al., (2001) 
tet(W) F-GAGAGCCTGCTATATGCCAGC 
R-GGCCGTATCCACAATGTTAAC 
168 Aminov et al.,(2001) 
erm(B) F-GAAAAGGTACTCAACCAAATA 
R-AGTAACGGTACTTAAATTGTTTAC 
639 Sutcliffe et al.,(1996) 
gyr(A) F-CGGGATGAACGAATTGGGTGTGA 
R-AATTTTACTCATACGTGCTTCGG 
141 Korten et al.,(1994) 
Virulence genes   
gelE F-TATGACAATGCTTTTTGGGAT 
R-AGATGCACCCGAAATAATATA 
213 Vankerckhoven et al.,(2004) 
asa1 F-GCACGCTATTACGAACTATGA 
R-TAAGAAAGAACATCACCACGA 
375 Vankerckhoven et al.,(2004) 
cylA F-ACTCGGGGATTGATAGGC 
R-GCTGCTAAAGCTGCGCTT 
688 Vankerckhoven et al.,(2004) 
esp F-AGATTTCATCTTTGATTCTTGG 
R-AATTGATTCTTTAGCATCTGG 
510 Vankerckhoven et al.,(2004) 
  F, forward; R, reverse 
  I = A, T, G or C; Y = C or T; R = A or G 
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Table 2.4  Concentration of enterococci in the feces of healthy and pyoderma dogs 
 
 
 Samples Mean±SEM 
(CFU per gram) 
Number of 
isolates (n) # 
 H-1 8.8 ± 1.6 x 10
5
 20 
 H-2 2.6± 0.2 x 10
5
 20 
 H-3 4.7 ± 0.1 x10
7
 20 
 H-5 2.6 ± 0.3 x10
6
 20 
 H-6 4.5 ± 0.6 x10
5
 20 
 H-7 4.7± 2.7 x10
5
 20 
 H-8 N/A 20 
 H-9 5.3 ± 0.8 x10
5
 20 
 H-10 1.5 ± 0.1 x 10
6
 20 
 Mean±SEM/Total 6.7 ± 0.2 x10
6
 180 
 P-1 N/A 20 
 P-2 17.3 x 10
5
  20 
 P-3 N/A 20 
 P-4 N/A 20 
 P-5 N/A 20 
 P-6 7.0 x 10
5
  20 
 P-7 N/A 20 
 P-8 N/A 20 
 P-9 N/A 20 
 Mean/Total 1.2 x 10
6
 180 
N/A, Not applicable (rectal swabs) 
#, selected for further analysis randomly 
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Table 2.5  Intra-species transfer of antibiotic resistance traits in E. faecalis and E. faecium isolates 
 
   Broth mating/Transfer rate 
 
Filter mating/Transfer rate 
Wild isolates 
 
Total 
isolates 
Enterococcus 
Recipient 
n (%) T/D 
Mean±SEM 
T/R 
Mean±SEM 
n (%) T/D 
Mean±SEM 
T/R 
Mean±SEM 
Tetracycline         
  E. faecalis 30 OG1SSp 7(23.3) 3.8 ± 2.1x10
-4
 10.3 ± 6.6x10
-8
 8 (26.6) 4.5 ± 1.9x10
-5
 4.4 ± 1.7x10
-6
 
 E. faecium 35 TX5034 14(40.0) 1.3 ± 0.6x10
-2
 3.0 ± 1.0x10
-7
 19(54.2) 2.0 ± 1.7x10
-3
 2.0 ± 1.2x10
-5
 
Erythromycin         
E. faecalis  6 OG1SSp 1(20) 1.0 x 10
-8
   0.3 x 10
-11
   1(20) 7.4 x 10
-10
   4.6 x 10
-13
   
E. faecium 10 E. faecium(45-26) 0 N/A N/A 0 N/A N/A 
Doxycycline         
E. faecalis 4 OG1SSp 1(25) 2.0 x10
-9
 1.4 x10
-12
 1(25) 3.4 x10
-11
 2.6 x10
-12
 
E. faecium 3 TX5034 0 N/A N/A 0 N/A N/A 
Gentamicin         
E. faecalis 10 OG1SSp 0 N/A N/A 0 N/A N/A 
E. faecium 5 E. faecium(38-42) 0 N/A N/A 0 N/A N/A 
Streptomycin         
E. faecalis 8 E. faecalis (41-31) 0 N/A N/A 0 N/A N/A 
E. faecium 5 ATCC-51559 0 N/A N/A 0 N/A N/A 
Enrofloxacin         
E. faecalis 3 JH2-2 0 N/A N/A 0 N/A N/A 
E. faecium 8 ATCC-51559 0 N/A N/A 0 N/A N/A 
Ampicillin         
E. faecalis 1 E. faecalis (41-31) 0 N/A N/A 0 N/A N/A 
E. faecium 5 ATCC- 19454 0 N/A N/A 0 N/A N/A 
T/D, Number of transconjugants per donor; T/R, Number of transconjugants per recipient 
N/A, Not applicable 
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Table 2.6  Intra-species transfer of tet genes from E. faecalis and E. faecium 
 
   Broth mating/Transfer rate 
 
Filter mating/Transfer rate 
Wild 
isolates 
Enterococcus 
Recipient 
tet genes n (%) T/D 
Mean±SEM 
T/R 
Mean±SEM 
n (%) T/D 
Mean±SEM 
T/R 
Mean±SEM 
E. faecalis OG1SSp tetM (n=21) 7 (33.3) 3.8 ± 2.1x10
-4
 10.3 ± 6.6x10
-8
 8 (38.0) 4.5 ± 1.9x10-5 4.4 ± 1.7x10-6 
  tetA (n=5) 0  N/A N/A 0  N/A N/A 
  tetS (n=21) 0  N/A N/A 0  N/A N/A 
E. faecium TX5034 tetM (n=5) 0  N/A N/A 3 (60.0) 3.0 ± 2.9x10
-5
 3.0 ± 2.9x10
-6
 
  tetO (n=12) 0  N/A N/A 0  N/A N/A 
  tetS (n=18) 14 (77.8) 1.3 ± 0.6x10
-2
 3.0 ± 1.0x10
-7
 16 (88.9) 2.3 ± 0.2x10
-3
 2.3 ± 1.4x10
-5
 
T/D, Number of transconjugants per donor; T/R, Number of transconjugants per recipient 
N/A, Not applicable 
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Figure 2.1  Diversity of enterococci from canine fecal samples 
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Figure 2.2  Diversity of enterococci in individual healthy dogs 
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Figure 2.3  Diversity of enterococci in individual dogs with pyoderma 
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Figure 2.4  Antibiotic resistance profile (%) of enterococci from canine fecal samples 
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Figure 2.5  Antibiotic resistance profile (%) of E. faecalis from canine fecal samples 
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Figure 2.6  Antibiotic resistance profile (%) of E. faecium from canine fecal samples 
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Figure 2.7  Antibiotic resistance profile (%) of E. hirae from canine fecal samples 
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Figure 2.8  Antibiotic resistance profile (%) of E. dispar from canine fecal samples 
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Figure 2.9  Antibiotic resistance profile (%) of E. canintestini from canine fecal samples 
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Figure 2.10  Antibiotic resistance profile (%) of E. casseliflavus from canine fecal samples 
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Figure 2.11  Prevalence and diversity of tet genes from the isolates phenotypically 
resistant to tetracycline 
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Figure 2.12  Profile and the prevalence of the esp and gelE gene in  
                                             E. faecalis and E. faecium and asa1 gene in E. faecalis 
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Figure 2.13  Correlation of gelE and gelatinase phenotype in E. faecalis 
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Figure 2.14  Clonal diversity of E. faecalis from healthy dogs 
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Figure 2.15  Clonal diversity of E. faecalis from pyoderma dogs 
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Figure 2.16  Clonal diversity of E. faecium from healthy dogs 
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Figure 2.17  Clonal diversity of E. faecium from pyoderma dogs 
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Table 2.7  Alignment of sequence of gyrA gene on selected quionolone resistant isolates 
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*, Isolates from this study 
AS, antibiotic susceptible (negative control); AR, antibiotic resistant (positive control) 
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Chapter 3 
 
Gut microbial diversity of healthy dogs 
 
3.1 Abstract 
The gastrointestinal microbiota of mammals play an important role in protecting the host 
from exogenous pathogenic microorganisms, and an imbalance among these microbes can lead 
to the development of disease. Our knowledge about these complex microbial communities is 
mostly based on the studies done on human gut commensals. As in humans, disruptions of gut 
microbiome can have an impact on the health of the dogs, but portion of the budget is allocated 
to small animal veterinary practices surprisingly, only few studies have been reported. In this 
study, we surveyed the gut microbial community from ten healthy dogs. Bacterial diversity was 
determined by the bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP) of about 
600bp of the 16S rRNA gene. We characterized a total of 76,758 sequences obtained from ten 
fecal samples and determined the bacterial richness and diversity (3% and 5% divergence). 
Bacterial sequences were assigned to twelve phyla and 178 genera. Firmicutes represented the 
most dominant phylum. Five of 12 most common phyla were shared among all the microbial 
communities. The composition of the microbial community differed among the dogs in both the 
abundance and richness. Based on 3% dissimilarity, the number of operational taxonomical units 
(OTUs) (analyzed by MOTHUR) was 183 and the Shannon diversity index was estimated as 
3.09 (mean). Our results indicate that the H-4 sample is the sample with great diversity at the 
species level and the H-9 sample at the phylum level, while the H-5 sample has the most diverse 
taxa. Twelve different genera were consistently identified in all the fecal samples. Among them 
Lactobacillus, Ruminococcus, Turicibacter, Clostridium, and Fusobacterium represented >2% of 
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the sequences and showed wide diversity in the bacterial species. Highest bacterial diversity was 
observed among the Clostridium genus (53 spp.) and lowest among the species belonging to the 
genus, Turicibacter (one spp). The dominant bacterial genuses identified in ten samples were 
Turicibacter, Megamonas, Lactobacilli, Escherichia, Clostridium, and Fusobacterium. In 
conclusion, this study provides data to support the hypothesis that the gut microbiota of healthy 
dogs is diverse and also provides baseline information about the canine gut microbial community 
in healthy animals. 
Key words: bTEFAP, healthy dogs, fecal microbiota  
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3.2 Introduction 
Commensal bacteria are considered to play an important role in the mammalian body. 
These are composed of an enormous number of microorganisms, forming a complex community 
of microbiota residing at various sites of the body such as the skin, the gastrointestinal, 
genitourinary and respiratory tracts (Chiller et al., 2001; Hull et al., 2007; Neish 2009; 
Verstraelen, 2008). The most densely colonized region in a vertebrate animal is the GIT. The cell 
densities in the colon are estimated to be 10
12 
cells/ml (Whitman et al., 1988). The composition 
of this gut microbial community is likely to be influenced by host-microbe co-evolution coupled 
with selection pressure over time (Lee et al., 2006). The interactions among this consortium of 
gut microbiota are critical to the health of the host animal. They play an important role in 
immune functions, protection from pathogens, nutrient acquisition, and the structure and 
functional development of gastrointestinal tract (GIT) (Sekirov et al., 2010). Alterations in these 
GIT communities will affect their protective and immunomodulatory functions and, hence, 
maintaining their balance is necessary for the maintenance of health (Backhead et al., 2005; 
Palming et al., 2006).  
Little is known about the bacterial composition in the GIT of healthy dogs. Similar to 
other mammals, dogs also likely harbor diverse microbiota in their GIT. The microbial content in 
the stomach of the dog is 10
4 
to 10
5
 CFU/gm (colony forming units per gram) (Benno et al., 
1992). Based on the culture dependant studies, in the stomach, aerobic and anaerobic bacteria are 
equally distributed with Gram positive bacteria being more dominant than Gram negative 
bacteria (Benno et al., 1992). Along the small intestine, the number of bacteria progressively 
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increases along the duodenum, jejunum and ileum. In the duodenum and jejunum, the microbial 
population accounts for 10
5
 to 10
6
 CFU/ g of content and in the ileum is 10
7
 CFU/g of content 
(Benno et al., 1992; Johnston, 1999). The numbers of aerobic, facultative anaerobes and 
anaerobes in the jejunum are equal (Mentula et al., 2005). Some of the common bacteria reported 
to be present in the small intestine of dogs include Eubacterium, Bacteroides, Clostridium, 
Fusobacterium, Bifidobacterium, and Lactobacillus among the anaerobes and Streptococcus, 
Staphylococcus, Pasturella, Escherichia, and Enterobacter among the aerobic and facultative 
anaerobes (Benno et al., 1992; Davis et al., 1977; Johnston, 1999). Along the GIT, the largest 
number of microbes is harbored by the large intestine, the caecum, and colon and ranges from 
10
9
 to 10
10
 CFU/gm of content (Greene, 1998). Gram negative aerobic bacteria and spore/non 
spore forming anerobic bacteria dominate in the large intestine of dogs (Greene, 1998). The 
predominant bacteria present in this part of intestine include Eubacterium, Bacteroides, 
Clostridium, Peptococcus, Bifidobacterium, Lactobacillus and Streptococcus (Benno et al., 
1992; Davis et al., 1977; Greene, 1998).  
Most of the studies available on dog GIT microbiota provide information on the effect of 
age, diet or antibiotics on the gut microbial structure (Simpson et al., 2002; Middelbos et al., 
2009; Suchodolski et al., 2010). In 2002, Simpson et al., studied the gut microbial diversity in 
dogs belonging to different age groups and breeds that were fed different fiber diets. This study 
included 18 dogs belonging to two different age groups (young and old) and 3 breeds (German 
shepherds, English setters, and Miniature schnauzers). They were fed on high or low fiber diet. 
Using the culture method Simpson et al.,(2002) identified Bacteroides, Fusobacteria, 
Lactobacilli and Streptococci as the major bacterial groups while Enterococci, Clostridia, 
Bifidobacteria and Eubacteria represented the minor groups from the dog fecal samples. The 
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inclusion of 10% fiber in the diet of the animals decreased the number of Bacteroides in older 
dogs compared to the number of Bacteroides in younger dogs. Similarly, the number of 
Clostridia increased in German shepherds and Fusobacteria in English setters. Suchodolski et 
al.,(2009) evaluated the shift in the jejunal microbial community of healthy dogs (with jejunal 
fistula) fed with the antibiotic, tylosin, for 14 days. Feeding tylosin changed the bacterial 
composition of jejunal microbiota. Some of the bacterial taxa such as Fusobacteria, 
Bacteriodales and Moraxella decreased while Enterococcus-like organisms, Pasturella spp and 
Dietzia spp increased. Screening of the samples on 14th day after the cessation of antibiotic 
treatment revealed that some of the bacterial taxa had completely vanished. Middelbos et 
al.,(2010) demostrated that changes in the gut microbiota of healthy dogs could be induced by 
dietary fiber. Fusobacterium, Firmicutes and Bacteriodetes were the most dominant phyla. When 
the animals were fed with the control diet, Fusobacterium, Firmicutes, Bacteriodetes, 
Proteobacteria, and Actinobacteria were present while feeding these animals a fiber diet showed 
the presence of Fusobacterium, Firmicutes, Bacteriodetes, and Proteobacteria phyla. The effect 
of dietary fiber varied among individual dogs with respect to the phylogenetic diversity of their 
gut flora. However, not much information is available about microbial diversity in clinically 
healthy dogs.  
Several techniques are available,(culture dependent and culture independent) to study the 
microbial diversity of GIT microbiota (Sekirov et al., 2010). Most studies have used culture-
based techniques to determine the microbial diversity in the GIT microbiota of dogs (Greetham 
et al., 2002; Mentula et al., 2005; Benno et al., 1992; Davis et al., 1977; Greene, 1998; Johnston, 
1999). Greetham et al.,(2002) studied the gut microbiota of Labrador Retrievers using cultural 
and genotypic approaches. Different culture medium were used for determining the number of 
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total aerobes and anaerobes, coliforms, Bifidobacteria, Lactobacilli, Gram positive bacteria, 
Clostridia and Bacteroides. Among all the bacterial species identified, Bacteroides were the 
dominant species in all of the samples followed by Gram positive cocci, Clostridia, aerobes, and 
lactic acid bacteria, respectively. The culture grown on these media were also identified by the 
16S rRNA sequencing. Sequence analysis data revealed the presence of new bacterial diversity 
that had not been identified with the culture method. Mentula et al.,(2005) compared the 
microbial communities of the small intestine and in the feces of Beagel dogs using a culture 
technique. The fecal samples were dominated by anerobes while in the small intestine, both 
aerobic and anerobic bacteria were present in about equal numbers. In the small intestine, 
Staphylococcus, Gram negative rods, and yeast were more prevalent while in the fecal samples, 
Gram positive rods, other than Clostridium, Streptococci, Bacteroides and coliforms, were the 
dominant bacteria. However, it is estimated that >80% of all gut microbiota cannot be cultivated 
in the laboratory (Sekirov et al., 2010) and hence the full species diversity was likely not fully 
assessed (Ward et al., 1990; Greetham et al., 2002). Several molecular methods for phylogenetic 
analysis are available and are commonly used to evaluate the microbial composition in fecal 
samples (Simpson et al., 2002; Middelbos et al., 2009). The development of such types of 
studies began when the domains of Bacteriae, Archae and Eucarya were proposed, based on the 
small subunit ribosomal DNA sequences (Woese et al., 1990). The conserved regions within 
these ribosomal DNA genes can be used to survey the uncultivable microbial diversity in the 
samples (Hugenholtz et al., 1998; Pace et al., 1985; Pace 1997). Several molecular techniques, 
such as DNA microarray, fluorescent in situ hybridization, and qPCR are available, but they 
cannot identify novel sequences (Bae et al., 2005; Sekirov et al., 2010). Identification based on 
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polymerase chain reaction amplification, cloning and sequencing of the single target gene can be 
time consuming (Randazzo et al., 2002). 
A metagenomic approach that included cloning and sequencing of 16S rRNA has been 
used to study the microbial community of the GIT of dogs by Suchodolski et al.,(2008). They 
identified 4 phyla: Firmicutes, Fusobacteria, Bacteroides, and Proteobacteria from the GIT. 
Lactobacillales were present in all parts of intestine. Enterobacteriales were more abundant in 
small intestine while Fusobacteriales and Bacteroidales were more abundant in ileum and colon 
and Clostridium was abundant in duodenum, jejunum, ileum and colon. A similar technique has 
been used to compare the gut microbial communities of healthy dogs to dogs with inflammatory 
bowel disease (Xenoulis et al., 2008). This technique is more expensive compared to other 
sequencing techniques such as 454 pyrosequencing (Sekirov et al., 2010). 
The metagenomic approach coupled with parallel DNA sequencing based on 
pyrosequencing can be used to study the bacterial diversity by comparing the sequence of the 
target gene from the sample to the available database. This method is more sensitive as it can 
detect less abundant species as well. Such an approach has been used to explain high bacterial 
diversity in the GIT microbiota of swine and cattle (Dowd et al., 2008a, 2008b). 
In this study, we used bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP). 
Pyrosequencing is a DNA-sequencing method based on the “sequence by synthesis” method 
(Armougom et al., 2009). During the enzymatic synthesis of the complementary DNA strand 
from the single-stranded DNA template, the nucleotide incorporation produced by DNA 
polymerase (DNA synthesizing enzyme) is accompanied by the release of inorganic 
pyrophosphate (PPi). An enzyme, ATP sulfurylase, subsequently converts PPI to ATP. This ATP 
oxidizes luciferase to luciferin and the signal light is generated. The amount of light is detected 
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by a charge coupled device (CCD) camera and is displayed as peak in a pyogram. 
Unincorporated dNTPs and excess ATPs are degraded by a nucleotide degrading enzyme, 
Apyrase. Since the added nucleotide is known, the nucleotide sequence of the target DNA can be 
determined based on the signal peaks of the pyogram (Figure 3.1) (Armougom et al., 2009).   
bTEFAP is an expansion of pyrosequencing technique. The target DNA is amplified on 
the DNA capture beads by oil emulsion PCR procedure. After amplification, DNA that is 
attached to the bead is denatured and then sequenced using a normal pyrosequencing method. In 
this method tagged fusion primers are incorporated for the sample identity. This enables 
sequencing of dozens of samples at a time, thus allowing a high throughput (Figure 3.2). 
The results retrieved from our analysis of fecal microbiota of healthy dogs are based on 
having employed bTEFAP technique using 16S rRNS as the target gene. We had hypothesized 
that the GIT tract of healthy animals would have a highly diverse community. 
3.3 Materials and methods 
3.3.1 Collection of fecal samples 
Ten clinically healthy household dogs were included in this study. All dogs were fed with 
commercial diet and none of them were exposed to antibiotics at least for an year prior to the 
sample collection. Freshly laid fecal samples were collected from these healthy dogs and stored 
in falcon tubes on wet ice and then kept frozen at -80°C until analysis as freezing has no effect 
on the bacterial diversity (Wu et al., 2010) 
3.3.2 Extraction of DNA 
Upon thawing, DNA extraction was performed from 1g of canine fecal sample taken 
from the center to minimize environmental contamination effect using QIAamp stool DNA mini 
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kit (Qiagen, Valencia, CA) according to manufacturer‟s instructions. The extracted DNA (1µl) 
was quantified using Nanodrop ND-1000 spectrophotometer (Nanodrop technologies, 
Wilmington DE).  
3.3.3 bTEFAP sequencing PCR 
3.3.3.1 Universal primer primary PCR 
DNA samples were diluted to 100ng/µl. Initially, a primary PCR was performed for 
amplification of 600 base pairs (bp) of 16S rRNA using 16S universal universal Eubacterial 
primers, 530F and 1100R. The forward primer sequence was (5‟–GTG CCA GCM GCN GCG 
G-3‟) and reverse primer was (5‟ –GGG TTN CGN TCG TTG-3‟). The PCR reaction mixture 
consisted of 50 µl HotStarTaq Plus Master Mix Kit and 100ng of DNA template. Amplification 
conditions were as follows: initial denaturation at 94°C for 3 min followed by 30 cycles of 94°C 
for 30 sec, followed by annealing at 60°C for 40 sec, elongation at 72°C for 1 min and final 
extension step of 5 min at 72°C. 
3.3.3.2 Linker-Tag-Universal Primer secondary PCR 
The primary amplicons were incorporated with specific sample tag and FLX linker 
sequence for the identification of individual sample sequence from multiple samples in a single 
PicoTiterPlate (Roche, Nutley, New Jersey). For this purpose, secondary PCR was performed. 
Primers were designed with different tag sequences for FLX amplicon sequencing. The forward 
fusion primer consisted of sequence adaptor A, sample specific tag and eubacterial primer 530F. 
The reverse fusion primer consisted of sequence adaptor B, and eubacterial primer 1100R. The 
PCR conditions were same and 1µl of original PCR reaction was used as a template.  
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3.3.4 AmBead purification 
After secondary amplification, the composite sample was prepared by mixing together 
equal volume of all the PCR products from different samples. The pooled amplicons were 
cleaned using Agencourt Ampure beads (Agencourt Bioscience Corporation, MA, USA) 
according to manufacturer‟s instructions. 
3.3.5 bTEFAP FLX massively parallel pyrosequencing 
The purified amplicon containing 9.6 E+06 double-stranded DNA molecules/µl with 
average size of 625bp were used for further processing. These samples were amplified after 
combining with 9.6 million DNA capture beads using emulsion PCR (Hori et al., 2007). 
Recovery and enrichment of amplified DNA capture beads was followed by denaturation of 
DNA that is immobilized on the beads by PCR by using NaOH. The samples were then used for 
FLX pyrosequencing using Genome Sequencer FLX system (Roche) according to 
manufacturer‟s instructions.  
3.3.6 bTEFAP sequence data analysis 
The sequencing data were processed within Microsoft®. NET (Microsoft Corp, Seattle, 
WA) development environment. Raw reads obtained from the FLX sequencing run output files, 
were sorted into individual samples files based on the 100% homology to assigned tag sequence 
and >150bp read length. All of the sequences were assembled using CAP3 (Huang and Madan et 
al., 1999) and sequences were blasted against RDP-II 16S database and GeneBank 
(http://ncbi.nlm.nih.gov). BLASTn best hits for the reads with sequence identity >98% and 
tentative consensus sequence length of 260bp were evaluated to the genus and species level. The 
genus clustering and their relative predicted proportion in the given sample was determined by a 
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post processing algorithm (% = [#sequences from an organism / total number of sequences from 
the sample] x 100%). 
3.3.7 Phylogenetic assignment, alignment and clustering of 16S rRNA gene 
fragments 
Based on the best BLAST hit, each sequence was linked with its appropriate taxonomic 
identification. The taxonomic assignment was followed by sequence alignment and distance 
matrix formation using MUSCLE and DNAdist programmes, respectively. Based on their 
sequence dissimilarity at 1%, 3% and 5%, they were clustered into operational taxonomic units 
(OTU).   
3.3.8 Biodiversity 
At each dissimilarity level, the rarefaction curves were generated and an estimation of 
species richness was performed by using ACE (abundance based coverage estimator), Chao1 and 
Shannon diversity indexes to predict the approximate frequency of species in our 16S rRNA 
library from the fecal samples of ten healthy dogs. 
3.4 Results 
3.4.1 Characteristics of pyrosequencing data 
An application of bTEFAP pyrosequencing technique was used for the analysis of fecal 
microbiota from dogs. Sequences were generated from the middle region (600 bp) of 16S rDNA 
genes in the bacterial DNA, and the libraries were constructed from ten fecal samples from 
healthy dogs. A total of 76,758 sequences were obtained from the pyrosequencing run for all 
samples. Each unique sequence read was searched against the Ribosomal Database Project 
(RDP) using the BLASTN tool. After the best match hits that met the required criteria (materials 
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and methods), 56,320 sequences remained for analysis (Table 3.1). The number of sequences 
varied among the animals from 4622 to 6102 with the mean of 5632. 
3.4.2 Abundance of microorganisms in gut microbiota of healthy dogs  
Aligned sequences were grouped into operational taxonomic units (OTU) at the 3% and 
5% divergence levels (Table 3.2). At the species level, the number of OTUs (mean±SEM)in the 
ten libraries ranged from 1.83±0.1x10
2
, while at genus level, a range of 1.39±0.08x10
2
 OTUs 
was observed. A rarefaction curve analysis based on the number of sequences in each sample 
shows that the curve at species, genus and phylum level in all the samples had reached the 
plateau, which indicates that these libraries were completely sampled (Figure 3.3).  
3.4.3 Biodiversity 
Based on the species richness estimators, ACE, at 3% dissimilarity, the OTUs ranged 
from 2.50 ± 0.1x10
2
and at 5% dissimilarity, from 1.90 ± 0.09x10
2
; and for Chao1, at 3% 
dissimilarity, the OTUs ranged from 2.5 ± 0.1x10
2
and at 5% dissimilarity, 1.90 ± 0.1x10
2
. Based 
on the species diversity index, Shannon diversity, at 3% dissimilarity, the OTUs ranged from 
1.95-3.73 and at 5% dissimilarity, from 1.81-3.23 (Table 3.2). 
Among the ten samples tested, H4 had the highest species richness (ACE-305.45, Chao1-
307.54) and at 5% dissimilarity, H9 had the highest species richness (ACE-237.20, Chao1-
237.20) (Table 3.2). But the H5 sample was the most diverse sample at 3% and 5% dissimilarity 
with values of 3.73 and 3.23 respectively for Shannon diversity index (Table 3.2). This shows 
that microbial community from H5 had high evenness. 
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3.4.4 Bacterial composition in the gut microbiota of healthy dogs  
Based on the phylogenetic classification of the sequences inherited from RDP-II 
database, about 178 different bacterial genera belonging to 12 different phyla were identified 
(Table 3.3).  
3.4.5 Phyla level 
Each fecal sample was represented by ≥ 6 different phyla out of which 5 phyla were 
present in the gut of all the dogs (Figure 3.4). Of the total bacterial sequences, Firmicutes 
represented the dominant phylum in our library. The other most dominant phyla detected were 
Fusobacteria, Proteobacteria, Bacteriodetes, Spirochaetes, Actinobacteria, Chloroflexi with 
sequences ranging from (mean) 1-5%. The rest of the sequences were distributed among the 
phyla (mean %) Lentisphaerae (0.06%), Fibrobacteres (0.03%), Verrucomicrobia (0.01%), 
Tenericutes (0.01%) and Synergistetes (0.01%) and comprised less than 1% of the intestinal 
bacterial population at the genus level (Figure 3.4). 
In the most dominant phylum, Firmicutes, the percentage of sequences ranged between 
95.9-36.9% with a mean of 77.1%. The majority of the sequences (range) belonging to the genus 
Turicibacter (77.2-0.3%), Lactobacillus (65.5-0.01%), Megamonas (38.13 and 0.07%), 
Ruminococcus (28.7-1.05%) and Clostridium (21.6-1.06%) were identified. All these species 
were ubiquitous in all of the 10 samples, with the exception of the Megamonas species, which 
was present in 9 out of 10 samples. 
Sequences belonging to the phylum Fusobacteria ranged between 22.7-0.1% with a mean 
of 5.3%.The dominant genus in this phylum was Fusobacterium (22.4-0.1%). 
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In the phylum Proteobacteria, (25.9-0.4%) with a mean of 5.1%, the more prevalent 
genera were Escherichia (22.3-0.01%) and Moraxella (5.7-0.02%), which were present in 8 out 
of 10 samples. 
Species belonging to the phylum Bacteriodetes were also identified and ranged between 
12.6-0.02% with a mean of 3.3%. Bacteroides species were detected in 9 fecal samples in this 
study. 
The other phylum that was encountered in the feces was Spirochaetes, which ranged from 
15.7-0.01% with a mean of 1.8%.  
3.4.6 Genus level 
Out of 178 genera present in our library, only twelve common bacterial genera (mean 
sequence %) were found in all of the libraries:  Leuconostoc (0.16), Weissella (0.23), 
Lactobacillus (26.75), Streptococcus (1.15), Lactococcus (0.13), Ruminococcus (5.84), 
Turicibacter (13.11), Clostridium (9.54), Roseburia (1.85), Dorea (1.28), Eubacterium (1.30), 
and Fusobacterium (6.89). Among these, Lactobacillus, Ruminococcus, Turicibacter, 
Clostridium, and Fusobacterium represented >2% of the sequences. A wide diversity in the 
bacterial species was observed among these genera except for Turicibacter, from which only one 
bacterial species, Turicibacter sanguinis was dominating in all the samples (Figure 3.6; 3.7; 3.8; 
3.9; 3.10). The highest diversity was observed among the Clostridium genus, which was 
comprised of 53 different bacterial species (Figure 3.10).  
Figure 3.5 shows the bacterial diversity at the genus level in individual dogs with ≥2% 
(sequences) cut off. The bacterial composition in each dog was different. The dominant sequence 
in each fecal sample was as follows: H-1, -8 Turicibacter; H-2 Megamonas; H-3, -6, -7, and -10 
Lactobacillus; H-4 Escherichia; H-5 Clostridium; H-9 Fusobacterium. 
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3.5 Discussion 
The gut commensals play important role in terms of nutrional, developmental, defensive 
and physiological processes in the host body (Mackie et al., 1999). In the U.S., the number of pet 
animals is increasing (Municipality of anchorage animal care and control services, statrtegic 
plan, 2006). The U.S. ranks first among the worlds top ten countries and has the largest pet dog 
population (http://www.mapsofworld.com/world-top-ten/countries-with-most-pet-dog-
population.html). Based on market research statistics, from 2007, the pet population accounts for 
more than 72 million. The average expenditure cost per household per pet is estimated to be 
$366 in U.S. (http://www.avma.org/reference/marketstats/sourcebook.asp). In comparison to the 
studies done on other animals such as cattle and pigs, the data available on the canine gut 
microbial community are very limited.  
Most of the information available with respect to the canine gut microbial community is 
based on cultivation approach (Benno et al., 1992; Davis et al., 1977; Greene, 1998; Greetham et 
al., 2002; Mentula et al., 2005). The data available from this technique are considered to be 
inadequate, as only 1-20% of the total gut microbiota is cultivable in the laboratory conditions 
(Sekirov et al., 2010); and thus, microbial diversity is greatly underestimated. The assessment of 
microbial diversity by using molecular techniques has facilitated the study of this diverse 
microbial community harbored by the host.  DNA-based techniques have been recently used to 
study the gut microbiota in different animals including cattle, pigs, monkeys and dogs (Durso et 
al., 2010; Dowd et al., 2008a; McKenna et al., 2008; Suchodolski et al., 2009; Dowd et al., 
2008a). Those studies that were done on dogs focused mainly on determining the effect of diet 
and antibiotics on the fecal microbial community of dogs (Middelbos et al., 2010; Suchodolski et 
al., 2009).  
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Our analysis of 16S rDNA sequences from the fecal microbiota of healthy dogs revealed 
a wide diversity of microorganisms, indicating that the digestive tract has a complex community 
of microbes. A total 12 phyla with the most prevalent being Firmicutes and five minor phyla 
(mean ≤ 1% sequences), were encountered in the fecal samples. Lactobacillus, Ruminococcus, 
Fusobacterium, Turicibacter and Clostridium represented some of the dominant bacterial genera 
in this study. Firmicutes is also reported to be the dominant phylum in the cattle, macaque and 
human gut microbiome (Durso, et al., 2010; McKenna et al., 2008; Eckburg et al., 2005). Our 
study shows great dog-to-dog variation in the composition of fecal microbiota of individual dogs.  
Most of the genera belonging to the phylum Firmicutes (86%) and Actinobacteria 94% 
were Gram positive bacteria (86%) while in the remaining phyla identified in this study, Gram 
negative bacteria formed the major group. In the phylum, Proteobacteria, 91% of bacterial 
genera were Gram negative bacteria. while Chloroflexi consisted of 50% Gram negative bacteria. 
In the phyla, Bacteroidetes, Tenericutes, Synergistetes, Fusobacteria, Spirochaetes, 
Lentisphaerae, Fibrobacteres, and Verrucomicrobia, all the bacterial genera were identified as 
Gram negative. In the present study Gram positive bacteria dominated the dog fecal sample and 
this matches with the previously published data (Mentula et al., 2005). The main bacterial genera 
present in healthy dogs include Lactobacillus, Clostridium, Streptococci and Bacteroides 
(Maskell and Johnson, 1993; Mentula et al., 2005) and were also identified in our samples. 
The fact that the rarefaction curves reached a stable value suggests complete estimation 
of species richness in all ten samples. Hence, most bacterial diversity has been included in our 
sampling size.  
We used the nonparametric estimators ACE and Chao1 to estimate richness in the ten 
libraries. Based on our statistical analysis of the OTUs, a difference in the relative abundance 
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(ACE, Chao1) and diversity (Shannon diversity) of bacterial taxa in all the samples was 
observed, which may be because the fecal samples from dogs belonging to different age groups, 
and breeds fed different diets were compared. Based on Chao1, the estimated species richness 
values (mean) at 3% sequence dissimilarity was 254.51. This richness estimate is similar to that 
observed in humans (264) (Eckburg et al., 2005) and is much lower than that reported in food 
animals such as cattle (637) (Durso et al., 2010). 
In this study, most of our samples did not show great difference in their diversity index 
(3% dissimilarity) (Table 3.2). The average estimate of the diversity index for all of the ten 
animals was 3.09, a value lower than that observed in cattle (4.85) (Durso et al., 2010) at 3% 
sequence dissimilarity. Although the diversity index is widely accepted for determining the 
biodiversity, and it takes into account both species richness and evenness, two communities with 
same index value cannot be considered to have same bacterial diversity as there may be 
differences with respect to high or low evenness or richness, respectively (Kennedy, 1999).  
In the present study, Lactobacilli, Clostridium, Turicibacter, Megamonas, 
Fusobacterium, and Ruminococcus were among the dominant bacterial genera that were 
distributed among the dogs. For bovine feces, Prevotella is reported as the most common 
bacterial genus (Durso et al., 2010), and in dairy cattle Clostridrium is most commonly found 
(Dowd et al., 2008b). Among macaques and humans, the Clostridrium spp. are reported to be the 
dominant bacteria in their digestive tract (Durso et al., 2010; Eckburg et al., 2005). 
Several studies have examined the gut microbial community in dogs (Suchodolski et al., 
2009; Middelbos et al., 2010; Greetham et al., 2002; Mentula et al.,2005; Simpson et al., 2002). 
Suchodolski et al., (2009) studied the effect of antibiotic tylosin on the microbial diversity in the 
canine jejunum using bTEFAP analysis. They identified 10 different bacterial phyla, with 
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Proteobacteria being the most dominant phylum. Inter-individual responses were observed for 
specific taxa in each of the dogs. During tylosin administration, the proportion of Enterococcus-
like organisms, Pasteurella, and Dietzia increased. Bacteria belonging to the family 
Spirochaetes, Streptomycetaceae, and Prevotellaceae were not recovered 2 weeks after antibiotic 
treatment. On the other hand, according to the data gathered by Middelbos et al., (2010), when 
they looked at the effect of fiber diet on the gut community, they found that Fusobacteria, 
Firmicutes, and Bacteroidetes were the dominant phyla in the gut communities of healthy dogs, 
which agree with the data in our study. Two phyla Lentisphaerae(<1%) and Fibrobacteres(<1%) 
were identified in our study that were not previously reported in healthy dogs.  
The number of OTUs (5%) and richness (5%) estimates in the present study was lower 
than that observed in the study done by Suchodolski et al., (2009) and higher than the number 
obtained by Middelbos et al.(2010). In the pyrosequencing studies conducted by Suchodolski et 
al.,(2009) and Middelbos et al.,(2010) the mean values for the following indices (5%) were as 
follows: OTU – 143, ACE – 191, Chao1 – 197; OTU – 135, ACE – 186, and Chao1 – 177, 
respectively. Based on the Shannon diversity index, a less diverse population was observed in 
our samples compared to what observed by Suchodolski et al., (2009) study. These differences in 
the richness and diversity likely reflects differences in the age, breed (Simpson et al., 2002) and 
diet of the individual dogs (Middelbos et al., 2010) and differences in the sampling site of 
intestine (Mentula et al., 2005). It must also be noted that in both of the above mentioned studies,  
Suchodolski et al., (2009) and Middelbos et al.(2010), the sample sizes were small (≤ 6 
samples).  
Thus, in the present study, bTEFAP analysis was used to study the microbial community 
present in the feces of healthy dogs. Additionally, using the bar-coded primers allowed the 
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bTEFAP technique to sequence ten samples simultaneously. Despite these advantages, the 
pyrosequencing technique, like any other molecular techniques, also has limitations. Because of 
the sequence conservation of the target gene, 16SrRNA, bTEFAP may not detect bacterial 
microbiota with divergent target sequences. The smaller length of the reads produced during 
pyrosequencing may allow for lower unique discrimination. Moreover, all of these sequence 
studies carried out in dogs, including the present study, rely on the PCR step and this may also 
affect the number of bacteria observed due to PCR‟s bias with respect to the variation in the 
primer binding site of the target gene (vonWintzingerode et al., 1997). DNA extraction bias due 
to incomplete extraction can also affect abundance and composition of the diverse bacterial 
community (Martin-Laurent et al., 2001). 
The results from this study suggest that there is difference in the composition of gut 
microbial community among individual healthy dogs. This difference may be attributed to age, 
diet and genetic make-up of the individual animals. It has also been noted that healthy dogs 
harbor more diverse bacterial population in their GIT as compared to dogs under selective 
pressure (Suchodolski et al., 2009). 
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3.6 Conclusion 
Gut microbiota, the most abundant commensals in a vertebrate animal, are important to 
the health of the host animal. The main objective of this research was to study the diverse habitat 
of the microbial community in the canine gut. Until recently, assessing microbial diversity 
completely was hindered due to the limitations of the traditional cultivation methods. Most of the 
microbes present in the GIT do not grow in laboratory culture media. Development of molecular 
techniques such as pyrosequencing allowed the analysis of diverse microbial community in the 
mammalian gut without culturing limitations.  
Using bTEFAP technique in this study, we determined the diversity in the fecal 
microbiota of the healthy dogs. A total of ten apparently healthy dogs were included in this 
study. The total number of sequences per sample ranged from 4622 to 12925. After quality 
trimming, a total of 56,320 sequences were used for further analysis. The sequences from ten 
libraries were grouped into OTUs based on 3% and 5% sequence dissimilarities (corresponding 
to species and genus level, respectively). The number of OTUs ranged from 118 to 224 and 88 to 
166 at 3% and 5% sequence dissimilarity, respectively. At the species level, the mean values for 
ACE, Chao1 and the Shannon diversity index were estimated as 253, 254, and 3.09, respectively. 
A total of 12 phyla and 178 genera were identified among the ten fecal samples. 
Our results indicate that the GIT of dogs is composed of a diverse population of bacteria. 
The rarefaction analysis revealed that there was sufficient sampling, indicating that this data 
likely represent the entire gut microbiota. Our study found two phyla Lentisphaerae (<1%) and 
Fibrobacteres (<1%) that have not been previously reported in healthy dogs. 
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Overall, the data revealed high variability in the composition of gastrointestinal 
communities of healthy dogs. This study serves as baseline information for future studies that 
aim to determine the gut microbial community structure in any pathological conditions, or for 
examining the impact of various factors on them or other related issues.  
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3.7 Figures and Tables 
 
 
              Figure 3.1  Principle of pyrosequencing technology (Armougom and Rauolt, 2009) 
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Figure 3.2  Graphical depiction of bTEFAP technique (Dowd et al., 2008) 
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Table 3.1  Number of reads and trimmed sequences per sample of canine feces microbiota 
 
Sample # # of sequences 
 Total sequences Trimmed sequences 
H-1 4622 4622 
H-2 11886 6101 
H-3 5218 5218 
H-4 11363 6102 
H-5 6634 6101 
H-6 5191 5191 
H-7 4915 4915 
H-8 8138 6102 
H-9 12925 6102 
H-10 5866 5866 
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Table 3.2  Species richness and diversity indices from fecal microbiota of healthy dogs  
 
Sample # No. of OTUs Species richness 
 
Species diversity 
 
Shannon index   ACE Chao1 
3% DNA sequence dissimilarity 
H-1 146 243.57 234.64 1.95 
H-2 218 284.48 278.00 3.17 
H-3 176 210.17 209.71 3.17  
H-4 195 305.45 307.54 3.50 
H-5 221 289.57 284.67 3.73 
H-6 160 239.16 247.00 3.23 
H-7 173 216.63 218.55 3.02 
H-8 118 182.44 193.00 2.81 
H-9 224 304.77 271.54 3.35 
H-10 204 258.70 300.47 3.00 
5% DNA sequence dissimilarity 
H-1 119 196.89 183.11 1.81 
H-2 166 211.25 226.11 2.91 
H-3 133 153.03 146.79 2.87 
H-4 141 199.93 201.06 2.90 
H-5 166 213.74 198.25 3.23 
H-6 122 181.23 183.88 2.62 
H-7 134 174.04 180.50 2.42 
H-8 88 136.09 129.33 2.45 
H-9 161 237.20 228.05 3.03 
H-10 162 200.90 226.40 2.54 
             OTU, Operational taxonomic unit,  ACE, Abundance –based coverge estimator; Chao1, Richness estimator 
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Figure 3.3  Rarefaction analysis of dog fecal samples 
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Figure 3.4  The number of bacterial phyla detected in the canine fecal samples 
 
 
166 
 
 
 
Figure 3.5  Bacterial diversity on the genus level in the dog fecal samples 
 
 
*Numbers below each pie diagram indicates the percentage of sequences corresponding 
  to Enterococcus genus in each sample 
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Figure 3.6  Structure of Lactobacillus spp. diversity in the fecal samples 
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Figure 3.7  Structure of Ruminococcus spp. diversity in the fecal samples 
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Figure 3.8  Structure of Fusobacterium spp. diversity in the fecal samples 
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Figure 3.9  Structure of Turicibacter spp. diversity in the fecal samples 
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Figure 3.10  Structure of Clostridium spp. diversity in the fecal samples 
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Table 3.3  Phylogenetic classification of sequences obtained from the dog fecal samples 
 
   Healthy dog # 
 
H- 1 H- 2 H- 3 H- 4 H- 5 H- 6 H- 7 H- 8 H- 9 H- 10 
Phylum Order Family Genus           
Proteobacteria   Total sequences (%) 1.5 2.94 0.98 25.95 1.62 0.59 0.49 0.44 8.43 8.36 
 Enterobacteriales Enterobacteriaceae Morganella 0.15          
   Citrobacter  0.02 0.03  0.01 0.03   0.04 0.01 
   Shigella 0.09  0.01 4.49 0.03    0.64 0.36 
   Enterobacter    0.01     0.01  
   Klebsiella 0.01    0.03      
   Pantoea     0.01    0.01 0.01 
   Escherichia 0.33  0.33 21.27 0.36  0.01 0.01 5.68 1.14 
   Cronobacter         0.01  
 Pseudomonadales Moraxellaceae Moraxella 0.64 0.27 0.03  0.06 0.02  0.03 0.75 5.70 
   Acinetobacter 0.01    0.02 0.06   0.01 0.04 
  Pseudomonadaceae Pseudomonas   0.08        
 Burkholderiales Oxalobacteraceae Massilia       0.02    
  Alcaligenaceae Sutterella  1.17 0.33 0.15 0.27 0.01 0.22 0.03 0.16 0.31 
   Achromobacter 0.03    0.03 0.03   0.01  
  Comamonadaceae Curvibacter          0.01 
   Brachymonas          0.01 
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Acidovorax 
0.07       0.01 0.01  
  Burkholderiaceae 
Lautropia 
0.07          
   
Burkholderia 
0.03 0.05   0.01 0.39 0.01  0.07 0.01 
  Burkholderiales Genera 
incertae sedis Leptothrix 
0.01 0.01      0.01   
 Legionellales Coxiellaceae 
Rickettsiella 
        0.02  
 Pasteurellales Pasteurellaceae 
Actinobacillus 
    0.02    0.03 0.18 
   
Pasteurella 
        0.81  
   
Haemophilus 
      0.02 0.04 0.02 0.10 
   
Psychrobacter 
 0.02        0.02 
   
Bibersteinia 
        0.03 0.15 
   
Volucribacter 
         0.06 
 Neisseriales Neisseriaceae 
Vogesella 
  0.01        
   
Microvirgula 
  0.01 0.02       
   
Alysiella 
         0.01 
   
Aquitalea 
    0.02      
   
Neisseria 
   0.01     0.09 0.09 
 Aeromonadales Succinivibrionaceae 
Succinivibrio 
0.01 0.54 0.01  0.29 0.05  0.01 0.01  
   
Anaerobiospirillum 
0.01 0.75   0.42    0.01  
   
Ruminobacter 
  0.01        
  Aeromonadaceae 
Aeromonas 
        0.01  
 Rhodobacterales Rhodobacteraceae 
Paracoccus 
 0.04         
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Rubellimicrobium 
  0.12        
 Campylobacterales Campylobacteraceae 
Campylobacter 
 0.02         
  Helicobacteraceae 
Helicobacter 
 0.04 0.01  0.04   0.29 0.01  
 Rhizobiales Rhizobiaceae 
Sinorhizobium 
      0.01  0.01  
   
Amorphomonas 
      0.12    
  Hyphomicrobiaceae 
Devosia 
 0.01     0.01 0.01   
 Xanthomonadales Xanthomonadaceae 
Xanthomonas 
        0.01  
   
Rhizobium 
0.03          
   
Stenotrophomonas 
      0.07  0.01  
   
Lysobacter 
         0.15 
  Sinobacteraceae 
Steroidobacter 
 0.01         
 Vibrionales Vibrionaceae 
Vibrio 
    0.01      
 Caulobacterales Caulobacteraceae 
Brevundimonas 
0.01          
Bacteriodetes   Total sequences (%) 0.14 12.60 2.6 0.66 5.97 0.02 0.54 1.09 8.85 0.45 
 Sphingobacteriales Sphingobacteriaceae Sphingobacterium        0.01   
 Bacteroidales Bacteroidaceae 
Bacteroides 
0.03 12.54 2.5 0.62 5.91  0.40 1.05 6.78 0.30 
  Porphyromonadaceae 
Porphyromonas 
0.03          
   
Tannerella 
0.01 0.01 0.03 0.01 0.01  0.03  0.01  
   
Parabacteroides 
0.01  0.03   0.01 0.05 0.01 2.05 0.04 
  Prevotellaceae 
Hallella 
   0.01 0.01 0.01 0.03 0.01  0.01 
  Rikenellaceae 
Alistipes 
 0.01         
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Rikenella 
0.05 0.03 0.03 0.01 0.04  0.03 0.01 0.01 0.01 
 Sphingobacteriales 
Sphingobacteriaceae Pedobacter 
0.01          
 Flavobacteriales Flavobacteriaceae 
Chryseobacterium 
 0.01 0.01 0.01       
   
Bergeyella 
         0.09 
Firmicutes    Total sequences (%) 95.9 57.9 85.1 60.16 78.66 97.37 92.59 84.62 36.99 82.17 
 Erysipelotrichales Erysipelotrichaceae Allobaculum  0.23 0.96 0.48 0.63 0.20 0.70   0.01 
   
Coprobacillus 
0.48  0.13 0.43 1.46 0.05 0.07   0.03 
   
Bulleidia 
0.09 0.08 0.09 0.06 0.03 0.29 0.09    
   
Turicibacter 
77.21 0.47 10.95 3.94 1.28 10.93 1.26 23.44 1.44 0.20 
   
Catenibacterium 
2.52  5.64 2.81  0.10 0.40  2.18  
   
Erysipelothrix 
0.01 0.01         
 Lactobacillales Carnobacteriaceae 
Alloiococcus 
 0.01       0.02 0.02 
   
Anaerostipes 
0.15  0.01 0.01       
   
Atopostipes 
 0.01         
   
Granulicatella 
 0.15   0.06    0.01 0.04 
   
Carnobacterium 
 0.11   0.11      
  Aerococcaceae 
Facklamia 
 0.21   0.31    0.01 0.23 
   
Aerococcus 
 0.91   0.08    0.01 0.23 
   
Abiotrophia 
0.01    0.42    0.25 4.34 
  Leuconostocaceae 
Leuconostoc 
0.29 0.05 0.20 0.01 0.11 0.36 0.18 0.13 0.09 0.20 
   
Weissella 
0.21 0.05 0.43 0.04 0.28 0.36 0.14 0.17 0.24 0.42 
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  Lactobacillaceae 
Lactobacillus 
0.03 1.14 41.41 23.3 19.15 58.84 65.53 0.01 0.05 58.04 
   
Paralactobacillus 
          
  Carnobacteriaceae 
Trichococcus 
 0.04   0.09    0.01  
  Streptococcaceae 
Streptococcus 
0.05 3.09 0.40 0.66 0.65 0.29 0.88 0.09 0.34 5.13 
   
Lactococcus 
0.13 0.01 0.16 0.01 0.34 0.29 0.25 0.03 0.02 0.09 
 Bacillales Bacillaceae 
Bacillus 
 0.02         
   
Paucisalibacillus 
 0.01         
  unclassified Bacillales 
Aerosphaera 
 0.13   0.01      
  Bacillales Family XI. 
Incertae Sedis Gemella 
 2.25   0.41    0.19 0.78 
  Staphylococcaceae 
Salinicoccus 
 0.46   0.08     0.01 
   
Macrococcus 
 0.01   0.13     0.01 
   
Staphylococcus 
 1.10 0.03  0.02 0.05 1.15  0.12 0.33 
   
Jeotgalicoccus 
0.03 0.17   0.41    0.05 0.15 
  Planococcaceae 
Sporosarcina 
0.01          
 Clostridiales Ruminococcaceae 
Sporobacter 
0.11 0.01 0.58 0.20 0.53 0.44 0.7 10.58   
   
Ruminococcus 
1.98 3.36 4.64 2.35 4.10 2.68 5.7 28.70 3.92 1.05 
   
Acetivibrio 
0.01        0.01 0.01 
   
Fastidiosipila 
         0.01 
   Acetanaerobacteriu
m 
   0.86       
   
Anaerofilum 
 0.34  0.04   0.34  0.01  
   
Anaerotruncus 
   0.23 0.31 0.01 0.03 0.07 0.18  
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Faecalibacterium 
  0.17 2.66 2.11 0.27 0.81 0.10 1.01 0.70 
   
Papillibacter 
0.01 0.01 0.08 0.21 0.23 0.03 0.01  0.10 0.03 
  Peptostreptococcaceae 
Filifactor 
 0.08        0.03 
   
Peptococcus 
 0.01  0.03    0.01 0.01  
   
Peptostreptococcus 
 0.10   0.03    0.20  
  Clostridiaceae 
Ethanoligenens 
   0.06     0.01 0.10 
   
Clostridium 
3.03 2.06 13.19 12.55 21.57 12.69 9.26 5.80 6.35 8.97 
   Candidatus  
Arthromitus 
 
1.30 0.27  3.99 
 
0.21    
 
0.07  
   
Megamonas 
0.97 38.13 0.83 0.15 14.95 0.15 0.07 6.70 13.24  
   
Anaerobacter 
4.39 0.67  0.01 0.18 0.01  0.03 0.36 0.07 
   
Sarcina 
   0.02       
  Clostridiales Family XI. 
Incertae Sedis Peptoniphilus 
       0.01   
   
Anaerovorax 
 0.06 0.16 0.08 0.01 0.10 0.28 0.09  0.01 
   
Finegoldia 
  0.01        
   
Soehngenia 
 0.04       0.04 0.45 
  unclassified 
Clostridiales Frigovirgula 
    0.04    0.01 0.01 
  Peptococcaceae 
Desulfotomaculum 
0.02   0.01       
  Lachnospiraceae 
Roseburia 
0.31 1.20 2.5 1.62 1.74 1.43 1.89 2.34 4.96 0.56 
   
Oribacterium 
   0.01     0.01  
   
Lachnobacterium 
    0.01      
   
Coprococcus 
 0.01     1.92 0.01 0.01  
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Butyrivibrio 
 0.01 0.01 0.01  0.03 0.05 0.01 0.01  
   
Lachnospira 
0.07  0.24 0.35 0.27 0.03 0.16    
   
Dorea 
1.10 0.75 1.22 1.74 3.26 1.28 0.39 1.94 0.65 0.51 
   
Pseudobutyrivibrio 
0.05 0.01  0.01 0.01   0.01   
   
Oribacterium 
   0.01     0.01  
  Clostridiales Family XI. 
Incertae Sedis Helcococcus 
 0.17       0.04 0.15 
   
Tissierella 
 0.01         
  Veillonellaceae 
Succiniclasticum 
  0.01 0.01  0.05 0.18 0.03  0.01 
   
Dialister 
  0.03        
   
Veillonella 
0.11 0.05 0.06  0.02 0.05  0.05  0.06 
   
Mitsuokella 
       0.01   
   
Acidaminococcus 
 0.19 0.01 0.05 0.59  0.19    
  Eubacteriaceae 
Eubacterium 
1.22 0.09 0.95 1.15 2.43 6.36 0.05 0.03 0.74 0.01 
 Thermolithobacteral
es 
Thermolithobacteraceae 
Thermolithobacter 
      0.01  0.01  
Chloroflexi   Total sequences (%) 0.21 0.02 0.06 0.02 2.42 0.03 0.09  0.10  
 Anaerolinaeles Anaerolinaceae Levilinea  0.01         
   Enterococcus 0.21 0.01 0.06 0.02 2.42 0.03 0.09  0.10  
Actinobacteria    0.08 4.40 0.78 1.81 1.84 0.82 0.92 0.01 1.13 5.97 
 Actinomycetales Propionibacteriaceae 
Luteococcus 
 0.01         
   
Propionibacterium 
 0.12    0.46 0.12    
  Actinomycetaceae 
Actinomyces 
 0.45  0.01 0.04   0.01 0.02 0.20 
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Arcanobacterium 
 0.01       0.01 0.80 
  Micrococcaceae 
Micrococcus 
 0.01         
   
Rothia 
      0.07   0.01 
   
Cellulosimicrobium 
 0.01         
   
Arthrobacter 
      0.07    
  Nocardiaceae 
Rhodococcus 
 0.02         
   
Friedmanniella 
 0.02   0.01      
  Dermabacteraceae 
Dermabacter 
0.01 0.13       0.01 0.09 
   
Brachybacterium 
 0.02   0.03      
  Promicromonosporacea
e Cellulosimicrobium 
 0.01         
  Microbacteriaceae 
Crocebacterium 
   0.01       
   
Pseudoclavibacter 
 0.06         
   
Leucobacter 
    0.01     0.07 
 
 
Micrococcaceae 
Kocuria 
 0.08   0.09    0.01  
 
 
Micromonosporineae 
Micromonospora 
 0.01         
 
 
 
Polymorphospora 
 0.01         
 
 
 
Salinispora 
 0.04       0.01  
 
 
 
Actinoplanes 
 0.01       0.01  
 
 
Cellulomonadaceae 
Cellulomonas 
  0.01        
 
 
Corynebacteriaceae 
Corynebacterium 
0.05 2.73 0.01  1.14    0.20 4.20 
 
 
Propionibacteriaceae 
Brooklawnia 
 0.01         
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Dietziaceae 
Dietzia 
0.01 0.01   0.01      
 
 
Intrasporangiaceae 
Ornithinimicrobium 
0.01          
 
 
Streptosporangiaceae 
Astrosporangium 
 0.02         
 
 
Gordoniaceae 
Gordonia 
 0.05         
 
Coriobacteriales 
Coriobacteriaceae 
Collinsella 
 0.47 0.75 0.27 0.47 0.12 0.64  0.75 1.29 
 
 
 
Eggerthella 
 0.01  0.23   0.01   0.01 
 
 
 
Asaccharobacter 
      0.01    
 
 
 
Slackia 
 0.02 0.01 1.29 0.01 0.24     
 
 
Brevibacteriaceae 
Brevibacterium 
 0.06   0.03    0.01 0.20 
Tenericutes   Total sequences (%)   0.01        
 Anaeroplasmatales Anaeroplasmataceae 
Anaeroplasma 
  0.01        
Synergistetes   Total sequences (%)         0.01  
 Synergistales Synergistaceae 
Aminomonas 
        0.01  
Fusobacteria   Total sequences (%) 1.16 16.69 6.37 8.97 6.94 0.50 1.53 5.1 22.72 0.11 
 Fusobacteriales Fusobacteriaceae 
Fusobacterium 
1.16 16.69 6.37 8.97 6.92 0.50 1.53 4.29 22.42 0.11 
   
Leptotrichia 
    0.02    0.01  
   
Cetobacterium 
  0.03     0.18 0.29  
Spirochaetes   
Total sequences (%) 
0.22 0.01 0.27 0.30 0.20 0.22 0.03 1.77 15.70 0.03 
 Spirochaetales Spirochaetaceae 
Spirochaeta 
0.03   0.07 0.06  0.03 1.77 2.37 0.03 
   
Treponema 
0.19 0.01 0.27 0.23 0.14 0.22  11.22 13.33 0.189 
Lentisphaerae   
Total sequences (%) 
     0.06     
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 Victivallaceae  Victivallis      0.06     
Fibrobacteres   Total sequences (%) 0.21 0.01   0.01 0.03 0.01 0.01 0.01  
 Fibrobacterales Fibrobacteraceae Fibrobacter 0.21 0.01   0.01 0.03 0.01 0.01 0.01  
Verrucomicrobia   Total sequences (%)    0.01       
 Opitutales Opitutaceae Opitutus    0.01       
Grey boxes indicate the sequences greater than 2% 
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Chapter 4 
 
Analysis of antibiotic and metal resistance genes in diverse bacteria 
of gastrointestinal tract of healthy dogs 
 
4.1 Abstract 
The problem of antimicrobial resistance is becoming a major concern in terms of 
treatment failures, economic losses and the inability to use antimicrobial agents. During the past 
two decades, the increase in the pet animal population and their close contact with humans has 
raised concerns regarding the transmission of resistant bacteria from pet animals to humans. 
Lack of surveillance programs makes evaluating the epidemiology of antimicrobial resistance in 
companion animals difficult. The present study determined the diversity of resistance genes in 
the fecal microbiota of healthy dogs. Using a spotted DNA microarray, we determined the 
presence of antibiotic and metal resistance genes in the fecal microbiota of 8 healthy dogs. Our 
microarray data revealed that the overall prevalence of antibiotic and metal resistance was low. 
Our results showed that among the antimicrobial agents, several tetracycline, erythromycin and 
aminoglycoside resistance genes were detected while among the metal resistance genes tested, 
four copper resistance genes were found. However, most of these originated from one of eight 
dogs that had history of antibiotic treatment for chronic skin disease one year prior to our 
sampling. 
Key words: microarray, healthy dogs, antibiotic and metal resistance genes 
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4.2 Introduction 
The occurrence of resistance to antimicrobial agents by pathogens and commensals is 
causing treatment failures in human and veterinary medicine. The cost associated with treating 
resistant bacterial infections in the U.S. is estimated to be $4 billion annually (McGowan et al., 
2001). The interaction of the antibiotics, microorganism, and host plays a role in the prevalence 
and persistence of antimicrobial resistance (Dowling, 1996). The resistant bacteria are 
maintained in the environment due to continuous selective pressure both by the routine use of 
antibiotics and by environmental conditions in which the co-selection of resistance genes and 
compensatory mutations occur due to the lack of fitness costs (Bjorkman et al., 2000). Thus, the 
development of multidrug resistant bacteria in turn directly reduces the clinical efficacy of the 
antimicrobial agents. This has led to the inability to use of some antimicrobial agents because 
their therapy has stopped being effective. The impact of antimicrobial resistance on clinical 
outcome varies depending on the level of resistance (at different hospitals and geographical 
areas) (Hidron et al., 2008), site of infection, and availability of novel or alternative therapeutic 
options (Rice 2009). Once they develop resistance to antimicrobial agents, the ability of bacteria 
to transmit their resistance genes to other bacteria or acquire new resistant determinants into their 
pre-existing conjugative element is alarming.  
Evidence suggests that commensal bacteria represent a reservoir of antimicrobial 
resistance genes (Salyers et al., 2004). The intestinal tract is considered the largest reservoir of 
commensal bacteria within the mammalian body (Berends et al., 2001). Furthermore, the gut is 
considered to be an ideal environment for the resistance gene transfer among bacteria (Lester et 
al., 2004; Scott 2002). The GIT of mammals is composed of a diverse population of microbes (> 
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10
14
) (Andremont, 2003) which colonize specific regions of the intestine. These enteric 
commensals can acquire or donate resistance among themselves as well as to other bacteria that 
enter the intestine through the fecal-oral route (Salyers et al., 2004). This resistant microbiota 
when excreted with feces may eventually be the potential source for resistance transfer to other 
mammals including humans. It has been suggested that investigating the antimicrobial resistance 
in commensals of healthy animals will be valuable in understanding their contribution to the 
increased antimicrobial resistance scenario, as they might be harboring resistance genes and 
under optimal conditions can transfer these genes to pathogenic bacteria (Guillemot et al., 2001). 
Due to the impact of the resistant bacteria on human and animal health, concerns have 
been expressed regarding the role of companion animals as a reservoir of resistant bacteria. The 
issue of antimicrobial resistance is becoming an emerging problem in these animals as well 
(Weese et al., 2008). Close contact and habitat sharing between humans and companion animals 
might serve as a source of resistant bacteria in humans (Clarke, 2006). Despite the increasing 
concern over this issue, only few studies have been carried out to evaluate the antimicrobial 
resistance in dogs in U.S. and most of the investigations were focused on Staphylococcus 
intermedius and Escherichia coli (Cohn et al., 2003; Rachal et al., 2009; Keefe et al., 2010). Till 
date no study has examined the diversity of resistance genes in the gut of the healthy dogs.  
With the recent advances in molecular techniques, several new approaches are available 
for the analysis of diverse microbial communities. A DNA microarray is a parallel detection 
system, which makes detecting thousands of genes simultaneously possible. Due to the 
availability of a large number of sequence data for antimicrobial resistance genes, this technique 
is well suited for identification of these genes (Call et al., 2003). A DNA microarray consists of 
thousands of gene specific spots containing conserved regions of the targeted genes. These gene 
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specific probes are immobilized by covalent attachment to solid surfaces such as glass slides. 
When the fluorescently labeled target DNA is added to the chip, binding and hybridization of the 
target DNA to the specific probe occurs. These hybridized targets are detected by the 
fluorescence of the reporter molecule (fluorescent dye having been added to the target DNA) 
emitted by laser excitation. The fluorescence intensity is then measured with a scanner. 
 In this study, we used a spotted DNA microarray to detect 227 antimicrobial resistance 
genes encoding 30 different antimicrobial agents and 99 metal resistance genes from healthy dog 
fecal samples using one sequence specific probe for each gene. Studying antimicrobial resistance 
in commensal bacteria provides information about different resistance mechanisms present in the 
bacteria that exist at the same site. The specific aims of this study were: (1) to identify antibiotic 
resistance genes and (2) to identify metal resistance genes.  
4.3 Materials and methods 
4.3.1 Collection of fecal samples 
Eight healthy dogs were included in this study. Fresh fecal samples were collected and 
used for analysis. 
4.3.2 Template DNA extraction 
Genomic DNA was extracted from 500 mg fecal sample using ZR soil Microbe DNA 
Kit
TM
 and its manufacturers recommended methods. The extracted DNA was purified using 
Geneclean Turbo kit (MP Biomedicals). The purified DNA (1µl) was quantified using Nanodrop 
ND-1000 spectrophotometer (Nanodrop technologies, Wilmington DE). The samples with DNA 
concentration 1.7-2.0 ng/µl were used for microarray analysis. This DNA was analyzed in the 
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laboratory at Department of Pathobiology, College of Veterinary Medicine, Kansas State 
University (Peterson et al., 2010). 
4.3.3 Preparation of labeled DNA 
4.3.3.1 Labeling 
Labeling of DNA was performed in amber tube, in a dark room using BioPrime Plus 
Array CGH Genomice Labeling System (Invitrogen Co., Carlsbad, CA) according to 
manufacturer‟s directions. DNA was labeled with Alexa Flour 555  via random priming using 
400U/µl Klenow fragment. Briefly, the reaction mixture consisted of 20µl Alexa Fluor 555, 1.5 
µg template DNA and adjusting the volume to 44 µl with sterile water. The labeling reaction 
mixture was incubated at 95°C for 10 minutes in heating block, and chilled on ice for 5 minutes. 
The reaction mixture was vortexed, and kept on the ice. This mixture was then subjected to 
extension with Klenow fragment by adding 10x nucleotide mix 555 (5µl), and Exo-Klenow 
fragment (1µl). After mixing and centrifugation, the reactions were carried out for 2 hours in a 
sealed film canister. 
4.3.3.2 Purification of labeled DNA 
Labeled DNA fragments were purified using Qiagen PCR purification column in the 
dark. This mixture present in the spin column was centrifuged for 1min at 10K x g and the flow-
through was discarded. 
4.3.3.3 Washing and elution 
Washing two times with washing buffer was performed in order to separate labeled DNA 
from the free dye. For this purpose 650µl washing buffer (available in the kit) with ethanol 
(100%) was added to the column. This was further followed by spinning and discard of flow-
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through. Then the columns were spinned with the caps opened for 3 min at 12K x g for drying 
the membrane. The washing step was followed by elution step where the column was transferred 
to a new amber tube and 15µl the elution buffer (10mM Tris HCl, pH 8.5) was added, incubated 
at room temperature for 1 min and centrifugation at 11K x g for 2 min. The amount of 
incorporated dye was quantified by using Nanodrop ND-100 spectrophotometer with microarray 
feature in order to determine the overall labeling efficiency. 
4.3.4 Microarray hybridization 
4.3.4.1 Slide preparation 
The microarray slides were printed by Genetix QArray2 System slide printer (Genetix, 
Hampshire, UK) crosslinked in a UV Stratlinker 2400. Each slide was printed with two identical 
fields. The array contained 489 oligonucleotide (70-mer) probes that consisted of 
227antimicrobial resistance genes conferring resistance to 30 antibiotics and 99 metal resistance 
genes. The slides were prehybridized by incubating at 42°C for one hour with shaking in the 
blocking solution (0.1% BSA; 5X SSC; 1% SDS) to block the nonspecific binding of the probe. 
The slides were spun dried by centrifugation at approximately 2200 x g. Finally, the elevated 
coverslips were applied over the oligo fields. 
4.3.4.2 Hybridization 
The labeled DNA was dried with a SpeedVac and the volume was adjusted to 14µl with 
water. Labeled DNA was mixed with equal volume of 2X hybridization mix (2%SDS; 30X SSC; 
50% formamide) and appropriate 25mer (1µl). The mixture was incubated at 80°C for 5 min, 
chilled on ice, spinned and applied to the slide under the coverslip. Hybridization was performed 
overnight in a chamber at 42°C. 
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4.3.4.3 Post hybridization washing 
Hybridized slides were transferred to the container containing wash 1 solution and were 
slightly agitated until the coverslips were floated off. Then the slides were washed for 10 min in 
each wash buffers: 10X SSC + 0.2% Sarkosyl; 10X SSC; 0.2X SSC at room temperature in the 
dark. After the last wash, the slides were immersed quickly in distilled water and spun dried. 
4.3.5 Data analysis 
A GenePix slide reader (Molecular Devices, Sunnyvale, CA) scanner with laser 
wavelength of 532 nm for Cy3 and 635 nm for Cy5 generated TIF images of the slide for 
analysis. The images were visualized and the software linked it to GenePix Array list (GAL) file 
created by the slide printer. This GAL file provides information about the layout and each feature 
within the block of microarray. The median pixel intensities were measured from each probe and 
the data were stored in the GenePix report (GPR) file. Finally, the average signal intensities for 
each probe were determined and used for further analysis. 
The data were analyzed by 3 methods: TIGR MultiExperiment viewer programe (TIGR, 
Rockville, MD), relative pathogen signal ratio (RPS) and Frye analysis.  
TIGR MultiExperiment viewer programe (TMeV) (TIGR, Rockville, MD) with one color 
setting is used for the analysis purpose. Briefly, the GPR file was uploaded and basic analysis 
were done by visualization of fluorescence intensity of the identified spots in order to get a quick 
overview of the sample. 
For RPS and Frye analysis, the GPR file data are uploaded in the Wildcat Fetch 1.0 
analysis programe. The output file obtained is the histogram with X-axis showing the genes and 
RPS or Frye ratios on the Y-axis. Based on the histogram, a threshold is determined and positive 
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or negative determinations are made. Based on the threshold value, the RPS and Frye analysis is 
performed.  
In the RPS analysis, the output file contains two sets of data for each gene i.e RPS data 
and RPS after PCV (Print control value) data. The RPS analysis data are obtained by dividing the 
average signal intensity measured for each probe by intensity of positive control probes (EUB 
and Frye 3).  
RPS data =   Average signal intensity of each probe 
                      Signal intensity of positive controls 
For RPS after PCV data, the average signal intensity measured for each probe is divided 
by PCV (Peterson et al., 2009).  
PCV = Mean of the median 25 mer signal of a particular spot 
           Mean of the median 25 mer signal of all spots on the chip 
RPS after PCV = Average signal intensity of each probe 
                                             PCV 
Generally, when RPS values were ≥ 0.25, the spot was scored positive.  
Further analysis was performed by Frye analysis, where also the output file consisted of 
two sets of data for each gene i.e Frye data and Frye after PCV data.  For Frye data, average 
signal intensity of each probe were divided by median value of hybridization intensity of all 70-
mer. When Frye ratio was ≥ twice the median value of hybridization intensity of all 70-mer, the 
hybridization was considered positive. 
Frye ratio =          Average signal intensity of each probe 
                      Median value of hybridization intensity of all 70-mer 
Frye after PCV were calculated by dividing Frye ratio by mean of the median 25 mer 
signal of all spots on the chip 
Frye after PCV =           Frye ratio 
                                           PCV 
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Generally, when Frye values were ≥ twice the median value of hybridization intensity of 
all 70-mer, the hybridization was considered positive. 
4.4 Results 
Of 8 dogs included in this study, none were associated with antibiotic exposure for at 
least 1 year prior to sample collection. All dogs were considered healthy by the owners during 
the time of fecal collection. To detect antibiotic resistance genes and metal resistance genes in 
diverse gut microbiota, we used a 70-mer oligonucleotide probe consisting of conserved regions 
(300-400bp) of the genes for screening canine fecal samples.  
4.4.1 Composition of antibiotic resistance genes in diverse fecal microbiota 
A microarray hybridization of genomic DNA extracted from the intestinal microbiota 
revealed the presence of several antimicrobial resistance (AMR) genes in the fecal samples. An 
overview of the result from the microarray array analysis is shown in Table 4.1. The microarray 
showed positive hybridization to probes corresponding to 10 different antimicrobial groups, e.g., 
tetracyclines, aminoglycosides, fluroquinilones, macrolides, streptogramins, lincosamide, beta-
lactams, glycopeptides, chloramphenicol and sulpha group drugs. Of 227 probes designed for 
different antibiotic resistance genes, 33 different resistance genes were detected in our samples. 
Most of the fecal samples (6 of 8) positive for antimicrobial resistance genes belonged to 
only two or three different groups of antibiotics except for the two samples (H-4 and H-10) in 
which the antimicrobial resistance genes belonged to ≥5 antibiotic groups.  
Sample H-1 and H-2 showed resistance to tetracycline antibiotic only. Resistance to 
aminoglycosides was observed in all the fecal samples, with the exception of sample, H-1 and H-
2. Macrolide resistance was detected in H-4 and H-7, and H-4 harbored most of the resistance 
genes. Dog H-10 was the only dog that showed positivity for fluroquinolone resistance gene, 
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parC. Beta-lactam and glycopeptides resistance determinants were observed only in H-4 and H-
10. 
Dog H-4 harbored most of the resistance determinants as compared to other dogs 
included in the study. Resistance to chloramphenicol, lincomycin, streptogramin, and 
sulphanilamide antibiotics were observed only in this sample. This dog harbored diverse 
resistance genes to macrolide, lincosamide, streptogramin, beta-lactam, tetracycline, 
aminoglycoside and glycopeptides.  
Each canine sample showed positivity for ≥2 antimicrobial resistance genes. Diverse 
resistance genes belonging to the same category were observed for the following antibiotics: 
macrolides, tetracycline, and aminoglycosides. Tetracycline was the only antibiotic against 
which resistance was detected in all samples with tet(O) as the most prevalent genotype. All 
tetracycline resistant samples harbored at least two tet genes. The tet genes tet(O), tet(C), and 
tet(Y) were detected in ≥ 50% of the samples. The aadE gene coding for putative 
aminoglycoside 6-adenyltransferase was the most prevalent aminoglycoside resistance 
determinant in our samples. 
4.4.2 Composition of metal resistance genes in diverse fecal microbiota 
Genes showing resistance to metals such as arsenic, cadmium, copper, cobalt/nickel, 
transferable copper, copper/zinc/cadmium and copper/silver (Table 4.2.) were detected by the 
corresponding oligonucleotide probes in the microarray. For the samples carrying metal 
resistance genes, most of them had one or two resistance genes, except the sample from dog H-4 
possessed 11 resistance genes conferring resistance to cadmium, copper, copper/zinc/cadmium, 
cobalt and transferrable copper.  
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Four of the fecal samples tested (H-3, H-5, H-7, and H-8) were negative for all of the 
metal resistance genes tested. Among the samples that were tested positive, H-1 and H-10 
harbored resistance determinant to only one metal, arsenic and cadmium, respectively. Copper 
and copper/zinc/cadmium resistance genes were present in sample H-2. Diverse resistance genes 
were detected for copper, and all of them were harbored by dog H-4. The gene, czcA2 copABCD 
conferring resistance to copper/zinc/cadmium was most prevalent (25%) among all the metal 
resistance genes identified in our samples. 
Table 4.3 shows the list of antimicrobial and metal resistance genes that were absent in 
our analyzed samples. 
4.5 Discussion 
The problem of antimicrobial resistance in bacteria is a global concern. The proliferation 
of these resistant bacteria can be driven by several factors. Studies have shown that genes 
conferring resistance to metals can play an important role in the dissemination of antimicrobial 
resistance genes (Summers, 2002). Multiple resistance genes encoding for metals and antibiotics 
are commonly localized together on the same mobile genetic elements such as plasmids and 
transposons conferring co-resistance (Summers, 2002). Sometimes cross resistance can also be 
observed in bacteria, in which a single enzyme can function as an efflux pump for both metals 
and antibiotics (Hayashi et al., 2000). In both cases, co-resistance and cross resistance, selection 
of one gene can result in the co-selection of other resistance genes in bacteria (Wright, 2007).  
The prevalence of antimicrobial resistance in commensal bacteria in various ecosystems 
suggests that commensal bacteria play an important role in the dissemination of antimicrobial 
resistance genes (Salyers, 2006). It is often proposed that food animals are responsible for the 
resistance development in humans through the transfer of resistant bacteria via food 
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(Guardabassi et al., 2004). But antimicrobial resistance in the commensal bacteria associated 
with pet animals with respect to the antibiotic resistance pool and its role in the horizontal gene 
transfer is not well known. In small animal veterinary practice, the antimicrobial agents used for 
therapy also include the ones that are liscensed for use in human medicine. Consequently, 
development of resistance in the commensals of these animals can pose a risk for the zoonotic 
transmission to humans. The transfer of variety of resistant bacteria and resistance genes from 
pets to humans has been reported (Manian, 2003). Hence, our overall objective was to determine 
the diversity of antibiotic and metal resistance genes in the healthy canine gut microbiota.  
It is a well known fact that there are several mechanisms by which bacteria can develop 
resistance to a particular antibiotic (Roe and Pillai, 2003). These resistance mechanisms are 
conferred by the alteration in the genes encoding the protein that is the antibiotic target site. 
Hence, several antimicrobial resistance genes are distributed among the bacteria conferring 
resistance to a single antibiotic group (Chopra and Roberts, 2001). Thus, the heterogenecity 
among the antimicrobial resistance genes makes the use of molecular techniques such as 
polymerase chain reaction (PCR) and southern blotting to detect resistance genes in a single 
isolate cumbersome and time consuming. Moreover, false-negative results can be obtained if any 
variants of the target genes are present (Cockerill III FR, 1999).  
Microarrays have been previously used for the detection of viruses and resistance 
determinants in bacteria. Microarray technology can be used for screening large amounts of 
genetic information simultaneously in a single assay. This technique can be used to detect the 
variety of genes harbored by any bacteria from the extracted DNA. In the present study, we used 
microarray analysis for a microarray containing 489 oligomers representing 227 antimicrobial 
and 99 metal resistance genes (Peterson et al., 2010) to determine the overall diversity of 
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antibiotic and metal resistance genes in the feces of healthy dogs. A microarray has an advantage 
over traditional PCR in that the identification of the target gene is based on its internal sequences 
and not on the length of the PCR product (Liu, 2009). Additionally, the microarray used in this 
study consisted of oligonucleotide probes (Peterson et al., 2010), which had the advantage of 
greater specificity than PCR probes (Kane et al., 2000). Several studies have been carried out in 
which DNA microarray has been used to detect the resistance genes in bacteria (Call et al., 2003; 
Frye et al., 2006; Monecke et al., 2003; Van Hoek et al., 2005). Call et al., (2003) developed a 
DNA microarray for the detection of diverse tetracycline resistance genes. A DNA microarray 
for the detection of genes conferring resistance to macrolide, lincosamide and streptogramin 
antibiotics was developed by Cassone et al., (2006). The assay we used was based on the direct 
detection of the genes using a single fluorescence dye.  
Based on the microarray results of the eight samples tested, all samples were identified as 
having resistance to at least one antibiotic. The overall prevalence of resistance genes was low in 
the healthy animals. Diversity among resistance genes was observed for the antibiotics: 
tetracycline, macrolide and aminoglycosides. Most of the resistance genes for antibiotics and 
metals were harbored by the sample H-4. According to the information obtained from the owner, 
this dog had a history of skin problems and had been on antibiotic therapy (gentamicin, 
neomycin, polymyxin B sulphate, cephalexin) several times two years before the sample was 
collected. This may be a possible explanation for the presence of most of the resistance genes we 
found in the fecal microbiota of dog H-4. It also indicates long lasting effects of antibiotic 
treatment on the gut microbiota. 
The high prevalence of tetracycline resistance observed in our samples is not surprising, 
since widespread use of this antibiotic has contributed to high rates of resistance (Roberts, 1996). 
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The PCR analysis for tetracycline resistance genes from the fecal enterococcal isolates (results 
from Chapter 2) correlated with the microarray profile for tetracycline resistance genes. Two of 
our samples were positive for glycopeptides resistance genes, vanD and vanH. However, vanD 
gene is located on the chromosome and is not self transferrable (Depardieu et al., 2003). Multiple 
resistance genes in combination are required for vancomycin resistance, and vanH is one gene 
that encodes for an enzyme that is essential for resistance (Murray, 1998). 
However, further verification of all of the positive resistance genes needs to be done with 
a PCR assay to confirm the microarray results. Moreover, one of the drawbacks of this approach 
is the detection limit. Without enrichment of the samples, the detection limit of the microarray 
assay used in this study is 10
9
 CFU/g of the fecal material (Peterson et al., 2009). In the present 
study the samples were analyzed without enrichment. Hence, the presence of resistance genes in 
low abundances probably has not been detected. To our knowledge this is the first reported 
instance of antibiotic and metal resistance in healthy dog fecal samples tested with DNA 
microarray. 
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4.6 Conclusion 
Antimicrobial use is often considered as the reason for the emergence and dissemination 
of resistant bacteria, thus posing a potential public health hazard. Indeed, the natural inhabitants 
of the GIT of healthy animals are known to harbor resistance genes (van den Bogaard, and 
Stobberingh, 1999; Witte, 2000). The gut commensals can acquire or donate the resistant 
determinants among themselves or among the bacteria that enter the intestine through the fecal-
oral route (Salyers et al., 2004). Food animals are often considered as the source for the resistant 
bacteria and transfer of these bacteria to humans is considered to be via food chain or direct 
contact (Kruse, 1999). In contrast to the food animals, the role of companion animals as a 
reservoir of antimicrobial resistance genes has not been explored. Close physical contact and 
common habitat sharing among the pets and their owners can increase owners at the risk of 
acquisition of resistant genes harbored by resistant bacteria from pet animals. There are reports 
indicating that resistant Staphylococcus spp can be transferred from small animal pets to humans 
via contact (Clarke, 2006). 
The present study was undertaken to assess the overall diversity of antibiotic and metal 
resistance genes in the fecal microbiota of healthy dogs using microarray analysis. Genes 
conferring resistance to chloramphenicol, macrolide, lincomycin, streptogramins, 
fluoroquinolones, beta-lactams, sulpha drugs, tetracycline, aminoglycosides, and glycopeptides 
were detected and most of them originated from the dog sample H-4. Among the metal resistance 
genes tested, the fecal samples were positive for the following metals: cobalt/nickel, copper, 
copper/silver, arsenic, cadmium, and copper/zinc/cadmium. However, most of them originated 
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from the dog H-4. Thus, the overall prevalence of antibiotic resistance genes harbored by the 
healthy dogs was low except for one dog that was positive for most of the resistance genes. 
To our knowledge, this is the first report to study the diverse antimicrobial and metal 
resistance genes in the gut of healthy dogs using microarray. The results obtained in this study 
provide the baseline information on the diversity of antimicrobial resistance genes in the fecal 
microbiota of healthy dogs. The data show that healthy dogs do not represent an important 
reservoir of resistance genes and consequently public health risks.  
204 
 
4.7 Figures and Tables 
 
 
Figure 4.1 Principle of DNA microarray 
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Table 4.1  Microarray analysis for detection of antibiotic resistance and metal resistance  
      genes 
Samples # H-1 H-2 H-3 H-4 
 
H-5 H-7 H-8 
 
H-10 
Chloramphenicol         
   catQ           
Macrolide         
   ereB         
   erm(TM)2         
   ermX         
   mef(A/E)         
Lincomycin         
   linA         
   carA         
Streptogramins         
   sat(G) vat(E-8)         
   vat(B)         
Fluroquinilones         
   parC         
Beta-lactams         
   bla2         
   blaZ         
   ccrB         
   penA         
Trimethoprim         
   dfrA1 2         
Sulphanilamide         
   sulII         
Tetracycline         
   tetC         
   tetD         
   tetM         
   tetO         
   tet37         
   tetY         
   tet31         
   tetR         
   tet38         
   tetA         
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Aminoglycosides         
   aadE         
   aac(6)-Ib*         
   aac(6)-Im         
   ant(4)-Ia         
   aphA-3         
Glycopeptides         
   vanD         
   vanH         
 Filled block (      ), positive; blank block (       ), negative 
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Table 4.2  Microarray analysis for detection of metal resistance genes 
Samples # H-1 H-2 H-3 H-4 
 
H-5 H-7 H-8 
 
H-10 
METALS         
Arsenic         
arsD           
Cadmiun         
cadD3         
cadD4         
Copper         
cusA         
cusB         
cusF         
cusS         
Copper/Zinc/Cadmium         
czcA2 copABCD         
Cobalt/Nickel         
cnrB         
Transferable copper         
tcrB         
Filled block (      ), positive; blank block (       ), negative 
208 
 
 
 
Table 4.3  Microarray analysis: Samples negative for the following resistance genes  
Antibiotic groups Resistance genes 
Chloramphenicol cat(TC), cat(B), cat(DP1), cat(S), cat-4, cat(P), flo ,cat-86, catp(XX), cfr, cat(DPS), cat(LM), cat(TC), 
cat(B) 
Macrolide erm(TR), ere(A), ere(A2), ere(B), erm(A), erm(B), erm(C), erm(D), erm(F), erm(G), ermQ, ermT, 
erm(TR)2, ermY, erm(BCT), ole(B), ole(C), srm(B), tlc(C), mef(A), mef(B), msr(A), mph(K), mph(B), 
mph(A), mph(BM) 
Lincosamide lmr(A), lin(A)2, lnu(A), lnu(B), lin(B) 
Streptogramins  vga(A), vat(C), sat(A), sat(G), sat4, vgb(A), vgb(B), vat(A), vat(D), vat(E), vga(B) 
Beta-lactam ccr(B), pbp4 , mec(A), mec(A-2),  
Rifamycin arr-3 
Streptothricin sat(4) 
Tetracycline tet(B), tet(E), tet(G), tet(H), tet(J), tet(K), tet(L), tet(AP), tet(U), tet(V), otr(C), tcr, tet(BP), tet(Q), tet(S), 
tet(T), tet(32), tet(36), otr(A), tet(X), tet(Z), tet(W), tet(30), tet(33), tet(35), tet(34), tet(39) 
Glycopeptides ble, van(A), van(B2), van(D), van(E), van(G), van(H),  
van(R), van(X), van(Y) 
Sulpha drugs sulII, dfr(A), dfr(D) 
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Microarray analysis: Samples negative for the following resistance genes (cont.) 
 
Metals Resistance genes 
Quaternary ammonium qac 
Aluminium BnALMT2, BnALMT1, yba(X) 
Arsenic ars(G), ars(B), ars(C), ars(H), ars(R) 
Cadmium cad(A), cad(D2), cad(D), col(R) col(S) 
Chromate cys(A) 
Cobalt/Nickel cnr(A), cnr(B), cnr(C), cnr(H), cnr(T), cnr(X), cnr(Y), ncr(A),ncr(B), yoh(M) 
Copper cop(B), cop(C), cop(D), cop(P), cue(O), cue(R), pco(B), pco(C), pco(D), pco(R), pco(S) 
Copper/Silver cus(C) 
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